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For my Grandparents
Don't Quit
When things go wrong as they sometime will 
When the road you're trudging seems all uphill. 
When funds are low and debts are high 
You want to smile but have to sigh.
When care is pressing you down a bit 
Rest if you must but don't you quit.
Life is queer with its twists and turns 
As every one of us sometimes learns.
And many a failure turns about 
When he might have won had he stuck it out. 
Don't give up though the pace seems slow 
You may succeed with another blow.
Often the goal is nearer than 
It seems to a faltering man.
Often the struggler has given up 
When he might have captured the winner's cup 
And he learned too late when the night slipped down 
How close he was to the golden crown.
Success is failure inside out.
The silver lining of the clouds of doubt 
You can never tell how close you are 
It may be near when it seems so far.
So stick to the fight when you're hardest hit 
It's when things seem worse that you mustn't quit.
Unknown Author
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Abstract
Objective
Pyruvate dehydrogenase (PDH) is a multienzyme complex situated on the inner mitochondrial 
membrane. Its principal function is to catalyze the irreversible oxidation of pyruvate to acetyl 
Co A. PDH is activated by a compound known as dichloroacetate (DCA). The principal 
metabolic effect of DCA administration is an increased availability of acetyl-CoA and 
acetylcarnitine for substrate phosphorylation, and a lowering of blood [lactate]. Studies using 
DCA during exercise have identified the availability of these acetyl groups as a major 
determinant of VO 2  increase at the start of exercise, suggesting a functional stenosis to VOj 
may reside at the level of PDH. It was the aim of these studies to further investigate whether 
DCA has an effect on the rate and magnitude of the VO 2  response for sub-maximal and 
maximal work intensities.
Procedures
A ramped incremental exercise protocol and 2 sub-maximal constant exercise protocols were 
undertaken on a cycle ergometer. The constant work protocols were undertaken at work 
intensities above and below that corresponding to the individual blood lactate threshold.
Measures of breath-by-breath POg and heart rate were made in conjunction with measures of 
muscle oxygen saturation (NIRS) and blood borne indices (Lactate, pH, Glucose, 
Bicarbonate). VO 2  kinetics were estimated using non-linear least squares regression 
strategies.
Results
Dichloroacetate had no significant effect on submaximal oxygen uptake. This was evidenced 
as no change in the amplitude or time course of the kinetic response during exercise above or 
below the lactate threshold, and no change in the slow component response above the lactate 
threshold. DCA administration did promote a small but significant increase inPD^max •
Blood [Lactate] was reduced at submaximal exercise intensities. However, no significant 
difference was evident during maximal exercise. DCA was shown to have chronotropic 
properties evident by an observed increase in heart rate at rest and during the initial stages of 
exercise.
Conclusions
The present studies clearly illustrate a haemodynamic response to DCA that has not been 
described previously. Control of oxygen uptake kinetics at the level of pyruvate 
dehydrogenase is not supported by this work.
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steady slate. For work rates betw een 0L  and CP, VO2 stabilises at a value higher than 
that predicted from  the underly ing exponential (dashed line). For h igher w ork rates,
VO2 does not stabilise but attains • R ight panel: E quivalent profiles o f  blood
[lactate] responses; note the sustained elevation  for work rates betw een 0L  and CP, but 
the progressive increase for supra-C P  w ork rates (taken from W hipp, 1994).
4. U pper diagram : The pow er-duration  relationship  for high intensity exercise. Low er 10
diagram : D eterm ination  o f  param eters W ’ and > P^L from  the linear P -  1/t
form ulation. 0]^ ;. is the estim ated lactate threshold using the ‘V -slope’ (V entilatory 
threshold) m ethod described by B eaver et a i  (1986). (Poole et al., 1988).
5. T em poral response o f oxygen uptake {VO^}  response to m oderate square-w ave 14
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disease (top right; taken by W hipp  and W ard, 1990; from S tie tsem a et al., 1986) and a 
patient w ith chronic obstructive pulm onary  diease (C O PD ) (bottom  right; taken by 
W hipp and W ard, 1990; from N ery et al., 1987).
6. (A) Pattern o f oxygen uptake ( V 0 3  response to a square wave change in w ork rate o f 15
m oderate intensity. (B ) T raditional view  w here VO^ rises m ono-exponentially  w ithout
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is also accounted for. (C) PO, response div ided into three phases (refer to text for 
further explanation). (D ) estim ation  o f  ‘m ean tissue O? consum ption’ (B arstow  et al.,
1990).
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forcing (exercise undertaken at a w ork intensity  below  the lactate threshold). The
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(W hipp and W asserm an, 1972).
9. Schem atic system  input/ou tpu t relationship . A ssum ing that m uscle oxygen uptake in 22
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stim ulus (Lam arra, 1990).
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10. G raph illustrating the relationship  betw een  oxygen uptake and w alking speed for tw o 23
subjects from  the early  w ork o f  H ill and Lupton (1923). N ote the linear relationship  
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increases, ÿ o ,  rises to, or tow ard, a m axim um  value (W hipp, 1994, m odified from
B oston et al., 1987).
13. Schem atic representation  o f the O 2 uptake (V O j)  response to constant-load exercise 31
at d ifferent w ork intensities. (W hipp and W ard, 1993).
14. G raph show ing an averaged VO, response to ‘heavy’ exercise. T he m odel indicates a 32
double exponential function w ith separate tim e delays, to characterise both the early
VO, response and the slow  com ponent independently  (B earden and M offat, 2000).
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coupled to ex tram itochondrial A TP hydrolysis in m uscle. D ashed lines indicate 
diffusion (M ahler, 1985).
19. Schem atic d iagram  illustrating a series o f m oiety conserved cycles associated with 48
energy m etabolism . B row n (1992) suggests that the rate o f energy m etabolism  can
be controlled at either end o f the pathw ay or in the m iddle. T he role o f calcium  in 
stim ulating  m uscle contraction , m atrix  dehydrogenases and possib le indirectly the 
synthase and respiratory chains is also show n (from  B row n, 1992).
20. Site o f  action o f D CA . T he PD H  com ponent o f  the pyruvate dehydrogenase com plex 58
is reversibly phosphorylated , and inactivated, by PD H  kinase. D C A  inhibits the
kinase, thereby m aintaining PD H  in its unphosphorylated, active form  (from  
Stacpoole, 1989).
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25. T he effect o f  the superposition  process on a data set. The red and blue open triangles 97
represent the actual collected  data. T he open circles represent the data after the 
superposition  process. Superposition  allow s data from a num ber o f  repeat collections
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m odel can be fit to the data (L am arra et al, 1987).
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28. G as exchange plots used for the estim ation  o f  the lactate threshold. A single 110
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Introduction
Chapter 1
1.0 Introduction
Since the end of the 19^ *’ century, m easurem ent of inspired and expired gases and 
calculation o f the gas exchange for oxygen has been used as a measurement of 
pulm onary oxygen uptake. W ith advances in technology, these calculations can now be 
reliably performed over a single breath.
Breath-by-breath m easurem ent in response to dynamic work rate forcing functions has 
led to the characterisation of consistent tem poral patterns o f response in pulmonary 
oxygen uptake. Furthermore, the fundam ental VO 2  kinetic response has shown to be a 
close approxim ation to that of muscle oxygen consum ption {QmusO^), and it presents 
an opportunity to infer readily and reliably the metabolic adaptation to changes in 
energetic demand (Barstow et a l ,  1990; Grassi et a l ,  1996; W hipp et a l ,  1982).
M uscle oxygen uptake increases in response to an augmented energetic requirem ent, to 
sustain m uscle contraction and cell hom eostasis. A ppropriate modelling and 
interpretation of the pulmonary VO^ response profile to a work rate forcing can express 
the characteristics of this underlying system  response and ensure the inferences made 
are not unfounded.
Arm ed with an understanding of the “norm al” or “typical” VO 2  response to exercise, it 
is possible to investigate m odulators of this response. Inferences can then be made as to
the putative m echanism  or m echanism s that may be controlling the adaptation to a 
change in energy demand.
M USCLE 0 2   ^ CO2 VENTILATION 
ACT! VIT Y TRANSPORT t 9 a  +  Vd » Ve )
Vcoj
LungsH eartBloodMuscle
QOa
Physiological onate  f s v  Recruit tV r
Responses:
tO o z  R ecruit tH R  Dilote i f
Figure. } - D iagram  illustrating  the gas transport system  for coupling cellu lar to pulm onary  respiration. 
T he gears represent functionally  independent, in terlocked com ponents o f  the system . An increase in O 2 
utilisation by the m uscles is met by an increased extraction  o f O? from each o f  the links in the oxygen 
transport system  (from  W asserm an et al, 1987).
The respiratory system, the cardiovascular system and the exercising muscle cells are 
functionally interlocked and interacting system s that transport oxygen from  the lungs to 
the muscle to support aerobic ATP resynthesis. This allows oxidative phosphorylation 
and m uscular work to continue (fig .l). D isruption of any com ponent of these systems 
can lead to an alteration in the gas exchange response and affect the efficiency and 
relative intensity of the m uscular work performed. For example the m uscular work 
performed as a large part o f everyday life ean in the diseased state, where the capacity 
to perform  exercise can be severely lim ited, prove to be a major barrier to improving 
quality of life and long term  health prospects. Conversely, in an athletic population, an 
improved performance may lie in understanding how the key com ponents govern the 
exercise response and how these com ponents respond to training.
Therefore further understanding of the m echanism (s) governing the VO^ response to 
exercise may have significant impact in health and disease.
1.2 Exercise Intensity Dom ains
The importance o f appropriately describing the intensity o f exercise when discussing 
oxygen uptake kinetics will become clear in the following chapter. Four recognised but 
not undisputed intensity domains, M oderate, Heavy, Very Heavy and Severe (W hipp, 
1996) are the preferred method of description for the study of VO^ kinetics. The gas 
exchange and m etabolic (blood lactate and pH changes) responses to constant ‘square 
w ave’ exercise are distinct for each. Therefore these measures provide a basis for 
defining the intensity of the exercise.
The range of work rates that do not result in a sustained increase in arterial blood lactate 
concentration and subsequently decrease arterial pH is termed the ‘m oderate’ domain 
i.e. the work is being undertaken below the lactate threshold. In this region, VO^ will 
increase to a steady state value in approxim ately 3 min, in response to a step change in 
exercise workload. An individual, in good health, exercising in this dom ain should feel 
no great discom fort in his/her breathing or any great tiredness in his/her legs (fig. 2 ).
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Figure 2  ~ A  schem atic represen tation  o f the tem poral response o f V O 2 to constant-load ‘square w ave’
exercise at d ifferent w ork intensities. A [L‘] =  change in blood lactate. A [ L ' ] =  change o f rate o f change 
in blood lactate. A =  change in hydrogen ion concentration. A [ / / '* ']  = change o f rale o f  change in 
hydrogen ion concentration. M oderate: below  0 l; there are no sustained increases in [L ] or [H^]. V O 2  
reaches a steady state. H eavy: above 9 l; V O 2  reaches a steady-state but w ith a delayed tim e course. 
Increases in [L ] and [H^] are sustained. V ery Heavy: above 0 l; V O 2  eventually  reaches a m axim um  
due to the contribution o f  the ‘excess Severe: supra-m axim al (i.e. W R  above an increm ental
WR,n„x) w ork rate where fatigue occurs so rapid ly  that the ‘excess V O 2  ’ has not had lim e to develop 
discernibly. indicates V O j  m a x . T he term  0 2 D ef is described in section 1.5 (from  W hipp, 1996).
During ‘heavy’ intensity exercise there is a sustained increase in arterial blood lactate 
and a sustained decrease in arterial pH. The responses in both stabilise or even decline. 
Exercise in this domain has therefore exceeded the lactate threshold. VO 2  in this domain 
can reach a steady state, the attainm ent of this steady state is however delayed by as 
much as 10-15 minutes (Poole et al., 1991, Ozyener et a i ,  2001).
Arterial blood lactate and arterial pH changes do not stabilise in the ‘very heavy’ 
exercise domain. They both increase throughout the duration o f the exercise to a 
maximum . The end point to a continuous exercise protocol in this dom ain is fatigue, 
with high levels of dyspnoea and tiredness in the legs evident. VO 2  follows a sim ilar 
response to lactate in that it fails to stabilise i.e. a steady state is not reached. From the 
start of exercise VO 2  continues to rise throughout until the m axim um  ) is
reached (fig. 2).
The ‘severe’ domain is the range of work rates above the m axim um  achieved by an 
individual during an incremental exercise protocol to exhaustion These are
term ed supra-maximal work rates as the m axim um  associated with an incremental test 
can be superseded during shorter duration ‘square w ave’ or intermittent work. Peak 
arterial lactate values and decreased arterial pH are associated with severe leg fatigue 
and very heavy breathing in the severe domain. VO 2 increases rapidly to FDsmax ^.nd
predictably does not reach a steady state. Fatigue ensues and work rates can only be 
m aintained for short periods (fig. 2).
The advantage of assigning exercise intensity in this way is that each domain reflects 
distinct physiological responses. These responses are functionally sim ilar across
individuals, in that they are bound by param eters that adapt to proportional changes in 
aerobic and anaerobic responses to stim uli such as training or disease.
A ssigning exercise intensity in this way is more appropriate than using the more 
com m only used percentage of m axim um  as each domain describes better the expected 
physiological demands and responses. For example a work rate assigned as a 
percentage of m axim um  oxygen uptake will be im possible to maintain as a
constant if the work rate lies within the very heavy or severe domain. The
inability of the VO^ response to reach a steady state in these domains means that a 
percentage of is not sustainable.
1.3 Critical Power
Critical power is functionally significant because it corresponds to the highest W R at 
which a VO 2  steady state can be attained (Poole et al, 1990., Hill et al, 2002) and 
coincides with the highest W R at which arterial [L‘] and [H"^ ] do not continue to rise 
throughout the work (Poole et al., 1988) i.e. it represents the border between the ‘heavy’ 
and ‘very heavy’ exercise dom ains (fig. 3).
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In their early work Hill and Lupton (1923) described a level of exercise where lactic 
acid and VO 2  continued to rise throughout exercise until fatigue set in. M argaria et al 
(1965) stated that this rise to is achieved progressively faster with increasing
work rate, a finding later supported by W asserm an et al (1967) and W hipp (1994). It 
has been clearly shown that there is a range of work rates where VOj cannot stabilise 
and continues to rise until is reached and fatigue ensues, fig. 3 (Poole et al.,
1988). This dem arcation point for VO 2  from a sustainable steady-state has been termed 
critical power (M oritani et a l ,  1981) for cycle ergometry or the ‘fatigue threshold’ 
(Hughson et al., 1984) for treadmill running and ‘critical velocity’ for swimm ing 
(W akayoshi er n/., 1992).
This relationship between power (?) and time to fatigue (t) has been well described by a 
num ber of authors as a hyperbolic function (M onod and Scherer, 1965; M oritani et al., 
1981; Hughson et al., 1984; Poole et al., 1988; Poole et a l ,  1990; M iura et al., 2002), 
sim ilar to equation 1.
( P - C p ) - t - = W '
Eqn 1.
W here Cp (or Pll in fig. 4) is the power asymptote termed ‘critical pow er’ and W ’ is the 
curvature constant (fig. 4). This relationship is often transferred into its linear 
form ulation (W hipp et a l ,  1982; Poole et a l ,  1988; Hill, 1993);
P = { W 'i t )  + Cp
where W ’ and Cp are the slope and intercept respectively (fig. 4).
Eqn 2.
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Figure 4 - U pper diagram : The pow er-duration  relationship  for high intensity  exercise. L ow er diagram : 
D eterm ination o f  param eters W ’ and > P l l  from the linear P -  1/t form ulation. 0|ae is the estim ated 
lactate threshold using the ‘V -slope’ (V entilatory threshold) m ethod described by B eaver et a l  (1986). 
(Poole et al., 1988).
1 0
Poole et al (1988) and W hipp and W ard (1990) have described the curvature constant 
param eter W ’ as an equivalent to a constant amount of work that can be perform ed 
above Cp regardless of the rate at which it is performed. Therefore in this region VO 2  
becomes a function of both time and power and the relationship between work rate and 
VO 2  (refer to section 1.8.2.) is discontinued.
At work rates below critical pow er-‘m oderate’ and ‘heavy’ domains- VO 2  is able to 
sustain a steady state. Therefore Cp represents, in theoretical terms, the upper limit for 
continuous constant load exercise of almost indefinite duration (Moritani et a., 1981) 
i.e. ATP resynthesis can be met by the transport and utilisation of oxygen. In practice 
this is not quite realised as the sim ple hyperbolic relationship between power and time 
breaks down for very long or very short exercise (for review see Hill, 1993).
Poole et al (1988) found Cp to lie on average at approxim ately 70% of maximal work 
rate (from a standard incremental work test) or 46% of the difference between the work 
rate corresponding to an estim ated lactate threshold and work rate max. However Poole 
et al (1990) demonstrated that Cp is a trainable parameter, showing a 10% improvement 
in Cp after 7 weeks of endurance training. This finding was supported by Jenkins and 
Quigley (1992) who showed a 30 % increase in Cp after 8 weeks of endurance training.
Therefore Cp is an important ‘threshold’ when regarding exercise intensity, one that is 
not immovable and appears to be closely linked to factors that respond to endurance 
training i.e. blood [Lactate] and acidosis (Poole et a l ,  1988).
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1.4 Sub-threshold V O 2 kinetics
W hen regarding the temporal response of VO 2  to a change in exercise intensity it is 
beneficial to contem plate first the factors influencing oxygen uptake at the lung.
Fundam entally, pulmonary VO 2  is well described by the rate at which partially reduced 
haemoglobin enters the pulmonary capillary bed. The affinity o f haemoglobin to bind 
oxygen is governed by a num ber of factors (i.e. pH, temp., ). Its delivery in to the
lung is a function of the pulmonary blood flow Qp {Qp = Cardiac output in healthy 
individuals) and the mixed venous oxygen content (C vO j). These variables can be 
related by the Pick equation for m easuring cardiac output, rearranged here in terms of 
pulmonary VO 2 '.
VO2 =Qp{Ca02-Cv02)
Eqn 3.
Here CaO? denotes arterial oxygen content.
W ith this relationship in mind let us consider three recognised ‘phases’ (W hipp et ai ,  
1982) o f the temporal VOj response to a step change in work rate within the moderate 
domain.
1 2
1.4.1 Phase 1*
At the onset of constant-load exercise there is an initial rapid increase in VO 2  that has 
been termed “Phase 1” (^d) (W hipp et a i ,  1982). This initial increase is thought to be 
dom inated by changes in cardiac output since the effect of any change in muscle 
m etabolism  on CvO^, will not be expressed as a change in VO 2  until the muscle venous 
effluent has passed to the lung vasculature. An increase in cardiac output at the onset of 
exercise, predom inantly due to an increased stroke volume, results in an increase in 
pulm onary blood flow ( Qp )  and hence an increase in VO2  (Eqn. 3). The nature of the 
increase in VO 2  during this initial phase has led to it being described as 
cardiodynam ically mediated (W hipp et a l ,  1982).
This phase of the response was theoretically proposed by Krogh and Linahard in 1912, 
however direct m easurem ent was only established in 1966 by Achincloss et al who 
directly recorded an increase in VO 2  from the onset of exercise. The rapid increase in 
VO 2  can account for up to 50% of the VO 2  response in this domain and is essentially 
invariant with respect to the m agnitude o f the step in work rate (W eissman et a i ,  1982). 
Support for the cardiodynam ic nature of this early response has come from a 
demonstration of proportionality between the early VO 2  and Qp responses (Cummin et 
al., 1986 and M iyam oto et al., 1982). Furthermore, factors affecting pulmonary blood 
flow at the onset of exercise have been shown to modulate the rate and magnitude of the 
VO 2  response. Attenuation of the size of the change in stroke volume at exercise onset 
by perform ing the exercise from a background of unloaded pedalling (W hipp et al., 
1982) or in a supine position (W eiber-Ravell et al., 1983; Karls son et al, 1975) have
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both been shown to evoke a sim ilar attenuation of (|)I VOj response. Stietsem a et al
(1986) demonstrated a dim inished c{)I VO 2  response in patients with cyanotic congenital
heart disease, a disease that results in little or no increase in pulm onary blood flow at 
the onset of exercise (fig. 5. U pper graphs). A sim ilar finding has been found in 
patients with chronic obstructive pulm onary disease (COPD) (Nery et rï/.,1982) (fig. 5. 
Low er graphs).
CO N TRO L CA R D IA C
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Figure  5 - T em poral response o f oxygen uptake ( U O j )  response to m oderate square-w ave exercise 
perform ed from a background o f  unloaded pedalling  for a patient with cardiac disease (top right; taken by 
W hipp and W ard, 1990; from  S tietsem a et al.,  1986) and a patient w ith chronic obstructive pulm onary 
diease (C O PD ) (bottom  right; taken by W hipp and W ard, 1990; from N ery et al. , 1982).
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1.4.2 ‘Phase II’
After the initial rapid increase during phase one, VO 2  continues to rise in a m ono­
exponential fashion until it reaches a plateau (Henry, 1951; Davies, 1972; Di-Pram pero, 
1970; Linnarsson, 1974; W hipp, 1971; W asserm an and W hipp, 1974; Hughson and 
M orrissey, 1982; O zeyner et al., 2001). A widening of the arterial-venous oxygen 
difference is the dom inant factor m odulating pulmonary VO^ during this phase; i.e. 
CaOz remains constant at the onset of exercise while muscle venous and subsequently 
m ixed venous oxygen content decrease. This additional component to gas exchange 
only exerts an influence once the vascular transit delay from muscle to lung has passed. 
The temporal dom ain within which these changes take place has been term ed “phase 2” 
{(})II) (W hipp et a l ,  1982; fig. 6, panel C).
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Figure 6 - (A) Pattern o f oxygen uptake { V O 2 ) response to a square w ave change in w ork rate o f 
m oderate intensity. (B ) T raditional view  w here V O ^  rises m ono-exponentially  w ithout delay; the venous
0 2 -stores (AVs, O 2) and a transient lactate 02 -equivalen t (Vem O 2 ) is also accounted for. (C) V O 2  
response divided into three phases (refer to text for further explanation). (D) estim ation o f ‘m ean tissue 
O 2 consum ption’. N ote that B and D lead to obligatory conclusion that V O 2  kinetics are slow er than 
m uscle oxygen uptake k inetics (B arstow  et a i ,  1990).
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In their pioneering work Krogh and Lindhard (1912) proposed that there would be a 
delay of at least 6-10 s before venous blood leaving the muscle reached the lung and 
that any changes in ventilation or gas exchange prior to this would be as a result of 
changes \nQ p .  This transit delay o f mixed venous blood from the muscle to the lung 
has subsequently been dem onstrated to be in the order o f 10-15 s (Cerretelli et al., 
1966).
The muscle oxygen consum ption (QO^ ) response to moderate exercise in isolated 
m uscle preparations has been shown to follow a m ono-exponential rise from the onset 
of exercise with little, or no, delay (M ahler, 1985). Similarly the phase II rise in 
pulmonary can be characterised by an exponential o f the form:
A r à „ „  =A V O „,„,(l
Eqn 4.
W here represents the pulmonary oxygen uptake above baseline any time (t)
after the onset of exercise, is the steady-increm ent, and k  is the rate constant of
the reaction (W hipp, 1971). The slope of the VO 2  response is given by the rate constant 
k. The faster the response is, the greater the value of k.
W hen describing the (|)II VOj response the rate of increase in VO 2  is often used.
Com m only however the param eter referred to is the time constant o f the response (t). 
The time constant is the reciprocal of the rate constant i.e. l//c. For a first-order system, 
one time constant represents the time taken to reach 63% of the steady state response. 
A long time constant represents a slow response, a short time constant represents a
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faster response. Similarly the half time for the response is often quoted and the three 
param eters are related thus (x = 1/k = t l /2  / 0.693).
The exponential nature o f the pulm onary VO^ response was described in the early work 
o f Henry (1951) and Henry and De M oor (1956) (fig. 7). M argaria et al (1965) first 
described this time course as a m onoexponential function with a half time of about 30s. 
Their work has subsequently found support for moderate intensity exercise (Cerretelli et 
al., 1966; Davies et a l ,  1972; W hipp, 1971; W hipp and W asserman, 1972; Linnarsson, 
1974; Hagberg, 1978; W hipp et al., 1982; Ozeyner et al., 2001). The time constant for 
the VO 2  response (ZVO 2 ) in a young healthy adult is typically approxim ately 20-40 s 
(W hipp, 1971; W hipp and W asserman, 1972; Davies et al., 1972; Bakker et al., 1980; 
W hipp and W ard, 1980; W hipp et al., 1982; Hughson and M orrissey, 1982). W hipp 
and M ahler (1980) reported invariance in W O 2  for different work rate changes in the 
moderate domain. H ow ever it does tend to be shorter in trained subjects (Hagberg et 
al., 1980), and longer in elderly sendentary subjects (Babcock et al., 1994) and patients 
with cardiorespiratory disease (Puente-M aestu et al., 2001).
EXERCISE RECOVERY
EX ERCISE
E X E R C IS E R E C O V E R Y
2 3-0 IT I M E  (MIN)
Figure  7 — Early w ork by H enry, (1950) show ing the V O 2  k inetics fo r both the on and o ff transient 
using 15 s D ouglas bag sam pling. T he m ono-exponetial characteristic o f  the responses is clearly  show n.
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The m ono-exponentiality o f the QmusO^ response as dem onstrated by M ahler, M. 
(1985) and M eyer (1988) is sim ilar to, yet not exactly, that that is expressed as VO 2  
during ‘phase IF. This is due to the value o f established at the muscle being
associated with a higher blood flow by the time it is expressed at the lung i.e. blood 
flow will have increased during the m uscle to lung transit time. However, Barstow et al 
(1990) modelled the relationship between an increase in Qmus02  and the subsequent 
increase in pulmonary VO 2 . They found that the time constant for muscle oxygen 
uptake was likely to be less than 10% different fro m rF O j. Grassi et al (1996), by 
taking VO 2  across the leg as a close approxim ation to Qmus 0 2 , found the rate of change 
for pulm onary VO 2  and QmusOj  to be sim ilar (T 1/2 25.5 + 2.6 s and 27.9 ±  5.7 s for 
alveolar and leg FOj respectively). Therefore, while separated by a necessary phase in 
time, the time course and am plitude of the phase II pulmonary VO 2  response is a close 
approxim ation to Qmus02 ■ Inferences made on the temporal response of muscle 
oxygen consumption from m easurem ents of VO 2  are therefore not unfounded. To 
consider these inferences however a suitable modelling strategy must be adopted and a 
num ber of assumptions made (refer to section 1.7).
1.4.3 ‘Phase III’
After approxim ately 3 min, or essentially 4 time constants, VO 2  reaches a plateau phase 
o f the response (in a young healthy adult). There is no further significant increase or 
decrease in the mean VO 2  and the response is said to have reached a ‘steady state’ 
(Phase 3, ((j)3)). In this phase the change in steady state VO 2  ( ) is equal to the
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mean rate o f oxygen utilisation at the m uscle (AQmusOj^,,^) i.e. the energy requirem ent 
o f ATP resynthesis in the exercising m uscle is being met aerobically (W hipp et al., 
1982). The I A W R , or steady-state gain, for m oderate cycle ergom etry exercise
is rem arkably consistent at approxim ately 10m /-m in-W "' across individuals regardless 
o f age or training status (W asserm an and W hipp, 1975; Hansen et al., 1984). It only 
appears to increase in the obese individual due to the increased work of moving the legs 
(W asserman and W hipp, 1975).
1.5 The O2 deficit and O2 debt for m oderate intensity exercise
D uring the steady state the transport and utilisation o f oxygen meets the metabolic 
dem ands of the muscle. H ow ever it is clear that a step change in work rate and 
therefore a step change in demand for ATP resynthesis is not met by a step change in 
VO 2 . This ‘short-fair or ‘lag’ in the VO 2  response is has been termed the oxygen 
deficit (Christensen and Hogberg, 1950). Figure 8 illustrates this concept. The area 
bound by the VO 2  on-transient response and the solid lines, represents the portion o f the 
energy requirem ent not met by O2 delivery and utilization.
2.0-
QJI-j?
Ht-i—‘5 MIN
Og DEFICIT
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ÜÜâ
R E S T
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EXERCISE RECOVERY
Figure 8 - T em poral V O 2  response for a norm al subject during a 125 W square wave exercise forcing 
(exercise undertaken at a w ork in tensity  below  the lactate threshold). The Solid line indicates the w ork 
rate change. A reas o f O 2 deficit and O 2 debt are labelled (W hipp and W asserm an, 1972).
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This shortfall in aerobic energy yield is met or ‘buffered’ by the breakdow n of 
phosphocreatine (PCr), the utilisation of oxygen stored in the m uscle bound to 
myoglobin and oxygen contained in the vascular system (W hipp et a i ,  1982; Ross iter et 
al.,\999). The predom inant energy buffer is PCr hydrolysis. The temporal response 
profile of PCr breakdow n is essentially dynam ically symmetrical to that of VO 2  and has 
led to suggestions for a linked m echanism  of control of VOj through the PCr 4-> Cr 
(creatine) reaction (refer to section 1.11.7, fig. 17) (Meyer, 1988; Rossiter et al.,1999).
The oxygen deficit is functionally significant as it represents the systems ability to ‘go 
into debt’ (Hill and Lupton, 1923) in order to undertake exercise that even in this 
moderate dom ain would not be possible if the lag in VO 2  was not com pensated for. The 
size of the oxygen deficit is a product of the effective time constant ( t ' , the result of a 
mean response exponential fit through phase I and II, see section 1.7) and the gain in 
steady-state VO 2  ( ) (Equation 5. W hipp and Ward, 1993).
02clef = t '-AV02^,,^
Eqn 5.
Therefore circum stances that lengthen x, such as chronic heart failure, COPD, inactivity 
and old age (Babcock et al, 1994), increase the size of the O 2 deficit. Therefore there is 
a greater reliance in these patients on finite energy sources. Conversely these energy 
stores are to an extent spared in the more athletic population where the time constant of 
the response has been reported to be reduced (Hagberg et al., 1978, Hagberg et al., 
1980).
2 0
At the cessation of exercise the VO 2  above that of the new steady state requirem ent has 
been termed the ‘oxygen debt’ as it represents the additional oxygen cost of 
replenishing the energy ‘borrow ed’ during the on-transient o f the response. Figure 8 
illustrates this region as the area beneath the off-transient response. In the moderate 
dom ain where off- and on-transient responses are symmetrical (Patterson and W hipp, 
1991; Ozyner et a l ,  2001), the size o f the O2 deficit and 0% debt are approxim ately 
equal (W hipp et a i ,  1970; W hipp and W asserman, 1972).
1.6 System  Linearity
It has been proposed that the phase II VO 2  kinetic response to moderate exercise is first 
order and dynam ically linear (W hipp and W asserman, 1972). That is, in adjusting to a 
change in work rate, the system will follow a predictable and consistent response. For 
example one would expect the time constant response to a step change in exercise to be 
invariant over the range of time or work rate i.e. the response to a ‘step-up’ or on- 
transient must m irror that o f a ‘step-dow n’ or off-transient.
This is described in engineering term s as, the output of the response must be predictable 
when the input into the system  and the transfer function are known (fig. 9). The input in 
this case being work rate and the transfer function being the time constant of the 
response. The transfer function is the mathematical relationship between the input and 
output of the response (W igertz, 1971). In the case of the modelled kinetic response, 
essentially the only dynam ic param eter is the time constant and therefore it can be 
considered the transfer function. If the relationship / AW/c in this domain is
linear and the time constant invariable then the system can be considered dynamically 
linear (Fujihara et al., 1973b). The ability to predict the output from an input is the
2 1
Boltzm ann’s principle of superposition (Fujihara et aL, 1973a) and the relationship must 
hold true over an infinite range of time and amplitude variations.
PhysiologicQ.!S tim u lu s  -----  R esponseProcess
Input T ran sfe rF unction O utput
u (t) H(t;0) y(t ,u ;0 )
Figure 9 - Schem atic system  input/ou tpu t relationship. A ssum ing that m uscle oxygen uptake in the 
m oderate dom ain is dependent on w ork rate and tim e, the transfer function is well described by x. 
T herefore the V O ^  response is calcu lab le  for any given w ork rate stim ulus (L am arra, 1990).
There is little dispute that the steady-state relationship between workrate and
proportional and therefore linear below the lactate threshold. Hill and Lupton (1924) 
showed in very early work that at low speeds of walking there was a clear linear 
relationship between walking speed and oxygen uptake (fig. 10). Henry (1951) noted 
work rate increased linearly at low work rates and that physical conditioning had no 
effect, a finding confirm ed by W hipp and W asserman (1972). These early findings 
have been substantiated and as previously m entioned the slope o f the 
AFOk,,)/AfF/c relationship has been shown to be approxim ately lOm l-min-W ' for 
cycle ergometry (W asserm an and W hipp, 1975; Hansen et al., 1984).
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Figure 10 - G raph illustrating  the re la tionsh ip  betw een oxygen uptake and w alking speed for two 
subjects from  th e  e a r l y  w o r k  o f  H ill and Lupton (1923). N ote the linear relationship  at low er w alking 
speeds and the non-linear rela tionsh ip  at h igher w alking speeds. This non-linearity  is a m anifestation  o f 
the ‘ex cess’ V O j  associated w ith exercise above the lactate threshold (see text for further details).
The dynamic linearity oirVO j  is however disputed. On-off symm etry of the VO-y 
response has been dem onstrated within the moderate intensity domain (Linnarsson, 
1974; Paterson and W hipp, 1991; Ozyner et al., 2001) and is independent of the 
duration of exercise (Knuttgen, 1970). This is consistent with a dynamic linear 
response. Furthermore, Cerretelli et al (1966), W hipp (1971) and W hipp et al (1982) 
reported the temporal response to a step change in work to be no different from a 
baseline of rest or light pedalling in this domain. In addition, the kinetic responses to 
impulse and sinusoidal protocols have reflected dynamic linearity (Casaburi et al., 
1977, 1978. Fukuoka and Ikegami, 1990). How ever these findings are not supported 
by the work of Hughson et al (1988) who reported that temporal VO 2  responses from 
step increases in work failed to predict the time course of the response to an impulse 
protocol i.e. the test of superposition failed (refer to page 22; Fujihara eta l. ,  1973a).
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Dynam ic linearity has also been questioned with respect to the effect o f initial baseline 
on the subsequent kinetic response. Di Prampero et al (1970) and Davies et al (1972) 
reported a faster response when moderate exercise was undertaken from prior exercise 
com pared to that undertaken from rest. In contrast, Diam ond et al (1977) found no 
difference in the response from a background of unloaded pedalling. Hughson and 
M orrisey (1982) and Inman et al (1987) reported a slowing o f the response when the 
step change in work rate was initiated from moderate exercise as opposed to rest. These 
findings were confirmed by Brittain et al (2001) who described a slowing of the VO 2  
kinetic response for a m oderate work-to-work transition.
The attraction of a dynam ically linear first order response is the suggestion of a 
relatively simplistic m echanism  of control. That is control by one fundamental process 
that remains invariant to challenges in everything but its rate o f adaptation. This 
suggestion of dynamic linearity, while now under challenge, has led many to attempt to 
elucidate this primary m echanism  of control (refer to section 1.11).
1.7 M odelling the V O 2 response
As described above, the FO , response to moderate square-wave exercise exhibits a 
three phase response, the second being o f a m ono-exponential form. The strategy for 
m odelling the VO 2  response in these three phases depends on what aspect of the 
underlying physiology is of interest, for example, is it the fundam ental phase II kinetics 
that are o f interest or an estim ate o f the Oidf? There are 3 recognised “m odels” for 
fitting an exponential to the tem poral VO 2  response in the moderate domain, figure 11 
(W hipp cf a/., 1982).
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If the fundamental kinetics o f VO 2  is the primary interest then “phase” 1 is excluded 
from the calculation, with the exponential fit starting after a delay o f approxim ately 15- 
20 s into exercise. This m ethod of fitting the exponential is term ed “m odel” 3. 
D iscerning the exact point where “phase” 1 becomes “phase” 2 can be difficult and can 
be a source of potential error, therefore this should be given careful consideration. 
Using breath by breath data, suitably averaged from a num ber of repeat tests 
(Linnarsson, 1974; Lam arra et al., 1987), the start of “phase” 2 can be estimated as the 
point after which VO 2  starts to increase m ono-exponentially. In addition, at the 
“phase” l - “phase”2 transition, the respiratory exchange ratio (RER) begins to decrease 
due to slower on-transient kinetics of VCO 2  (T~ 40-50 s, W hipp et al., 1982) compared 
to VO 2  (primarily due to the filling of C O 2 stores in tissues during the early phases of 
exercise). Furthermore, this abrupt decrease in RER is accom panied by a decrease of 
PET02 and increase in PETco2 (Cerretelli et al., 1966).
The exponential nature of the phase II kinetic response in theory permits the ‘fitting 
range’ to begin at any point along the exponential. Therefore allowing a suitable time 
delay should prevent any contam ination of the phase II response by the phase I 
response. How ever in practice it is preferable to use the m axim um  number of data 
points for analysis to optim ise the confidence of the fit (Lam arra et al., 1987). The 
distinction between phase I and phase II will therefore be important in protocols 
designed to assess the m agnitude and time course of phase I, or optim ise the confidence 
o f a phase II fitting strategy.
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Figure I I -  B est fits o f single-exponential m odels, I (top), 2 (m iddle), and 3 (bottom ) to averaged 
b reath-by-breath  response o f  V O j  to 100 W  exercise from  an unloaded baseline (left) and from  rest 
(right). N ote that m odel 3 clearly  yields the best fit o f  the phase 2 response (W hipp et al.,  1982).
For calculation of the oxygen deficit both “phase” 1 and “phase” 2 should be included 
in the exponential fit, as the curve then I'epresents all the non steady-state data. This can 
be done by either forcing the exponential to start at time zero (start o f exercise, “model 
1” , fig. 11), or by using a best fit exponential through the two phases (“m odel” 2, fig. 
11). “M odel” 2 results in a delay period from the start of exercise to the start of the fit. 
Therefore an adjustm ent must be made to align the start of the fit with the beginning of 
the transition. It must be em phasised that the delay term, and T obtained from the best 
fit exponential (“m odel” 2) are purely descriptive and hold no physiological 
significance. How ever the same param eters generated from model 1 do have some
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credence as they represent a valid index of the total O2 actually utilised (W hipp et al., 
1982).
1.8 Supra-threshoid V O 2 kinetics
Consideration of the VOj response to moderate, square wave exercise is an appropriate 
fram e of reference for further consideration o f the response to higher intensity exercise. 
A t work rates above the lactate threshold the VO^ kinetic response becomes more 
com plicated (Linnarson, 1974; W hipp and M ahler, 1980; Paterson and W hipp, 1991; 
Bars tow and Mole, 1991; Hughson et al., 1996; Ozyener et al., 2001). Rather than 
being dominated by a single exponential component, a second slower and delayed 
com ponent is evident in the response,
1.8.1 ‘H eavy’ exercise
A fter an initial rapid response (phase I), sim ilar to that for m oderate exercise, the early 
kinetics of the response remain exponential and project towards a steady state gain 
(AV02(,,) /AW R) that is sim ilar to that expected for sub-threshold work rates (Paterson
and W hipp, 1992; Bars tow and M ole, 1991; Ozyener et al., 2001). Furthermore the 
tim e constant for this response is sim ilar to that o f sub-threshold exercise (M argaria et 
al., 1965; Paterson and W hipp, 1992; Ozyener et al., 2001) or slightly slower (Barstow 
and M ole, 1991). Some 2-3 m inutes into the transient a second, slower component is 
evident in the response (Linnarsson, 1974; W hipp and W asserm an, 1972; Paterson and 
W hipp, 1992). There are two main consequences of this slow rise in VO 2  within this 
dom ain l)a  necessary delay in attaining a steady-state due to the slow rise of this second 
com ponent (fig. 12), 2) an increase in the steady-state PO j-W R  relationship.
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Figure 12 - Tem poral profiles o f V O j  and arterial blood lactate in response to six constant load exercise 
tests on a cycle ergom eter. T est duration  w as either 15min or to the limit o f  to lerance. N ote that at w ork 
rates at which blood lactate increases yet stabilises, steady-state V O j  is delayed. A t w ork rates w here
b lood lactate continues to increases, VO 2  rises to, or tow ard, a m axim um  value (W hipp, 1994, m odified 
from  R oston et al., 1987).
A time to teach steady-state of 10-15 min is not uncommon in this domain, considerably
delayed when com pared to a typical time of 3 min for moderate exercise (W asserman et
al., 1967; Poole et a i ,  1988; Poole et a i ,  1991; Ozyener et al., 2001). This delay is
proportional to work rate within this domain, that is the higher the work rate the longer
the time it takes to reach steady state (Henry and DeM oor, 1956; W asserman et al.,
1967; W hipp and W asserman, 1972; Hagberg, 1978). Roston et al (1987) and W hipp
(1987) have both reported an increased steady-state gain of -1 3  ml-min '-W (for cycle
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ergom etry) in this region com pared to that of -  ml-min’*-W for m oderate exercise. This 
‘excess’ VO 2  over and above the steady state requirem ent for O2 projected from the 
sub-threshold relationship has been termed VOj^xs) (W hipp and W ard, 1993).
Som e of the proposed theories behind the origin of this excess oxygen requirem ent are 
reviewed in section 1.12.
1.8.2 ‘Very heavy’ exercise
As discussed previously (refer to section 1.3.) critical power marks the transition from 
the heavy domain to the very heavy domain (fig. 3). The early kinetics in this domain 
once again remain true to the fundam ental response described for moderate exercise 
(Ozyener et al., 2001), with no evidence of the fundamental t  lengthening. The slow 
com ponent in this dom ain fails to allow a steady-state to develop and drives VO 2  
rapidly towards attainm ent of ; upon which fatigue soon follows (Ozyener et al.,
2001). The greater the work rate the more quickly attained (M argaria et al.,
1965). Thereby maximal VO 2  is associated with a range o f work rates rather than a 
unique or ‘m axim al’ work rate (Poole et al., 1988). VOj kinetics in this domain are 
therefore dom inated by the slow com ponent and dictated to in large, by the power time 
relationship.
1.8.3 ‘Severe’ exercise
The slow and delayed onset o f the response has the consequence of little or
none of its influence being m anifest in the ‘severe’ exercise dom ain (fig. 3). The work 
rates in this domain are those above that associated with m axim um  W R determined
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from a standard incremental cycle ergom etry protocol. The result is exercise that may 
last less than 2 m inutes giving the V02^sc) time for expression (Hill and Stevens,
2001). Therefore the tem poral VOj kinetic response in this domain remains a first order 
mono-exponential rise that, depending on the ‘severity’ of the work rate, may or may 
not reach VOn2 max '
1.9 The O 2 Deficit in supra-threshoid exercise dom ains
The m ono-exponential VO 2  response observed in the severe domain allows definition of 
the O2 deficit in a sim ilar fashion to sub-threshold exercise. Assum ing that the m ono­
exponential time course still represents a fundam ental response, the oxygen deficit can 
be defined as:
02cif = V 02^,,^x t ' Eqn  6.
W here r  is the mean time constant for the response. However the deficit under these 
conditions is not dependent on the as in the moderate domain, but on
(fig. 13, panel D).
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Figure 13 - Schem atic representation  o f the O 2 uptake { V O 2 ) response to constant-load  exercise at 
d ifferen t w ork intensities. (A) B elow  the lactate threshold; (B) above the lactate threshold, w ith V O 2  
reaching a steady-state but w ith a delayed tim e course; (C) above the lactate threshold, but w ith a 
com ponent o f  “excess” V O 2  that leads V O 2  to attain the m axim um  V O 2  and (D ) a
supram axim al w ork rate w here fatigue occurs so rapidly that the excess V O 2  com ponent has not had 
tim e to develop discernibly. O 2D represents the calculable 0% deficit. N ote that O 2 D is not calculable for 
situations (C) and (B) due to the influence o f the slow  com ponent, see tex t for further details (W hipp and 
W ard , 1993).
As already discussed (refer to section 1.8), the functional significance o f the slow 
com ponent in the ‘heavy’ and ‘very heavy’ dom ains is an increase in steady-state 
AVO 2 / àWJe gain or a prevention of a steady-state altogether. Therefore the asymptote 
o f the VO 2  response in these domains is not a true reflection of the fundamental 
response and the O2 deficit cannot be accurately determined (fig. 13, panels C and B). 
Therefore the conventional strategy for calculation of the oxygen deficit is not 
applicable for these work rates. An attempt is often made to estimate the Ozdf in this 
region by extrapolating the sub-threshold VOj-W R gain, this is often referred to as the 
‘accum ulated oxygen deficit’ (M edbo et a i ,  1988). This is inaccurate for the reasons 
described above and the method has recently been shown by Ozyner et al (2003) to
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result in a negative accum ulated oxygen deficit in heavy and very heavy exercise 
domains.
Bearden and M offatt (2000) have suggested an alternative strategy for calculation of 
the O2 deficit in these domains. They describe a double monoexponential function with 
separate time delays that characterises both the early VO 2  response and the slow 
com ponent independently (fig. 14).
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Figure 14 - G raph show ing an averaged V O j response to ‘heavy’ exercise. T he m odel indicates a 
double exponential function w ith separate tim e delays, to characterise both the early  V O 2  response and 
the slow  com ponent independently  ( B earden and M offat, 2000).
They found that areas 1 and 2 (fig. 15) represent a plausible estimation of the O 2 deficit 
in this domain when com pared with post exercise oxygen consumption. This strategy 
assum es that the relationship between O2 deficit and O2 debt above the threshold is the 
same as that for below the threshold i.e. that the debt represents the oxygen cost of 
replenishing energy stores ‘borrow ed’ while the system catches up with the demand.
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Figure 15 - A  schem atic d iagram  o f  the Y O ^  response to ‘heavy’ exercise. T he fundam ental and slow  
com ponent responses are represented  as separate com partm ents (2-com partm ent m odel). B earden and 
M offat, 2000; suggest that areas 1 and 2 represen t a p lausible estim ation o f  the O 2 deficit in this dom ain 
w hen com pared w ith post exercise oxygen consum ption. H ow ever the assum ption  is m ade that the slow  
com ponent response is exponential in nature due to it being well fit by an exponential function. T his 
assum ption does not alw ays hold true as the projected  steady-state for this exponential term  is often 
projected  above (A dapted from  B earden and M offat, 2000).
This same conclusion cannot be made for supra-threshold kinetics until the mechanisms 
behind the are more fully understood. In addition, the asymptotic value for the
slow com ponent in the ‘very heavy’ dom ain (fig. 14) will be greater than i.e. A2
does not represent the projected asymptote of X2  (unlike A in panel D fig. 13). A 
consideration not accounted for in this model.
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1.10 The V O ^  response to increm ental exercise
Gas exchange responses to ramp exercise protocols are used extensively because they 
provide values for the param eters of > estimated lactate threshold ( 0 l T ) and work
efficiency (W asserman et aL, 1994). D uring a ramped incremental exercise protocol, 
after a slight delay, VO 2  increases linearly until a maximum VO 2  is reached. At all 
points along this linear increase V 0 2 (,^  lags behind the VO 2  steady state response (fig. 
16).
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Figure 16 - Schem atic representation  o f  the V O 2  response to increm ental w ork rates during the steady- 
or quasisteady- state proeedure vs the ram p response. T he solid lines reflect the actually  determ ined 
w hole-body response. T he stippled  area below  the ram p response represents a possib le relative shortage 
o f  the O 2 u tilisation  in the contracting  m uscles that, w hen offset by the increased requirem ents evident on 
the steady-state  test, results in a relatively  linear V O 2  response in the supra- ‘anaerob ic’ threshold (9n„) 
region, jii represents (W hipp, 1987).
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This delay is due to the delay in the system response and is equal to the system time 
constant { t ' )  (W hipp et aL, 1981). Therefore A W jj^ is  equal to at { i - r ' ) .  It
is important that this correction is made when calculating steady state work rates based 
on param eters estim ated during an incremental test. The VO^ and work rate (WR) 
established at the upper lim it of perform ance during an incremental test are term ed 
max and WRmax respectively. The influence of the slow com ponent o f VO 2  response 
is minimal during rapid incremental tests. Only when the increments are o f longer 
duration i.e. 3-4 minutes is the slow com ponent manifest as an upward curvature of the 
VO 2  -W R relationship (fig. 16, W hipp and M ahler, 1980 and Hansen et al., 1988).
1.11 Control o f sub-threshold  V O 2
The aforementioned first order response in oxygen uptake kinetics to ‘m oderate’ 
increases in energy dem and suggests a single rate-lim iting locus of control governing 
Q,„02. This apparent simplicity in system  design has encouraged many to attem pt to 
elucidate this m echanism  of control. There are two main theoretical approaches to this 
subject. The first is that VO 2  is set by the rate at which oxygen can be transported from 
atmospheric air to the m itochondria (Hughson, 1990; Hughson et al., 1996; Hughson et 
al., 1993; M acDonald et al., 1997), the second is that the locus of control lies within the 
metabolic m achinery itself (Cerretelli et al., 1990; W hipp and M ahler, 1980).
M itochondrial oxidative phosphorylation generates the ATP necessary for the 
maintenance o f muscle cell function over a wide range of metabolic demand. It is the 
focal point of a close interaction between several metabolic pathways and has the ability 
to rapidly achieve the necessary rates of ATP production solely through the interaction
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of reactants and products (W ilson, 1994). ATP production is so tightly controlled that 
even at the most extreme demands for ATP, cellular [ATP] is maintained relatively 
constant (Brown, 1992) and cellular function remains intact (Chance and W illiams, 
1955).
M itochondrial respiration utilises the energy from  the transfer of reducing equivalents 
down the electron transport chain to synthesise ATP from ADP and inorganic 
phosphates (Pi). These reducing equivalents, predom inantly NADH but also FA DH 2, 
meet oxygen at the terminal electron transport chain com plex (cytochrom e oxidase) 
where they are further reduced generating H2O. The overall reaction is as follows for 
NADH:
NADH + 1/2 O2 + H+ + 3ADP + 3Pi o  NAD+ + H 2O + 3ATP
Eqn 7.
The value of 3 is proposed by Le M asters et al (1984) to best represent the ATP/O 
stoichiom etries of mitochondrial oxidative phosphorylation.
It is probable that control of VO 2  lies somewhere in the delivery or utilisation of these 
reactants and products and it seems likely from the uniform  concentrations of ATP, 
during sometimes large swings in demand, that the controlling mechanism is tightly 
linked to ATP breakdown.
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1.11.1 Feedback control through [ADP]
Early theories on the m echanism  of control advocated ADP concentration as the 
prim ary signal affecting the rate of m itochondrial respiration (Lardy and W ellman, 
1952; Chance and W illiams, 1955; Chance and Conelly, 1957). Observations using 
isolated m itochondria showed that respiratory rate increased m arkedly when ADP 
concentration was increased (Chance and W illiams, 1955), suggesting a sim ple 
substrate limitation effect may be regulating ATP synthesis. Furthermore it was 
calculated that at rest AD P existed at a concentration well below that for its Km, a 
system requirem ent for kinetic control (Chance et al., 1986). These observations were 
consistent with M ichaelis-M enton kinetics control of respiration, and the ADP 
hypothesis assumes that the rate of oxidative phosphorylation is determined by the 
degree of saturation with AD P following first order (Lardy and W ellman, 1952; Chance 
and W illiams, 1955; Chance and Conelly, 1957; Chance et a l ,  1985) or second order 
(Jeneson et al., 1996) control characteristics.
1.11.2 The Adenine Translocase H ypothesis
The adenine translocase hypothesis centres around the transport of adenine nucleotides 
from site of production to site of utilisation. ATP is synthesised in the m itochondrial 
matrix, yet is utilised at active sites in the cytoplasm. The reverse is true for ADP. The 
adenine translocase hypothesis suggests the rate limiting factor in cell respiration is this 
transport of ADP into the mitochondrial matrix and the transport of ATP into the 
cytoplasm. Transport is directed by the adenine nucleotide translocase with ATP and 
AD P exchanged in a 1:1 ratio (Klingenberg, 1980). Pfaff and Klingenberg (1968) first 
suggested that the rate of extram itochondrial ADP uptake is dependent on
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extramitochondl'ial [ATP] due to com petitive inhibition by ATP on ADP transport. 
Therefore the rate of neucleotide translocation, and mitochondrial respiration, is thought 
to be dependent on the extram itochondrial [ATP]/[ADP] ratio rather than [ADP] alone 
(Jacobus et aL, 1982).
1.11.3 Feedback control through [Pi]
A principal point of criticism  levelled at both the AD P hypothesis and adenine 
translocase hypothesis is they both exclude a significant role for [Pi]. [Pi] in isolation is 
thought to be less likely than [ADP] to exert a high degree o f control because 31P-NM R 
spectroscopy m easurem ents in vivo have [Pi] at values greater than 1 mM, very close to 
the estim ated value for the Km of respiratory control in isolated m itochondria (Chance 
et al., 1955). It has been shown however that in preparations where [ADP] and [ATP] 
are kept constant, [Pi] can exert a small but significant effect on respiratory rate in 
isolated m itochondria and intact cells (Holian et al., 1977; Erecinska et al., 1977).
1.11.4 The ‘near equilibrium  hypothesis’
The early “near equilibrium  hypothesis” advocated a role for [ATP], [ADP] and [Pi] in 
the mechanism  for control (Klingenberg, 1961; Owen and W ilson, 1974; Holian et al., 
1977). The apparent Km for ADP has been observed to be dependent on the 
concentrations of both ATP and Pi (Owen and W ilson, 1974; Holian, 1977). The 
suggestion is that respiratory rate is more dependent on [ATP]/[ADP] [Pi] ratio, 
therefore any combination o f the 3 components can alter the respiratory rate in response 
to a change in dem and i.e. no single com ponent exerts prim ary control.
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This theory has subsequently been expanded to include a role for mitochondrial 
reducing power, or the [NADH]/[NAD"^] ratio, through cytochrom e c oxidase. The 
oxygen reduction reaction of cytochrom e c oxidase is irreversible (equation 8).
2c^+ + 1/2 O2 + ADPe + Pi e + 2H"' 2c^+ + H2O + ATPe
Eqn 8.
In the steady state the rate of oxygen reduction by cytochrom e oxidase is equal to the 
overall respiratory rate. Therefore respiratory rate cannot exceed cytochrom e oxidase 
flux, advocating a high probability of cytochrom e c oxidase acting as a “rate lim iting 
step” . How ever the supply of the reduced form of cytochrom e c is determined by:
/ [c^*] = ([NADH] /  [NAD*])''^ * [ADP]. [Pi] / [ATP] * K eq " '
Eqn 9.
W here [c^ "*"] and [c^^] are the reduced and oxidised form of mitochondrial cytochrome c. 
Therefore the rate of the cytochrom e oxidase reaction is linked to the “phosphorylation 
potential” and provision of reducing equivalents. The balance of equation 9 is near 
equilibrium -hence the name-and a role for [NADH]/[NAD‘^ ] in driving this reaction has 
found support (W ilson et al., 1979).
Therefore there are two aspects to control through these interlinked moieties. A demand 
based hypothesis through [ADP].[Pi]/[ATP] and a supply based hypothesis with the 
intramitochondrial reducing power as the functioning variable ([NADH] / [NAD^]). It 
follows that m odulation o f either o f these factors may influence the rate o f respiration.
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1.11.5 Gibbs Free Energy
In contrast to, yet also som ewhat sim ilar to, the “near equilibrium  hypothesis” is the 
non-equilibrium  models based on changes in Gibbs free energy o f cytosolic ATP 
hydrolysis (A G atp) (Kushmerick, 1983; M eyer, 1989; M eyer and Foley, 1994). The 
two theories are sim ilar in that they are dependent on [ATP], [ADP], [Pi] and 
[NADH/NAD^]. W here the non-equilibrium  hypothesis differs is that it is independent 
of kinetic properties of m itochondrial enzymes i.e. it is dependent on the cytoplasmic 
free energy of ATP hydrolysis or phosphorylation potential (ln[ATP]/[ADP] [Pi]) which 
is ultimately dependent on the intra mitochondrial [NADH]/[NAD^] ratio (as described 
above). M eyer (1988) has advocated a linear model of respiration that describes well 
therm odynam ic control o f respiration based on phosphocreatine utilisation. Barstow et 
al  (1994a&b) found the non-equilibrium  hypothesis to hold during incremental calf 
exercise (Barstow et al., 1994a), and moderate exercise transitions (Barstow et al., 
1994b).
1.11.7 Phosphocreatine breakdown
In response to an increase in work rate there is a m ono-exponential decrease in 
phosphocreatine that has time and amplitude similarities to the oxygen uptake response 
(Meyer, 1988; Barstow et al., 1994a&b; Rossiter et al., 1999). This has been well 
described in hum ans by Rossiter et al (1999) who used 31 P-NM R spectroscopy and 
breath-by-breath gas exchange sim ultaneously to make inferences on intram uscular and 
oxygen uptake param eters respectively (fig. 16).
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Figure  77 - S im ultaneously  determ ined m easures o f  pulm onary O 2 uptake and in tram uscular 
phosphocreatine concentration  in response to, and during recovery from, 6 m inutes o f constant load 
exercise in a single represen tative subject (R ossiter et a i ,  1999).
This apparent co-relationship between [PCr] and VO 2  has led to speculation that some 
aspect of PCr degradation exerts a controlling influence on mitochondrial respiration 
(Mahler, 1985). The basis of this is that the principal controller of the VOj response 
should exhibit the same tim e course and magnitude o f change as VOj if first order 
control is to hold (Lamarra, 1990). The “creatine shuttle” hypothesis (Bessman, 1985) 
suggests that creatine kinase plays a pivotal role in delivering ADP to the ATPases in 
the m itochondrion. In many ways this is synonymous to the much earlier theories of 
[ADP] as the rate limiting function. Experim ental data (Chance and W illiams, 1955) 
has suggested that, in isolated preparations, the amount of AD P formed is only a few 
percent of the amount expected. This suggested that the [ADP] arriving at the 
m itochondria during a twitch may not be sufficient enough for direct control by this
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m echanism alone. The proposal from those advocating the “creatine shuttle” theory 
(Bessman and Fonyo, 1966; Bessman and Geiger, 1981; M ahler, 1985) is that creatine 
acts as an energy buffer between the sites o f ATP synthesis and utilisation dam pening 
the changes in ADP and ATP (fig. 17. M atisone et aL, 1996; Kushmerick, 1998). W ith 
degradation of PCr into AD P and Cr supplying the required substrate, and subsequent 
metabolic stimulus to the m itochondria (Jacobus, 1985).
ATPase
ADP +ATP
ICK]
creatine PC
m itochondrial
o u te r m em brane
creatine PC
CK
ADI
ADP + PiATPr  L ^NADH t
electron transbort Incha l
GOg + HjjO
F igure 18 - S im plified schem atic d iagram  o f  the reactions by w hich oxygen consum ption is coupled  to 
ex tram itochondrial A TP hydrolysis in m uscle. D ashed lines indicate d iffusion (M ahler, 1985).
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The close proxim ity of creatine kinase to both the A TP/A D P translocase and 
crossbridge binding site, lends support to this hypothesis (Bessman and Geiger, 1981); 
as does the increase in respiratory rate that occurs after ingestion o f exogenous creatine 
(Katz, 1934; Belitzer and Tsybakara, 1939), albeit not proven in intact human muscle 
(Stroud et a l ,  1994; Sanz and M arco, 2000; Jones et a i ,  2002). The results from 
R ossiter et al (1999, 2001, 2002) showing time and amplitude sim ilarities between PCr 
breakdown and VOj increases below and above the lactate threshold clearly 
dem onstrate a functional link between the two processes. Kushm erick (1998) suggests 
that locus of control between these two processes is creatine kinase, with feed forward 
and feedback control not refutable. H ow ever feedback control is described better by the 
m odels employed and therefore suggested as the more likely.
1.11.8 O xygen delivery
The role of oxygen as the terminal electron transport chain oxidant puts it in a position 
as a strong candidate for prim ary control. The electron generating reactions can only 
proceed if oxygen is available at the end of the chain to accept protons in the form of 
hydrogen. It is a requirem ent then that, to facilitate aerobic resynthesis of ATP, oxygen 
m ust be delivered in adequate quantities from atm osphere to m itochondrion. This 
delivery and utilisation of oxygen has found favour in some quarters as the principal 
m echanism  of respiratory control (Hughson, 1990; Tschakovsky and Hughson, 1999). 
This thinking has developed largely from observed changes in the time constant for 
VO 2  kinetics with increasing or decreasing delivery of oxygen.
Linnarsson (1974) has shown slow ing of VO 2  kinetics with a reduction in the inspired 
fraction o f oxygen, as have Hughson and Kowalchuck (1995). Hughson et al (1993) and
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M acDonald et al (1998) have shown a slowing of VOj kinetics in the supine position 
com pared to upright cycling, findings confirm ing those by previous authors (Cerretelli 
et a l ,  1977; Convertino et a l ,  1984). This slowing was speeded by the addition o f a 
lower body negative pressure (Hughson et a l ,  1993) and has been directly related to 
fem oral artery blood flow (M acDonald et a l ,  1998). Koike et al (1990) showed a 
slowing of the VOj response during m oderate exercise when arterial oxygen content 
was reduced using carboxyhaem oglobin. Similarly Hayashi et al (1999) showed that 
impeding 0% unloading, through a leftward shift of the O 2 dissociation curve, also 
caused a slowing of the VO 2  response. The implication from these studies is that 
convective or diffusive 0% delivery affects muscle VO 2  on-kinetics. How ever results 
from M acDonald et al (1997), Gerbino et al (1996) and the work by Grassi et al (1996) 
suggest this is not the case when ‘norm al’ conditions for O2 delivery reside.
M acDonald et al (1997) dem onstrated no change in the time constant for VO 2 , in 
response to a work load above but not below the lactate threshold while inspiring a 
hyperoxic gas mixture. This finding was supported by Hughson and Kowalchuck 
(1995). Gerbino et al (1996) dem onstrated an apparent speeding of the VO 2 kinetics 
above but not below the lactate threshold when exercise was preceded by a ‘prim ing’ 
bout of heavy intensity exercise. The reactive hyperaemia associated with the prim ing 
bout did not therefore influence the first order m ono-exponential response in the 
moderate domain. Grassi et al (1996) showed, by sim ultaneous measurement o f leg 
VO 2 , blood flow and arterial-venous oxygen difference ( C ( a - v ) G 2(fc^ ,j ) during sub­
threshold cycle ergom etery, that blood flow rose immediately on exercise while there 
was a 10-15 s delay before a rise in C{a -  v)02(i,.^). This provides evidence that at the
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start of exercise the supply of O2 was in excess of the demand i.e. muscle oxygen 
kinetics lag behind the kinetics of bulk O2 delivery to the muscle.
1.11.9 M itochondrial Inertia
The lag in muscle oxygen kinetics described by Grassi et al (1996) has been proposed to 
be due to an inherent inertia in the m itochondrial response to an increase in ATP 
demand. ‘Feed forw ard’ control of VO 2  through ‘stock piling’ of respiratory substrate 
has been proposed as the prim ary m echanism  of control (Tim mons et a l ,  1998).
Using the extent o f PCr degradation as a direct marker of the oxygen deficit, Tim m ons 
et al (1998) found it to be reduced by ingestion of dichloroacetate (DCA, a potent 
stim ulator of pyruvate dehydrogenase, PDH). During submaximal (~ 45 % W Rmax) 
single leg extension they found that PC r breakdown and by inference 02df. was reduced 
by 50%. DCA increased resting PDH activity threefold, and elevated acetylcarnitine 
fivefold at rest. The increase in the tricarboxylic acid (TCA) cycle pool size, due to the 
increased pyruvate flux into the m itochondria, was proposed as rate lim iting to TCA 
flux and to the rate of oxidative phosphorylation (Sahlin et a l ,  1990).
Howlett et al (1999) reported sim ilar results to that of Timm ons et al (1998). They 
found that during constant work exercise (-65%  )> DCA resulted in reduced
phosphocreatine utilization during the first two minutes of exercise. This was 
accom panied by lower levels o f muscle lactate accumulation. Like Tim m ons et al
(1998), they found DCA increased both acetyl-CoA and acetylcarnitine at rest; these 
increased levels were maintained during the first 2 minutes of exercise.
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The results from these studies suggested that the provision of substrate is limiting the 
increase in oxidative phosphorylation at the onset of exercise. Tim m ons et al (1996) 
termed this the ‘acetyl group deficit’ and have demonstrated this inherent lag in VO 2  to 
be insensitive to oxygen delivery in canine muscle (Timmons et aL, 1997). Therefore 
acetyl-CoA and acetylcarnitine are proposed by Tim m ons et al as the “major 
determ inants” o f the oxygen deficit. They hypothesized that on the com m encem ent of 
exercise, any lag in substrate supply was overcom e by the increased acetyl group 
“store” in the m itochondria. M ore recently the same group (Roberts et al., 2002) 
demonstrated this lag in acetyl group provision and PDH activation in the same isolated 
muscle preparation used by Tim m ons et al (1996).
The results of Parolin et al (2000) lend support to this hypothesis. During 15 min of 
constant load cycle ergom etry (55% WRmax) in hypoxic conditions, they found that 
DCA increased PDH activity, acetyl-CoA concentration and acetylcarnitine at rest and 
at 1 min of exercise. This was accom panied by a reduction in PCr breakdown and 
blood lactate concentration throughout exercise.
Therefore, for m oderate intensity exercise, the data support the notion of an ‘acetyl 
group deficit’ with pyruvate dehydrogenase acting as a ‘functional stenosis’ for 
oxidative phosphorylation. This is likely to be responsible, at least in part, for the 
observed lag in VO 2  at the onset of exercise.
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Similarly, Cytochrom e oxidase has also been suggested as a site for regulation of 
mitochondrial inertia at the onset o f exercise. Jones et al (2003) dem onstrated a 19% 
speeding of the phase II VOj response to moderate exercise when nitric oxide synthase 
was inhibited. Nitric oxide has been shown to reversibly inhibit m itochondrial 
respiration, by binding to the O 2 binding site at cytocrome c oxidase in the electron 
transport chain (Brown, 2000). Using nitro-L-arginine methyl ester (L-NAM E), an 
inhibitor of nitric oxide synthase, Jones et al (2003) may have reversed this inhibition 
and augmented the VO^ response. The speeding of the phase II response was 
accom panied by no change in the steady-state gain of the response, a finding supported 
by the results of Frandsen et al (2001) and Radegran and Saltin (1999) who 
demonstrated no effect o f L-NAM E on steady-state Kindig et al (2002) found the 
same result in horses during moderate dom ain running. L-NAM E caused a 32% 
reduction in the tim e constant of the fundamental VO-, response with no change in 
baseline or steady-state VO^- Interestingly this apparent speeding of the VO^ kinetics 
with nitric oxide synthase inhibition occurs from a background of reduced O2 delivery. 
Nitric oxide is a potent vasodilator and its inhibition has been shown to reduce cardiac 
output in the horse (Kindig et a l ,  2000) and reduce muscle blood flow in rats (Hirai et 
al., 1994). The results o f Jones et al (2003) and Kindig et al (2002) add evidence to 
argument against control of VO^ kinetics - in the moderate domain - through a 
lim itation in O2 delivery. The evidence suggests nitiric oxide is an important 
component in the partial regulation of the temporal VO 2  response to moderate exercise. 
Certainly the results of Kindig et al (2002) and Jones et al (2003) are the first to show a 
reproducible alteration of the VO^ kinetics during whole body dynamic exercise within 
‘norm al’ exercising conditions. However, from a functional viewpoint, the efficacy of 
whole body vasodilator inhibition during exercise remains to be seen.
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1.11.10 Sum m ary o f putative controllers o f V O 2 in m oderate exercise
Factors regulating the control of VO 2  is a complex conundrum  particularly when 
considering control at the level of the mitochondria. M any factors have been identified 
that can play a role in the overall VO 2  response yet their influence and interaction is yet 
to be fully understood. Brown (1992) has offered an in depth review of the subject from 
a m itochondria and cell perspective. He suggests the concept is best viewed as a chain 
of inter linked moieties (fig. 19), that is, the rate o f energy m etabolism  can be controlled 
at either end of the pathway (or in the middle). M any of the links in the chain illustrated 
in figure 19 have been sum m arized here. Also included is the regulation by Ca 
concentration proposed by Hansford (1994).
2 +
Muscle NADHIcontractlonl
Muscle(relaxed)
Cttrdto
^  NAD* — ^  ’^ OxaloacDiateH,0 CO,
Acetyl-CoA
-CoA C O ; +  H jO
Figure 19 - Schem atic d iagram  illustrating  a series o f  m oiety conserved cycles associated with energy  
m etabolism . B row n (1992) suggests that the rate o f  energy m etabolism  can be controlled at e ither end o f 
the pathw ay or in the m iddle. T he role o f calc ium  in stim ulating  m uscle contraction, m atrix 
dehydrogenases and possible indirectly  the synthase and respiratory chains is also show n (from  B row n, 
1992).
W hile the studies of isolated m itochondria have given us insight into putative 
m echanisms of control, they provide limited information as to what governs oxygen 
uptake in intact hum an muscle. M any have looked at preparations in a steady-state 
and/or under controlled conditions that precluded one or more possible co-controllers. 
The result is often plausible theories that often com plem ent or contradict (Funk, 1990),
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Indeed it has been com m ented (W hipp and Mahler, 1980) that many of the studies 
advocating ADP availability as the principal ‘controller’, made no attempt to 
substantiate their models of control by com paring their predicted responses with that 
observed for intact muscle. Therefore, the ‘acetyl group deficit’ proposals of Tim m ons 
et al (1996), the L-NAM E work by Jones et al (2003) and the in vivo VOj / PCr work 
of Rossiter et al (1999, 2001,2002), present the clearest picture o f putative controllers of 
VO 2  kinetics during whole muscle dynamic exercise. How ever Brow n’s concept 
illustrated in Figure 19 is an im portant frame of reference when considering this subject.
1.12 Control o f Supra-threshold V O ^ ' -  Origin o f the V O 2 slow com ponent.
The principal question surrounding the slow component of the supra-threshold VOj 
response is whether the ‘excess’ VO^ is representative of an additional oxygen cost of 
ATP resynthesis in the exercising muscle or an additional oxygen cost of the system 
response to exercise?
Poole et al (1991) revealed (through sim ultaneous m easurem ent of pulmonary VO 2  and 
leg VO 2 ), that leg VO 2  could account for 86% of the rise in pulmonary VO 2  during 
cycle ergometry. Rossiter et al (2002) confirmed that the exercising muscle is the 
primary source of the slow com ponent by demonstrating that -90%  of the magnitude of 
the F02(,,)is reflected within the muscle by its [PCr] response. Both studies suggest
there is a link between this ‘excess’ oxygen cost of exercise and the ATP generating 
processes in the muscle.
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The arterial blood lactate profiles in the supra-threshold exercise domains follow a 
sim ilar profile to the VO 2  response. That is; in the heavy dom ain blood lactate stabilises, 
in the very heavy domain it continues to rise and in the severe dom ain it rapidly reaches 
a m aximum  (fig. 12). Furthermore the work rate corresponding to critical power also 
appears to correspond to m axim um  work rate for blood lactate stabilisation (Poole et al., 
1988). M oreover the m agnitude o f the slow component has been shown to be highly 
correlated with the rise in blood lactate during exercise (Roston et a i ,  1987; Poole et 
al., 1988., W hipp and W asserm an, 1986). Correspondingly, Casaburi et al (1987) 
reported that a reduction in the blood lactate response to exercise, after a period of 
endurance training, coincided with a reduction in the slow component.
Although this close correlation between lactate and VOj suggests a cause and effect 
mechanism , this relationship can be dissociated. Roth et al (1988) have also shown that 
circulatory occlusion during exercise, elevating blood [lactate] to a peak of 
approxim ately 5 mmol/1 has no effect on the post-exercise VO 2  response. Accordingly 
Paterson and W hipp (1991) and Ozyener et al  (2001) demonstrated the on- off- 
sym m etry of the VO 2  response at work rates where a high post exercise blood lactate 
concentration would be expected. Additionally, Poole et al (1994) elicited lactate 
concentrations of muscle lactate greater than 9 mmol/1 by infusion into dog 
gastrocnem ius muscle without any appreciable effect on V O j . Accordingly, the oxygen 
cost of lactate catabolism  during exercise has been shown, in absolute terms, to be small 
(Bertram  et a i ,  1967; Ryan et al,, 1979). Therefore although there is a high correlation 
between blood [lactate] and , in absolute terms the contribution is likely to be
small (Whipp, 1987).
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One of the favoured proposals regarding the origin of the slow com ponent surrounds the 
recruitm ent of Type II muscle fibres. Studies using isolated muscle preparations have 
shown that Type II fibres require a larger energy cost of force production than type I 
fibres (Crow and Kushmerick, 1982; Kushm erick et al., 1992). The same findings have 
been dem onstrated with hum ans (Coyle et aL, 1991, 1992; Horowitz et al., 1994; 
Bar stow et a l ,  1996, 2000). Therefore recruitm ent of additional type II fibres during 
heavy exercise would be m anifest by an increase in the oxygen cost of the exercise. 
Support for this theory comes from Bars tow et al (1996) who reported that the 
percentage o f type II fibres was positively correlated with the m agnitude of , and
Shinohara and M oritani (1992) who dem onstrated that the integrated electrom yogram  
(lEMG) of the muscle was positively correlated with the rise in pulmonary VO 2 . 
Scheuerm ann et al (2001) on critiquing Shinohara and M oritani (1992) suggested that 
the positive correlation found in their study, which came between the 4^ '^  and 7^ ’' min of 
exercise, was after the expected onset o f the slow component of 2-3 min (Linnarsson, 
1974; Paterson and W hipp, 1992). Furtherm ore the iEM G did not allow for distinction 
between which muscle fibre type was being recruited. Scheuerm ann et al (2001, 2002), 
using an EM G strategy that allowed an estim ate of proportional fibre type recruitment, 
found no evidence of significant recruitm ent of additional m otor units. Therefore they 
concluded that there is no association between fibre type recruitment and the 
response during ‘heavy’ constant load and ramp incremental exercise.
Gerbino et al (1996), M acDonald et al  (1997) and Bohnert et al (1998) have shown an 
apparent speeding of the VO 2  response for supra-threshold exercise when preceded by a 
prior “heavy” exercise bout. It was suggested that a reactive hyperaem ia from the prior 
exercise bout may augment the delivery o f oxygen to the active muscle fibres increasing
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the rate of VO 2 . This provides support for the notion o f an oxygen availability 
lim itation to oxidative phosphorylation at these work intensities (Gerbino et aL, 1996). 
These studies employed a mean response analysis for supra-threshold kinetics. Burnley 
et al (2000) using a more descriptive m ulti-com ponent model to describe the 
fundamental and slow com ponent responses separately, found that the fundamental 
response remained unchanged in response to a prior bout of heavy exercise. This 
suggests that it was the significant reduction in the slow com ponent that better described 
the results of Gerbino et al (1996), M aeDonald et al (1997) and Bonhert et al (1998). 
Studies by Bars tow et al (Abstract Koppo and Bouckaert (2000) and Scheuermann 
et al (2001) have confirm ed the findings of Burnley et al (2000). All studies 
demonstrated a reduction in the slow com ponent with a prior bout of heavy exercise. 
The original suggestion of a reactive hyperaem ia speeding VO 2  kinetics does not appear 
therefore to hold true for the fundam ental VO 2  response. This non reliance on 0% 
delivery during supra-threshold exercise is supported by the data of Gras si et aL, (1998). 
Using an isolated in situ dog gastrocnem ius preparation they demonstrated no speeding 
of VO 2  kinetics when blood flow was artificially increased, prior to and during an 
isometric tetanic contraction at 70% . Furthermore, Engelen et al (1996) showed
a slowing of the fundamental response while breathing a hypoxic inspirate but no effect 
on the slow com ponent response. Bangsbo et al (2000) on measuring limb blood flow 
and oxygen uptake responses during intense knee-extensor exercise, suggested that 
insufficient oxygen availability is not a lim iting factor at the onset of exercise.
Campbell O ’Sullivan et al (2002) suggest that the lag in the oxidative ATP delivery at 
the onset of exercise can be over come by a prior bout of exercise. They showed a 
speeding of the mean VO 2  response and a decrease in blood lactate and phosphocreatine
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utilisation during exercise when exercise was preceded by a prior warm up bout. They 
suggested that this is evidence o f an acetyl group deficit at the onset of exercise, and 
confirm ation of previous work by the same group who reported sim ilar results using 
dichloroacetate (Timmons et aL, 1996, 1998, refer to section 1.11.9). However Savasi 
et al (2002) found no difference in PCr degradation and muscle lactate concentration 
during 90 s of cycle ergom etry at 90% upon DCA administration. Grassi et al
(2002) measured the oxygen uptake response to DCA infusion in isolated canine 
gastrocnem ius muscles to 4 min bouts of electrical stimulation at -60 -70  % •
They also found aeetylcarnitine to be increased after DCA infusion, however they found 
no differences in PCr degradation, muscle lactate accumulation or VO^ on-transient 
kinetics. Furthermore Bangsbo et al (2002) directly m easured leg VO^ during high 
intensity (-110%  thigh ) one legged knee-extensor exercise after DCA infusion.
No differences in thigh VO^, muscle PCr and muscle lactate production were found 
(however arterial [lactate] was reduced).
M ore recently Rossiter et al (2003) found DCA had no effect on the time constant of the 
fundamental VO 2  and PCr responses during 8 min of high-intensity constant-load 
quadriceps exercise. How ever a reduction in the amplitude of the fundamental, and 
slow component responses was observed. This was accom panied by a reduction in 
end-exercise lactate, intram useular acidification and Pi. Therefore neither O2 
availability or m itochondrial inertia at the level of PDH appear to be prim ary 
com ponents in the control of the fundam ental component or slow com ponent of the 
supra-threshold VO 2  response.
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Further proposed m echanism s behind the slow com ponent include an increase in 
circulatory levels of epinephrine (G aesser et aL, 1994), a reduction in unloading of O 2 
via the Bohr effect (W asserm an et aL, 1991), the O2 cost o f ventilation (Aaron et aL, 
1992; Carra et aL, 2003), the 0% cost of extraneous m uscular work, an increase in 
tem perature (QIO effect), and a decreased efficiency of P-O coupling subsequent to a 
tem perature rise (W illis and Jackm an, 1994). W hile these m echanism s are plausible 
their influence on VO 2  is likely to be limited. Their role in the V02^,,) is likely to be
only m inor as demonstrated by the on-off-asym m etry in the VO 2  kinetic response for 
work rates above the lactate threshold (Patterson and W hipp 1991, Ozyner et al 2001). 
Increases in muscle tem perature and the QIO effect would be expected to be exhibited 
in the off transient as well as the on transient response.
W hile the mechanism/s controlling VO 2  in these exercise dom ains are unknown it is 
apparent that the slow com ponent of the response is only evident at work rates which 
coincide with a sustained increase in blood [lactate] (Boston et aL, 1987; Poole et aL, 
1988; W hipp and W asserman, 1986), and it is dependent on a relative work rate rather 
than an absolute work rate (Casaburi et aL, 1987). W hile blood laetate is unlikely to be 
a primary cause o f the VO 2  excess, these two components of the exercise response 
appear linked. Studies that have shown a reduction of the slow com ponent with a prior 
exercise bout have often shown a concom itant decrease in blood lactate (Bonhert, 1998; 
Gerbino et aL, 1996; Barstow et a l ,  2000). A similar effect has been demonstrated in 
response to endurance training (Poole et aL, 1990; Casaburi et aL, 1987; Carter et aL, 
2000). Therefore some aspect o f m uscular adaptation to endurance training is an 
im portant factor in determ ining the VO 2  response to supra threshold exercise. W hile 
Sheuerm an et al (2001, 2002) have suggested that muscle fibre type recruitment during
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exercise is not a principal com ponent in the developm ent o f the slow component, the 
predom inance o f a particular fibre type does appear to have a role. Barstow et al (1996, 
2000) suggested that the VO 2  gain (AVO^ I AWlc ) during ramp and incremental exercise 
is greater for a high proportion of type I fibres and that the relative contribution of the 
VO 2  slow com ponent to the total VO 2  response to heavy exercise is negatively related 
to aerobic fitness (as ) and/or the proportion of type I fibres in the working
muscles. Furtherm ore Pringle et al (2003) suggest that the time constant for heavy 
exercise, the slow com ponent of the response, and the fundam ental gain are all 
correlated with Type I muscle fibres. Therefore high aerobie developm ent appears to 
have an attenuating effect on the slow com ponent but a surprising increase in the 
AVO 2 1 AWlc gain and a possible influence on the speed of the kinetic response. The 
suggested increase AVO 2  f AWlc is surprising because fast twitch (type II) muscle fibres 
have been shown to be less efficient than slow-twitch (type I) fibres (Crow and 
Kushmerick, 1982; Kushm erick et aL, 1992). The findings of Barstow et al (1996, 
2000) and Pringle et al (2003) are sim ilar in some ways to the findings of Koga et al
(1999) who dem onstrated a reduction in the fundamental gain with no change in the 
VOj time constant and an increase in the VO 2  slow component when heavy exercise 
was performed in the supine position. The results of Koga et al (1999) are thought to be 
as a result of a reduced perfusion pressure due to attenuated O2 delivery, however the 
sim ilarity o f the results may suggest that the fundamental gain in type I muscle fibres is 
somehow related.
W hipp et al (2002) suggest that slow com ponent should not be viewed as a single 
metabolic com partm ent with a single t  and a single gain. As described in section 1.9, 
this does not hold true for models like that o f Bearden and M offat (2000) because of the
55
inappropriate steady-state value projected from  the tim e course o f the response i.e. a 
steady-state is projected beyond . W hipp et al (2002) suggest that the slow
com ponent is unlikely to represent a single additional metabolic com partm ent recruited 
as a square wave at its onset. They propose that it is more likely the VOj response is 
projecting towards a continually moving asym ptote that reflects an additional energy 
cost of force production within the muscle. This model fits with the on-off-sym m etry of 
the VO 2  response above threshold and lends itself more to progressive fibre type 
recruitment throughout exercise rather than fibre type per se as the likely ‘prim ary’ 
factor controlling the tim e course and extent o f expression.
The factors influencing the fundamental VOj response to supra-threshold exercise 
appear to be associated to those governing the sub-threshold VO 2  response. However 
the origin of the VO 2 slow com ponent rem ains a mystery. W hat is clear is that its 
expression is slow and of delayed onset, and that it is only apparent above the lactate 
threshold when given time to develop.
1.13 Dichloroacetate
The potential m etabolic and clinical properties o f Dichloroacetate (DCA) have been a 
subject of keen interest since the 1960s (Stacpoole et aL, 1998); yet due largely to early 
fears over its toxicity, the vast majority o f studies have been confined to the animal 
world and only a little is known about the extent of its application in health and disease.
DCA is a generic com pound formed from, amongst others, the chloridation of drinking 
water. Previous incarnations include D-gluconodim ethylam ino acetate or Pangamic
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acid (vitamin B |5, its earliest form); and di-isopropyl am m onium  Dichloroacetate the 
subsequently discovered, aetive component, o f the early Pangamic acid preparations 
(Stacpoole, 1989). Stacpoole and Feltz (1970) first discerned the active m oiety in the 
com plex was Dichloroacetate itself. It is now more com m only used in a sim pler form: 
Sodium  Dichloroacetate.
DCA acts on a num ber of enzym e processes throughout the body, impacting on the 
heart, skeletal musculature, liver, kidneys, nerve and brain function. Its main m etabolic 
action is to activate the pyruvate dehydrogenase complex (PDH), lowering levels of 
blood lactate and increasing pH (Stacpoole, 1989). It is also known to stim ulate 
glycogenesis, inhibit fatty acid oxidation and suppress gluconeogenesis.
The therapeutic value of these m etabolic actions has been tested in conditions such as 
lactic acidosis, diabetes and heart failure, often with positive results (Stacpoole, 1989). 
Lactate lowering properties have earm arked it as a possible ergogenic aid and its role in 
activating PDH make it a viable tool for studying metabolic control and response.
1.14 M etabolic actions o f DCA.
1.14.1 Activation o f Pyruvate Dehydrogenase.
Pyruvate dehydrogenase is a m ultienzym e com plex situated on the inner mitochondrial 
membrane. Its principal function is to catalyze the irreversible oxidation of pyruvate to 
acetyl CoA (fig. 20). PD H exists in two forms one inactive, and one active. Regulation 
of its activity is determ ined by reversible phosphorolation, with the phosphorylated 
com plex being the inactive form.
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Figure 20  - Site o f action o f  D CA . The PD H  com ponent o f the pyruvate dehydrogenase com plex Is 
reversib ly  phosphorylated , and inactivated , by PD H  kinase. D CA  inhibits the k inase, thereby m aintain ing 
PD H  in its unphosphorylated , active form  (from  Stacpoole, 1989).
PDH kinase and PDH phosphatase mediate the phosphorylation and dephosphorylation 
respectively o f the PDH complex, Fig. 20 (Stacpoole et aL, 1998). DCA inhibits the 
kinase, preventing rephosphorolation of PDH by ATP and therefore m aintains the 
‘com plex’ in its active form. Dichloroacetate acts directly on the kinase com bining 
com petitive and non-com petitive inhibition with ATP. Pratt and Roche (1979) showed 
that in the presence of AD P the inhibition was competitive, and in the absence of ADP 
the inhibition was non-com petitive. Furthermore, in the absence of ATP and/or 
calcium , dichloroacetate has no effect (Crabb et aL, 1981), and in the presence of 
acetate the effects can be partially reversed (Putman et aL, 1995).
58
The result of PDH activation is an acceleration of pyruvate flux into the m itochondria, 
accum ulation of available acetyl groups for the tri-carboxylic acid (TCA) cycle, and a 
decrease in circulating levels o f lactate and alanine. As lactate is associated with a 
hydrogen ion, its reduction results in a rise in pH and production of HCO3' (Crabb et aL, 
1981).
This activation of PDH by DCA is rapid and marked in nearly all mammalian tissues, 
except the testes and the gut (Stacpoole, 1989). The speed with which DCA exerts its 
effects (hypolactatemic effects can be detected within 15 min of a single oral dose 
(Curry et aL, 1985; Curry et aL, 1991)) is due largely to its rapid uptake by the 
mitochondria. DCA has been shown to be an excellent substrate for the 
monocarboxyl ate transporter o f plasm a m em branes (Stacpoole, 1989). This is the same 
transporter used by pyruvate, and the two directly compete. In high doses it is therefore 
possible that DCA may inhibit pyruvate uptake and oxidation by the cell.
Oral doses of DCA (50 mg/kg), lead to plasm a concentrations o f approxim ately 1 
mmol/1. This is the concentration required for maximal stim ulation of enzyme activity 
in intact cells or tissues (Stacpoole, 1989). The extent to which DCA activates PDH in 
intact human muscle appears to be approxim ately 2-4 fold at rest (Timmons et aL, 1998; 
Howlett et al., 1999a&b; G ibala and Saltin, 1999; Parol in et aL, 2000).
As already mentioned, hypolactataem ic effects can be detected within 15 min of a single 
oral dose. This effect reaches a m axim um  after approximately 60 min, and is sustained 
for a m aximum  of 2 h (Curry et aL, 1991; W ells et aL, 1980). The half-life of DCA in 
plasm a is 30 min- 2 h (Henderson et aL, 1997). DCA has an unusual and thought to be 
unique ability to inhibit its own m etabolism  (Stacpoole., 1989). An initial dose will
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increase the half-life of any subsequent dose. Chu (1987) has found that individuals 
required from 1 to 8 weeks between identical doses, before the original plasm a 
clearance rate was restored.
The notion of responders and non-responders to dichloroacetate is not one that has been 
discussed significantly in the literature. It is however an im portant consideration when 
interpreting findings. Stacpoole et al (1983) noted that when adm inistering DCA to 13 
patients with lactic acidosis that only 7 o f the patients responded to treatm ent with 
DCA. A response was classed as a 20% decrease in arterial lactate concentration. 
Carraro et al (1989) also noted that out o f six healthy subjects, PDH activity was not 
effectively increased in one individual. It is difficult to draw conclusions from the 
results from Stacpoole et al (1983), because the aetiology o f the lactic acidaem ia in the 
subject group was diverse, however the results o f Carraro et al (1989) suggest this is a 
consideration.
1.14.2 The effect o f DCA on lactate metabolism.
DCA has been shown to be effective in significantly reducing lactic acidaem ia resulting 
from genetic predisposition (Stacpoole et al., 1983), acquired clinical conditions 
(Stacpoole et al., 1983), exercise (M errill et a i ,  1980) and hypoxia (Parolin et al., 
2000).
Lactic acidosis is a clinical condition caused by the hydrogen ions associated with lactic 
acid. The aetiology of this disease is diverse. Common causes are diabetes and a 
genetic deficiency in one or more o f the enzymes involved in oxidative metabolism. 
Typically, blood lactate levels are >5 mmol/1, bicarbonate levels <15 mmol/1, and
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arterial pH <7.25 (Park and Arieff, 1982). The mortality in patients with lactic acidosis 
can be greater than 85% (Park and A rieff 1982). Park and A rieff (1982) have shown 
in dogs, and Stacpoole et al (1983) in humans, that the actions o f DCA are enough to 
significantly reduce lactic acidosis and increase pH.
The successful reduction of blood lactate levels in lactic acidosis has led to the 
investigation of the effects of DCA in reducing the levels of lactate during exercise. 
During exercise where there is high anaerobic energy yield, there is a significant 
production of lactate, and an associated decrease in pH. The production of H^ ions 
contributes significantly to the m echanism s of muscle fatigue and muscle soreness 
during exercise. Therefore reducing lactate concentrations during exercise would be 
beneficial, especially when considering populations where everyday activity can place 
significant demands on anaerobic m etabolism  i.e. heart failure and COPD.
M errill et al (1980) used exercising dogs to study the effect of DCA on circulating 
lactate in vivo. At three workloads of light, m oderate and strenuous intensity the rise in 
lactate was significantly attenuated. A reduction in lactate levels of 60% was reported. 
Durkot et al (1995) using an exercising rat model found lactate levels to be lower after a 
treadmill run at approxim ately 60% ^intil exhaustion. Schneider et al (1981)
again using a rat population, found lactate levels to be reduced during exercise until 
exhaustion where peak blood lactate was the same in both the DCA and placebo group. 
A sim ilar finding by Carraro et al (1989) in humans, showed that during an incremental 
increase in work rate DCA decreased lactate concentrations up to approxim atly 80% 
. However there was no reduction in the peak lactate concentration at 
exhaustion. Hatta et al (1991) dem onstrated a reduetion in blood lactate during
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submaximal prolonged exercise but no reduction after supra maximal short duration (2- 
3 min) exercise.
There are two main theories as to why blood lactate concentration increases during 
exercise. Classically it was thought that a deficiency in the supply of oxygen led to an 
impairm ent of respiratory chain function, increasing cytosolic NADH, thereby 
increasing the reduction o f pyruvate to lactate (W asserm an et aL, 1973). A lternatively, 
it has been suggested that increases in exercise intensity result in stim ulation of 
glycolysis, increasing the form ation o f pyruvate. W hen the amount o f pyruvate exceeds 
its rate of uptake in to the mitochondria, the rate of lactate production is increased 
(Stanley et aL, 1985).
It may be the case that the reduction of lactate observed at submaximal but not maximal 
work rates with DCA, is due to a com bination of mechanism s resulting in lactate 
increase. Carraro et al (1989), suggested that a limitation in pyruvate dehydrogenase 
activity contributes to the increase in plasm a lactate during submaximal exercise but at 
maximal intensities their data are consistent with oxygen availability being rate limiting. 
The dose of DCA they em ployed was adequate to reduce lactate concentration early 
post exercise when blood lactate levels were equal to if not greater than that at end 
exercise. Presum ing pyruvate levels rem ained equally high this would suggest that the 
DCA dosage was sufficient to lower lactate levels at exhaustion, providing that there 
was adequate oxygen availability for the m aintenance o f the respiratory chain function 
(Carraro et aL, 1989). This would suggest that if DCA were to have any effect on 
exercise perform ance it would be better employed in longer duration submaximal 
exercise.
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However, in contrast to Carraro et cil (1989), Ludvik et al  (1993) using a sim ilar 
exercise protocol found laetate to be reduced throughout exercise, and Roberts et al 
(1997) found lactate levels to be significantly reduced only between 80 and 100% 
VGjmax • More recently Howlett et al (1999), Savasi et al (2002), Grassi et al (2002) 
and Bangsbo et al (2002) found no lactate lowering affect of DCA adm inistration in 
high intensity, short duration exercise (<4 min). Rossiter et al (2003) however found 
end exercise and m uscular acidification to be reduced after 8 min of high-intensity knee 
extensor exercise.
Therefore the effect of DCA on lactate metabolism appears dependent on the intensity 
and duration of exercise, with an effect more likely to be seen during longer sub- 
m aximal exercise bouts. This may reflect an increase in blood lactate removal by the 
liver and non-exercising muscles rather than maintenance o f heightened pyruvate flux 
through PDH of the recruited musculature. DCA administration would activate PDH in 
nearly all mammalian tissues (see section 1.14.1) therefore the balance between lactate 
production and clearance may favour clearance at lower exercise intensities where 
production is less rapid.
1.14.3 The effect o f DCA on metabolism : general.
In conditions where glycolytic m etabolism  is not limited DCA appears to have no effect 
on circulating glucose levels. How ever DCA is effective in long term reduction of 
hyperglycaem ia in diabetes, and short term reduction of blood glucose levels in the 
nondiabetic fasted state (Stacpoole and Felts 1970).
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The principal m echanism  behind this decrease in glucose is stimulation of 
phosphofructokinase and pym vate dehydrogenase, increasing glycolysis. The 
m echanism  behind pyruvate dehydrogenase activation has already been discussed (refer 
to section 1.14).
It is thought that DCA induced inhibition of fatty acid utilisation by muscle may play a 
part in the regulation o f phosphofructokinase activity. It has been proposed that cells 
exposed to high levels o f free fatty acid, such as occuring in diabetes or starvation, 
oxidise these in preference to glucose (Stacpoole and Felts, 1970). The result would be 
an increase in the levels of citrate, a known inhibitor o f phosphofructokinase. A 
decrease in fatty acid oxidation has been reported upon administration of DCA (Crabb 
et aL, 1981). Citrate levels should therefore be reduced and glycolysis subsequently 
stim ulated; lowering glucose levels.
The decrease in circulating level o f alanine and lactate due to increased pyruvate 
dehydrogenase activity denies the liver important gluconeogenic precursors. This 
disruption of the alanine and Cori cycles by which lactate and alanine released from the 
periphery are utilized for hepatic glucose synthesis, further contributes to a reduced 
circulating glucose levels upon DCA administration. Diamond et at (1982) showed that 
the effect on hepatic glucose production was due to not only a decrease in the release of 
alanine and lactate, but also a direct inhibitory effect on hepatic glucose synthesis.
Furtherm ore DCA has also been shown to inhibit gluconeogenesis from lactate in renal 
cortical slices from both fed and fasted diabetic and nondiabetic rats (Pratt and Roche, 
1979).
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At very high concentrations (>10 mmol/1), DCA has an inhibitory effect on fatty acid 
synthesis. At lower levels (Immol/1) it has a significant stim ulatory effect. The 
apparent difference between the effect o f high and low concentrations is thought to be 
due to a difference in concentrations in the products of DCA m etabolism  (glyoxylate or 
oxalate). Both of which have been linked with an inhibitory effect on the liver, 
particularly at the level of pyruvate carboxylase (Crabb et aL, 1981).
Blackshear et al (1974) have reported evidence that suggests DCA inhibits fatty acid 
oxidation. They proposed that the lowered P-hydroxybutyrate/ acetoaeetate ratio and 
lowered citrate levels in their isolated liver preparations, indicate decreased fatty acid 
oxidation. Crabb et a l{ \9 '^ \ )  suggest that the results indicate more a decreased release 
of fatty acids rather than an increased extraction.
1.15 The effect o f DCA on H aem odynam ics.
Stacpoole et al (1983) reported that DCA increased systolic pressure and cardiac output 
in critically ill patients with hypotension and lactic acidosis. This apparent positive 
inotropic effect occurred before any changes in systolic acid-base status, and was 
unaccom panied by any changes in heart rate or diastolic blood pressure.
W argovich et al (1988) have shown a positive effect from DCA on cardiac function in 
Coronary Artery Disease. Left ventricular (LV) stroke volum e was increased on 
adm inistration of 35 mg/kg DCA; as was myocardial efficiency (LV/myocardial oxygen 
consumption). Heart rate, mean aortic pressure and myocardial oxygen consumption 
were unchanged. A decrease in system ic vascular resistance was also noted.
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Ludvick et a / (1991), found sim ilar results in healthy volunteers. On administration of a 
single dose of DCA (50 mg/kg, DCA), cardiac index and oxygen delivery were 
increased, and peripheral vascular resistance was decreased. No effect was seen in heart 
rate, oxygen consum ption or carbon dioxide output.
The increase in myocardial efficiency reported by W argovich et al (1988) is thought to 
be due to the inhibition of fatty acid oxidation and stimulation o f glucose metabolism. 
This change in substrate utilisation increases the amount of adenosine triphosphate 
synthesised per m olecule of oxygen. This alternative substrate selection has also been 
reported in isolated heart preparations (W hitehouse et aL, 1974).
This positive effect of DCA on haem odynam ic param eters may prove to be of benefit in 
heart disease where cardiac function is limited, in hypotension, and with exercise 
intensities where improved perfusion and oxygenation of peripheral tissues may 
augment the system  response to a change in energy demand.
1.16 DCA and exercise perform ance.
The main factors thought to contribute to muscle fatigue during exercise include [Pi], 
pH, alterations in Ca '^*’ release and sensitivity, and muscle glycogen content. Of these 
DCA has been shown to decrease [Pi] and increase pH and elicit a muscle glycogen 
sparing effect (Tim mons et aL, 1996; Grassi et aL, 2002; Schneider et aL, 1981; Durkot 
et aL, 1995; Rossiter et aL, 2003). Coupled with a potential speeding of VO^ kinetics, 
these properties have identified DCA as a possible ergogenic aid for exercise 
performance. This could prove valuable for understanding/im proving athletic
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performance. M ore importantly it may prove significant in improving activity levels 
and quality of life in some patient groups.
An improvement in m uscle function upon DCA administration has been reported for 
isolated muscle preparations. Tim m ons et al (1996) dem onstrated that DCA reduced 
muscle fatigue by -35%  during 20 min o f ischaemic contraction in a canine model. 
Similarly Grassi et al (2002) found that the fatigue index in electrically stim ulated dog 
gracilis muscle was im proved by -8 %  after DCA infusion during a 4 min electrically 
stim ulated isometric tetanic contraction corresponding to -60-70%  of peak VO2 .
The exercising rat studies by Schneider et al (1981) and Durkot et al (1995) further 
support a role for DCA in im proving exercise performance. Schneider et al (1981) 
found DCA enabled rats to swim  for an additional 99 s before exhaustion. Durkot et al 
(1995) found improved run times in DCA treated rats when com pared to controls (169 
min vs. 101 min). In both studies improved performanee was associated with 
attenuation in the levels of blood and muscle lactate, and an increased efficiency o f 
glucose utilisation.
Hatta et al (1991) found that DCA significantly decreased blood lactate concentrations 
and inereased the oxidative removal of lactate during prolonged exercise in mice. They 
found no effect however, on lactate concentration or removal in supram axim al exercise 
where the duration of exercise was 2-3 min. The absence of a lactate lowering effect 
was reflected by equivalence in the exercise duration between both groups. The effect 
on prolonged exercise duration was not reported.
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Ludvik et al (1993), Carraro et al (1989) and Roberts et al (1997) studied the effect of 
DCA  on maximal exercise performance in healthy humans. A positive effect was found 
by Ludvik et al (1993). They reported a decrease in blood lactate concentration 
throughout exercise, an increase in , an increase in m aximal work capacity, and
an increase in VO 2  at the lactate threshold (LT). H ow ever no effect was found by 
Carraro et al (1989) and Roberts et al (1997). Carraro et al (1989) found no differences 
between peak lactate or time to exhaustion during an incremental work protocol, even 
though blood lactate concentrations were lowered until approxim ately 80% •
Roberts et al (1997) reported lower lactate concentrations between 80-100% .
This was not associated with a prolonged tim e to fatigue or an increase in .
A lthough there is evidence to suggests that DCA has a positive effect on muscle 
function (Timmons et aL, 1996; Grassi et al., 2002; Schneider et al., 1981; Durkot et 
a l ,  1995; Rossiter et al., 2003), an improvement in exercise performance has not yet 
been well described for exercising humans. The research to date suggests that the 
effects of DCA may be more effective during submaximal rather than maximal exercise. 
This may be due in part to the relative activity of PDH. In high intensity exercise 
resulting in exhaustion after ~3 min, PDH activity is only higher during the first minute 
o f exercise as a result o f DCA ingestion (Gibala and Krustrup AbstracP^”^). Increased 
activity during this time period appears to be unable to com pensate for the underlying 
mechanisms of fatigue. During more prolonged exercise DCA can activate PDH above 
normal levels for a longer period of time (Gibala et al., 1997).
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1.17 Toxicology o f DCA
There has previously been some concern over administration o f DCA to humans, due to 
potential toxic effects. There have been suggestions that unpurified preparations of 
DCA were mutagenic. However, studies using DCA o f established purity and 
hom ogenity failed to show m utagenicity, and early chronic studies using DCA in 
rodents and dogs revealed no evidence o f serious toxicity.
W hen administered orally for several weeks to Ratsor dogs at doses > 50 mg/kg, DCA 
is potentially neurotoxic. Peripheral neuropathy has been reported in one young adult 
man with homozygous fam ilial hypercholesterolaem ia who received single daily doses 
of 50 mg/kg DCA for up to four months. Several weeks after cessation of therapy these 
changes were resolved. In short term studies with other human subjects no drug related 
adverse effects have been reported (Stacpoole, 1998).
Therefore, short term studies using “therapeutic” doses 35-100 mg/kg present minimal 
risk to human subjects. The only potential noticable side effect is a mild sedative, or 
tranquilizing effect, that in some cases may cause drowsiness for several hours 
(Stacpoole, 1998).
1.18 The effect o f DCA on m itochondrial respiration.
Increased pyruvate flux through PDH as a result of DCA administration has the 
potential to influence the rate of m itochondrial respiration by increasing substrate 
availability for the electron transport chain and decreasing the production of lactate 
associated hydrogen ions.
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At the beginning of exercise, energy dem and cannot be met solely by aerobic means. In 
the steady state, the rate of m uscular oxidative phosphorylation is able to meet the 
dem ands for ATP hydrolysis. D uring the transition to this steady state however, 
oxidative phosphorylation is unable to meet the new demand and a fall in ATP is 
buffered by phosphocreatine (PCr) temporally, until the rate o f oxidative 
phosphorylation can “catch up” .
Using the extent of PCr degradation as a direct marker of the oxygen deficit, Tim m ons 
et al (1998) found it to be reduced by DCA ingestion. During submaximal ( -  45 % 
W Rm ax) single leg extension they found that PCr breakdown and by inference Oidef. 
was reduced by 50%. DCA increased resting PDH activity threefold, and elevated 
aeetylcarnitine fivefold. It was suggested that the increased PDH activity with DCA 
ingestion, results in an increase in the Tricarboxylic acid (TCA) cycle pool size due to 
the increased pyruvate flux into the m itochondria. Sahlin et al (1988) have proposed 
that an increase in TCA pool size is rate limiting to TCA flux and to the rate of 
oxidative phophorylation. The TC A  pool (or TCA intermediates (TCAI)), does increase 
on exercise. However, not all the evidence suggests that this is the principal mechanism 
behind the results described by Tim m ons et al (1998). Indeed, G ibala and Saltin (1999) 
noted that TCAI intermediate pool size actually decreased on DCA infusion. They 
hypothesised that the increased PDH activity at rest, actually diverts pyruvate away 
from the TCAI pool toward acetyl-CoA formation. Constantin-Teodosiu et al (1999) 
suggested that the TCA pool acted more as a buffer for increased pyruvate availability; 
and had little significance to TCA flux. This is a notion supported by G ibala et al 
(1998) who observed large changes in TCA cycle flux with relatively small changes in 
TC A I pool size. In an earlier paper they recom mend that TCAI pool size should not be 
used as an indicator of TCA  flux (Gibala et al., 1997).
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Howlett et al (1999) reported sim ilar results to that of Tim m ons et al (1998). They
found that during constant work exercise (-65%  ), DCA resulted in reduced
phosphocreatine utilisation; m easured during the first two m inutes of exercise. This 
was accom panied by lower levels of lactate. Like Timm ons et al (1998), they found 
DCA increased both acetyl-CoA and aeetylcarnitine at rest; these increased levels were 
maintained during the first 2 min of exercise.
The results from these studies suggest that the provision o f substrate is limiting the 
increase in oxidative phosphorylation at the onset of exercise. Acetyl-CoA and 
aeetylcarnitine are proposed by Tim m ons et al (1998) as the “m ajor determ inants” of 
the oxygen deficit. They hypothesise that on the com m encem ent of exercise, any lag in 
substrate supply is overcom e by the increased acetyl group “store” in the mitochondria.
1.19 The effect o f Dichloroacetate on oxygen uptake.
Evidence from the studies o f Tim m ons et a l (1998) and Howlett et al (1999) indicating 
a reduction in the deficit with DCA administration, suggests that there may be a rate 
limiting step for VO^ kinetics at the level of PDH (see section 1.11.9 for further 
discussion). The apparent reduction in the size of the O2 deficit would suggest that 
activation of PDH increases the rate o f VGj during the exercise transition. However, 
evidence from the study of Rossiter et al (2003) which directly m easured VO 2  kinetics 
in response to DCA administration does not support this. Rossiter et al (2003) 
sim ultaneously measured muscle PCr breakdown and pulmonary oxygen uptake using 
^'p-m agnetic resonance spectrometry and breath-by-breath gas exchange respectively.
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A reduction in PCr breakdown was not accom panied by a speeding o f the kinetics for 
VO 2 . The extent to which the kinetics may be speeded through the m echanism  
suggested by Tim m ons et al (1998) and Howlett et al (1999) is not reported. Therefore 
it is possible that the sensitivity of the m easurem ent in the Rossiter et al (2003) 
study was not great enough to detect a change. This is possible as the metabolic 
demand of the exercise em ployed (supine, knee extensor) was low and therefore the 
AVG2 in oxygen uptake small (see section 4 .1 .2). The results from Howlett & Hogan 
(2003) support this possibility. They dem onstrated an accelerated decrease in PO 2 in 
isolated single frog muscle fibres with DCA administration, a finding that agrees with 
the studies of Tim m ons et al (1998) and How lett et al (1999). However, the magnitude 
o f the change ( -2  s) is possibly too small to be appreciable in vivo.
DCA may also influence the ÛG, response at work rates above the lactate threshold. As 
discussed earlier (section 1.12) the temporal response of VOj above the lactate threshold 
does not follow first order kinetics. An added slow com ponent to the response is 
observed that delays, or prevents the attainm ent of a steady-state (Patterson and W hipp, 
1991). The slow com ponent is only observed at exercise intensities where there is 
lactate accumulation in the blood. This association has led to the two responses being 
linked (see section 1.12). The effect of DCA on lactate production has already been 
discussed (see section 1.14.2). Its lactate lowering properties during exercise would 
suggest that any link between the blood lactate response and VO 2  during supra- 
threshold exercise could be borne out through DCA supplementation.
A further speeding of the VO 2  kinetic response may be realized through its reported 
haemodynamic properties (Ludvik et a l ,  1991). Gerbino et al, (1996) reported that
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VO 2  kinetics above the lactate threshold were speeded by a prior bout of heavy intensity 
exercise (above LT). The suggested m echanism  behind this speeding was an improved 
m uscle perfusion during exercise, as a consequence of a residual metabolic acidaemia.
A sim ilar effect may be seen upon DCA administration. Peripheral vasodilatation and 
increases in cardiac contractility are both reported effects of DCA. These may be 
significant enough to prom ote the same form of kinetic speeding observed in the 
Gerbino et al (1996) study. Evidence against this comes from the isolated dog muscle 
preparations of Tim m ons et al (1996), These investigators reported no changes in 
m uscle perfusion during the DCA trial. However these findings have yet to be 
demonstrated in vivo.
DCA therefore has the potential to affect the VOj response to dynamic exercise. A 
better description o f these responses may identify it as a useful tool for the investigation 
of possible controllers of the VO 2  response to exercise. The exact underlying 
m echanism s behind this response remain to be determined and the actions of DCA may 
well provide valuable insight. In disease the VO 2  response to exercise can be 
dram atically impaired as a result of severe functional limitation. A positive effect on 
oxygen kinetics through DCA administration may improve such limitations. Identifying 
it as a possible ergogenic aid for patient groups.
1.20 Objectives and hypothesis
The studies of Tim m ons et al (1998), How lett et al (1999) and Parolin et al (2000) all 
demonstrated a reduced PCr breakdown on DCA administration. By inference, this was 
suggested as a clear dem onstration o f a reduced oxygen deficit by either a reduced
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steady state gain or a speeding o f the kinetic response (Tim mons et al., 1988). H ow ever 
none of these studies directly m easured VO 2  and the biopsy frequency for PCr 
m easurem ent did not allow tem poral resolution in any of the studies.
A reduced oxygen deficit may be apparent in a speeding o f the VO 2  on response or a 
reduction in the fundamental gain com ponent during m oderate exercise. If this is the 
case, a reduced substrate oxidation may also be borne out in an increased ‘aerobic 
range’. This may be evident in a rightward shift o f the lactate threshold during 
incremental exercise, as shown by Ludvik et al (1993) but not by Carraro et al (1989) 
and Roberts et al (1997).
Therefore the first two studies were designed to look at the effects of DCA on ramped 
incremental exercise and moderate sub-threshold exercise, using breath-by-breath 
m easurem ent of VO 2  for high temporal resolution, blood analysis (lactate, bicarbonate, 
pH and glucose) and near-infrared spectroscopy as an index o f muscle oxygen 
saturation.
Study 3 was designed to look at the effects of DCA on supra-threshold VO 2  kinetics 
using the same measures as above. Rossiter et al (2003) most recently showed a 
reduction in end-exercise lactate, intram uscular acidification and a reduction in the VO 2  
slow component, with no change in the time course of the fundam ental response. These 
effects of DCA may be borne out in an improved exercise performance during 
prolonged sub-maximal exercise, as found by Schneider et a l { \9 ^ \ )  using rats.
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Therefore the aim of this series o f experim ents is to further investigate the effects of 
dichloroacetate on oxygen uptake and exercise perform ance; with a view to 
understanding more fully the role o f pyruvate dehydrogenase as a functional ‘stenosis’ 
in the response, and explore the ergogenic effects of DCA on maximal exercise 
and exercise duration.
The nul 1-hypotheses for these studies is that metabolic actions of DCA do not change 
the rate or m agnitude of increase in during exercise at sub-m axim al and maximal 
work rates.
The alternate hypothesis is that DCA increases the rate and m agnitude of the ŸO^ 
response to sub-maximal and maximal exercise.
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Chapter 2 
General Methods
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2.1 Subjects
Subjects were healthy male volunteers between 18-35 years of age. All procedures 
were reviewed and approved by the University of Glasgow Research Ethics Com m ittee. 
The proposals are shown in Appendix 1. After obtaining informed consent all subjects 
were fam iliarised with the laboratory set-up and all procedures to a point where they felt 
entirely comfortable with the protocols and equipm ent used, A health questionnaire 
was adm inistered to ascertain health status Appendix 2. Subjects were excluded if they 
had any history o f dizziness, faints, heart or lung disorders, asthm a or if they were on 
any medication or supplem ent that may have affected heart rate, breathing or exercise 
performance. All subjects were physically active but not involved in a structured 
training program or com petitive sport.
2.2 Instrum entation
2.2.1 M etabolic Cart
The QP9000 (Morgan M edical, Kent, U.K.) was used for all gas exchange 
measurements and calculation of metabolic variables. The system comprises o f a 
quadrupole mass spectrom eter integrated with a computer and a turbine flow meter. 
The system allows continuous output o f 4 dry gas concentrations and 4 analogue inputs 
every 20 ms. Results are displayed on-line during the test, saved to disk and were 
displayed on a chart recorder for continuous hard copy.
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2.2.1.2 M ass Spectrom eter: Principle o f O peration
At the heart o f the mass spectrom eter operation is the quadrapoie. The quadrapole 
com prises of four precision ground, electrically charged, cylindrical rods arranged 
concentrically and housed within a vacuum. The quadrupole theory works on the basis 
that ions of differing mass will behave uniquely when subjected to electrical fields of 
differing strength.
M easurem ents are made by drawing gas through a narrow bore sample line at a rate of 
approxim ately 50 ml/min. A small portion of this gas is directed into an ion source 
through the “m olecular leak". This is a tiny aperture that lets only a fraction o f the gas 
sample pass through. An ion source bom bards the gas m olecules with electrons 
creating ions. These ions are extracted and fed to the quadrupole.
W ith the appropriate potentials applied to the rods, only the ions of a pre-selected 
molecular weight range will pass the filter to create a small electrical charge on 
detecting plates. Therefore, the quadrupole acts as a “tuneable filter” allowing only one 
species of gas to pass at a time. The rapidity of the analyser allows eight channels, 
therefore if required eight gases, to be sam pled every 20 ms. The electrical signals 
detected are amplified, digitised and fed to the computer.
2.2.1.3 Flow Sensor; Principles o f Operation
A light weight turbine volume m easurem ent module (Interface Associates, Laguna, 
Nigel, CA.) was used for m easurem ent of expired volume. As the subject breathes, the 
rotation of a low resistance helical impeller is detected by 4 infra-red light beams
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aligned across the flow m eter bore. The light beams are broken in sequence as the 
im peller spins and the breaks in the light beams are detected by phototransistors which 
generate a voltage output. The num ber of revolutions per unit tim e provides a m easure 
of gas flow. Integrated over tim e this gives volume. The output is linear from 0.005 to 
12 1/s with an accuracy o f 1.5% (M anufacturer’s literature).
2.2.2 Cycle Ergom eter
All exercise was performed on an electrom agnetically-braked cycle ergom eter 
(Excalibur Sport, Lode, NL). The ergom eter is cadence independent and linear between 
40 rpm and 120 rpm (M anufacturer’s handbook). Figure 21 shows a Bland/Altman 
comparison of the output from the ergom eter against the input from a Vacum ed 
ergom eter calibrator (Vacumed, M odel 17800, Ventura, California, USA). The mean 
difference between the two devices was 4 W  over a 20 W  - 500 W  range.
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Figure 21 -  B iases and lim its o f agreem ent for m ethod o f m easurem ent plotted against the mean o f  the 
reference plus the m ethod (B land/A ltm an, 1986). The plot show s a mean bias o f 4 W + 2.6 W (m ean + 
SD ) over a 20 -  500 W range.
The work rate for each test was pre-program med into a controlling com puter interface 
prior to each test starting. Every attempt was made to ensure that the ergom eter was 
set-up to be as com fortable as possible for each individual. Once a position was 
established it was m easured to ensure the same position was held on each subsequent 
visit. The addition o f triathlon bars allowed the subjects to support their upper body 
reducing any extraneous work performed by the musculature of the arms, shoulders and 
torso. When subjects were advised to adhere to a particular range of cadence (RPM ), 
they had the aid of visual feedback in the form of a dial indicating RPM mounted on the 
front of the ergometer.
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2,2.3 Near Infrared Spectroscopy (NIRS)
2.2.3.1 Principles o f O peration
NIRS provides a convenient, non-invasive method for investigating the oxygenation 
status of skeletal muscle. Developed by M illikan (1937) NIRS works on the principle 
o f selective absorbance of near-infrared light (wavelengths between 760 and 1000 nm) 
by the region of study. W hen near-infrared light (NIR) is shone at tissue, some is 
scattered, some is absorbed and some travels through unaffected. The amount of light 
absorbed is dependent on the oxygenation status of haem oglobin (deoxygenated (Hb), 
oxygenated (HbOz), m yoglobin (deoxym yoglobin (Mb), oxym yoglobin (MbOz) and 
cytochrom e oxidase (CtOx). These compounds all contain a strong chrom ophore group 
which selectively absorbs NIR light.
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F igure 22  - D iagram  illustrating the absorp tion  spectra for Hb & H bO ; in the N IR  region. 650-1000 nm. 
(E lw ell, 1995)
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Figure 22 shows the absorbance spectra for Hb and HbOz and illustrates the selective 
absorbance o f N IR at different wavelengths. Consequently changes in [Hb] and [HbOz] 
in skeletal muscle can be spectroscopically separated (Elwell, 1995). This is described 
by a modified version of the Beer-Lam bert law:
AA = Ac.a.d.B
Eqn 10.
AA = change in absorption, Ac ~ change in concentration, a  = specific extinction 
coefficient (known for each chrom ophore), d = geometrical distance between light 
em itter and detector, and B = differential path length factor (constant for a given tissue). 
A detector picks up the unabsorbed light that passes through the tissue and allows an 
absolute concentration difference in Hb, HbO? and HbT (the sum of Hb and HbOz), 
from an arbitrary zero, to be obtained.
It is im possible to distinguish between the contributions of haem oglobin and myoglobin 
to tissue oxygenation. How ever the relative contribution of myoglobin compared to 
haem oglobin has been shown to be small (Mancini et al, 1994) and can essentially be 
assum ed to be insignificant with regard to [Hb] and [HbOi]. Absorbance of NIR by 
water and lipids in the field of study remains constant and contributes to absorbtion 
continuously and uniformly (Elwell, 1995).
Differences in the [Hb] signal were assum ed to represent oxygen extraction within the 
muscle since this has been shown to be essentially blood-volum e insensitive, in 
com parison to the [HbOi] signal which depends significantly on 02-delivery into the 
field of interrogation (Ferrari et a i ,  1997; M cCully & Hamaoka, 2000). It might be
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expected that the [Hb] and [HbOi] signals are the reciprocal of one another during 
exercise and this holds tme for exercise in which blood flow is kept constant. However, 
during dynamic exercise when arterial O2 delivery and muscle perfusion are not 
constrained, the anticipated decrease in [Hb0 2 ] as O2 is extracted is offset by an 
increase in the m easured [Hb0 2 ] as a result of greater Hb0 2  delivery into the field of 
interrogation. Greater H b02 delivery, in this case, is prim arily due to increased muscle 
blood flow and perfusion (Kowalchuk et al, 2002).
2.2.3.2 NIRS: experim ental setup
Intram uscular oxygenation status was measured using a Niro 500 (Hamamatsu) which 
works on the principles described above. The NIR emitting and receiving optodes were 
fixed in a light plastic holder that m aintained the distance between them at exactly 4 cm. 
The holder was positioned above the vastus lateralis muscle of the right leg and taped to 
the skin. A wrap of optically dense material was taped around the thigh to prevent 
contam ination of the signal by additional extraneous light. Tape and bandages were 
used to add further support. The position of the optodes was checked post- test to 
ensure the optode position rem ained constant.
2.2.4 Blood sam pling, handling and analysis
Arterialised venous blood (Forster et al, 1972; M cLoughlin et al, 1992) was sampled 
through a 2 1 0  venous catheter (Becton D ickinson, Utah, USA), from  a dorsal vein on 
the back of the hand. The venous line was kept clear by a continuous flush o f non­
heparin ised saline (Baxter Healthcare, Norfolk, U.K.) applied through a standard drip. 
Venous blood was arterialised at rest by incubation for 10 min in a bath o f water heated
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to 42°C (Forster et al, 1972). Throughout exercise the catheterised hand was heated 
using a variable-intensity heat lamp.
The procedure for taking blood was standardised. The procedure began 15 s before the 
tim epoint the blood sample was to be taken. W aste saline was removed first using a 
separate syringe. The blood was drawn over 20 s either side o f that minute. A 2.5 ml 
blood sample was taken each tim e for analysis. The blood was transferred into a 
container containing EOT A  as an anti-coagulant. Once mixed with the EDTA, two 
400 jll aliquots were pipetted into two Epindorf tubes containing 800 |0.1 o f perchloric 
acid. Perchloric acid de-natures proteins preventing any further metabolism in the 
sample of blood. Repeated depressions of the pipette were used to mix the solution. 
The samples were held on ice, then centrifuged (Hermle Instrumentation Laboratory, 
W arrington, U.K.) at the earliest opportunity. A small sample of supernatant was 
analysed immediately for glucose, the rest was transferred to sealable containers and 
stored at minus 70°C until subsequent analysis for lactate was performed. The lactate 
samples were run as one batch at the end of each study. This benefited the analysis by 
ensuring that the same batch of standards and reagents were used for each complete 
study.
A further 1 ml sample o f blood was taken in a heparinised syringe (Radiometer, 
Copenhagen, Denmark) for analysis o f blood gases and pH. The syringes were sealed 
and stored upright during the protocol for imm ediate analysis post test.
Blood gases and pH were m easured using a blood gas analyser (Synthesis 10, 
Instrumentation Laboratory, W arrington, U.K.). All samples were analysed within 90 
min of sampling. Pilot work from this laboratory has found no variation in blood gas
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results com paring sam ples analysed straight after sampling with those stored on ice for 
up to 90 min.
Analysis o f glucose, lactate and pyruvate were carried out on an autom ated 
spectrophotom eter (Cobas Mira, ABX, M ontpellier, France), using standard 
m ethodology (M aughan et al, 1982).
The volume of blood taken during all experim ents never exceeded 60 ml.
2.2.5 Dichloroacetate: Preparation and dosing
DCA was prepared by pharm acy at The W estern Infirmary, Glasgow. The DCA was 
purchased in a pure form and made up into a 5% solution (5g / 100 ml). This was 
dispensed as a series of 100 ml bottles. The composition of the solution is listed in table 
1. The placebo solution was sim ilar in taste, appearance and consistency (Table 1). All 
solutions were stored refrigerated (5°C).
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Table 1 - Com position of DCA (5%) and Placebo solutions (supplied by Pharmacy at 
the W estern Infirm ary Glasgow).
D ichloroacetate Solution
Dichloroacetate 5 g
Glycerin 20 ml
Sodium  Benzoate 100 mg
Aspartam e 100 mg
Sodium  Acid Phosphate 0.7-53 g
Phosphoric acid to pK 3.5
Lem on Spirit 0.1 ml
Distilled W ater to 100 ml
Placebo Solution
Sodium  Benzoate 100 mg
Glycerin 20 ml
Aspartam e 12.5 mg
Lemon Spirit 0.05 ml
Sodium  Chloride 50 mg
D istilled water to 100 ml
DCA reduces the blood lactate concentration through two m echanism s 1) an increased 
flux through pyruvate dehydrogenase reducing the amount o f pyruvate converted to 
lactate, 2) a reduction in the rate o f glycolysis. For these studies a 50 mg/kg dose was 
given orally on the morning of the test after an overnight fast. Typically DCA given 
orally begins to exert a lactate lowering effect after -15  min (Curry et al, 1985; Curry et 
al, 1991), reaching a m aximum  after approxim ately 60 min (Curry et al, 1991; W ells et 
al, 1980). Thereafter DCA reportedly has a half-life o f between 30 and 120 min 
(Henderson et al, 1997). Pilot work showed that our preparation and protocol resulted 
in a lactate lowering profile sim ilar to that described above (Curry et al, 1991 ; W ells et 
al, 1980). Figure 23 shows the lactate profile over a 2 hour period after a single dose of 
50 mg/kg DCA for a representative subject. Based on these results and those in the 
literature all exercise protocols were started exactly 1 hour after a given dose of DCA or 
Placebo.
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F igure 23  - The effect o f  D C A  adm inistra tion  (50 m g/kg) on resting  blood lactate concentration: A 
representative subject. B lood lactate concentration  declines to a m inim um  at ~ 60 min post D CA  
ingestion. T hereafter it rem ains at this reduced level for the further 60 min o f da ta  collection , indicating 
that the D C A  preparation is show n to be effective at m aintain ing a reduced b lood lactate concentration  
during the tim e period 60-120 m in post ingestion. T herefore all exercise p rotocols w ere co-ord inated  to 
take place during this period.
Previous studies have employed an intravenous route for the adm inistration of DCA 
(W ilson et al, 1988; Carraro et al, 1989; Ludvick et al, 1991; Ludvick et al, 1993; 
Timm ons et al, 1998; How lett et al, 1999). W hile this was an option as an intravenous 
line was in place to sample blood, the oral route was chosen so that any problem s with 
the catheter would not preclude the tim ing and administration of the DCA. Stacpoole 
(1998) has reported that, although the peak plasm a drug concentrations occur 
immediately after intravenous administration, the bioavailability of DCA after 
administration by both methods is similar.
None o f the subjects reported any discom fort or side affects after DCA administration.
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2.2.6 Calibration
2.2.6.1 M ass spectrom eter and flow sensor
Calibration of both the mass spectrom eter and the flowhead were carried out prior to 
each test. The mass spectrom eter is calibrated using a precision analysed gas of known 
concentration (BOC Gases, Guildford, Surrey, U.K.). The calibration gas is passed 
through the system  producing a series of peaks at points on the mass spectrum 
corresponding to the relevant masses of nitrogen (28), oxygen (32) and carbon dioxide 
(44). The system tunes each channel to the apex of the peak and applies the gas 
concentrations entered to calculate a gain that passes through the origin. The calibration 
is checked by passing two high-precision analysed gas mixtures through the system to 
provide representative sets o f values. This was repeated before and after each 
experiment. If drift of more than 1% was encountered in the measured gas values then 
the results from the experim ent were disregarded.
The volume m easurem ent module or flow head was calibrated using a precision 3 litre 
syringe (Hans Rudolph, Kansas City, MO, USA). This volume was passed 10 times 
through the system to produce repeated measures for inspiratory and expiratory 
volumes. The mean volumes were com pared with the known volume and the 
calibration was accepted if they differed by no more than 0.2%.
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2.2.6.2 Transit delay
The raw signals for br x br volum e and gas composition are separated by the tim e it 
takes the gas sample to reach the analyser (the volume signal is electrical and therefore 
alm ost instantaneous). This time difference is termed the transit delay. Calculation of 
the transit delay ensures that both signals are appropriately time aligned. This is 
achieved by incorporation the result into the br x br algorithm  (refer to section 2.2.7).
The delay time was established before each test. To do so a bolus o f gas was introduced 
into the breathing valve apparatus manually using a syringe filled with expired air 
(Beaver et al, 1973). The com puter detects the rise of the flow and C O 2 signals. These 
signals are then time aligned and the calculated time difference is offered for acceptance 
to the operator. The procedure is repeated 3 times to check the result is repeatable 
before the value is accepted, and autom atically incorporated into the gas exchange 
computations. Normal transit delay tim e was approxim ately 500 ms.
2.2.6.4 Near infrared spectroscopy
The NIRO 500 was calibrated using a standardised m aximal voluntary contraction 
(MVC) of the right quadriceps (Chance et al, 1992; Belardinelli et al, 1995). To do this 
the subjects assumed a seated position with the right leg at an angle of 90°. The 
subjects achieved a contraction by pushing down through their foot. The contraction 
was maintained until the [AHb] signal reached a maximum. The duration of the 
m anoeuvre was typically 30 s.
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The M VC m anoeuvre allowed m axim al values for [AHb], [AHbOi] and [AHbT] to be 
determined. These values were used to express the data as a percentage o f maximum, 
norm alised to a zero baseline (Chance et al, 1992; Belardinelli et al, 1995). Therefore 
the M VC m anoeuvre and the subsequent data correction act as a physiological 
calibration o f the system. The alternative to a maximal contraction was inflation of a 
pressurised cuff around the proxim al girth of the quadriceps (Mancini et al, 1994). 
How ever pilot work showed this method to be less effective. Figure 24 shows clearly 
two repeated M VC m easurem ents followed by a less saturated cuff m easurem ent during 
cuff inflation to 180 mm Hg. The use o f maximal exercise to induce complete O 2 
extraction is supported by Chance et al (1992), who dem onstrated no further 
intram uscular desaturation when ischaem ia was induced by an inflatable cuff at the 
point of exhaustion. On this basis the M VC manoeuvre was preferred as the method of 
calibration. H ow ever it was decided that the M VC should be perform ed post test as 
perform ing the m anoeuvre pre test may effect DCA metabolism. On the familiarisation 
visits the M VC was performed pre and post test to assess the affect o f the exercise 
protocol on the maximal contraction. No differences were found between pre and post 
M VC values.
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Figure 24. - A  com parison  o f  the m axim al voluntary contraction  (M V C ) m anoeuvre for N IR S calibration , 
and m easurem ents taken upon inflation o f a h igh-pressure inflatable cuff. T he M V C  m anoeuvre is show n 
to be repeatable in accordance w ith p reviously  published results (C hance et al, 1992; B elardinelli et al, 
1995). An alternative to the M V C  m anoeuvre is inflation o f a high pressure cu ff around the proxim al 
length o f  the quadriceps (M ancini et al, 1994). T his m ethodology lessens the m etabolic im pact in 
com parison  to the M V C  m anoeuvre. H ow ever, the m axim al level o f  H b desaturation  achieved through 
this m ethod was not as great as that achieved through the M VC m anoeuvre. T herefore, an M V C  
calibration  o f the N IR S setup was perform ed post exercise  to avoid im pacting  on the level o f  PD H  
activation prior to exercise.
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2.2.7 Gas exchange algorithm
Gas exchange in the lung is calculated using algorithms based on those of Beaver et al 
(1973) from the m easurem ents of fractional gas concentrations and expired volume. 
Beaver et al developed the algorithm  to calculate gas exchange over a breath (defined: 
beginning of inspiration to the end o f expiration), correcting for the dead space of the 
breathing apparatus, water vapour condensation, changes in lung gas stores and a phase 
difference between the generated flow and gas signals (delay time). W hat follows is a 
sim plified sum m ary of their rationale to illustrate the principle behind calculation of 
VO^ over a single breath.
The total volume of oxygen is equal to the volume of inspired oxygen minus the volume 
of expired oxygen i.e.
Eqn II.
W here is inspired volume of O 2, and is expired volume of O 2. It follows
that:
VO^ = j v i d t  - F i O^ -  jvEdt ■ FgO,
insp exp
Eqn 12.
VI is inspired volume, VE  is expired volume and F[02 and Fe02 are fractional inspired 
and expired oxygen content respectively.
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The computation of VO 2  is based on the m easurem ent of expired volume. The 
assum ption is made that there is no net transport of nitrogen across the lung; and that 
any changes in nitrogen concentration measured occurs from changes in lung gas stores 
i.e. changes in end expiratory lung volum e and/or the com position of the lung gas 
stores.
Therefore the term for inspired volume in equation 13 is com pensated for by the 
assum ption that there is no net exchange of inert gases, principally nitrogen, in the lung. 
Thus:
VIxF, N^=VExF^N^
Eqn 13.
Therefore
VI=(FElil FIN^)xVE
Eqn 14.
W here F1N2 is the fraction of inspired nitrogen and FEN2 is the fraction of expired 
nitrogen. Argon is com pensated for in the calculations by norm alising the sum of the 
com posite gases to 99.07%  i.e. assuming argon has a constant atmospheric value of 
0.93%  and F1N 2 + F1O 2 + F1C O 2 = 0.9907.
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It follows that
(1 -  FIO FICO J
Eqn 15.
Therefore equation 13 becomes:
V O .  =
FIO^ x{ \ -FEO^ -FECO^)  
{I-FIG,  - f /C O J F E D . x y E
Eqn 16.
The same principle is applied to calculation of COg output, except that expiration and 
inspiration are reversed in the calculation as the net direction of CO 2 flow is out of the 
lung. The algorithms of Beaver et al (1973) go further than this sim plified derivation to 
take into account the effect of breathing valve dead space (i.e. com pensating for a small, 
initial volume of the inspired gas having an expired gas com position), water vapour 
dilution and tem perature (expired gas is normally assumed to be fully saturated at body 
tem perature at the site o f sampling). Prior to the start of every test, values for barom etric 
pressure, ambient tem perature, ambient hum idity and the mass spectrom eter delay tim e 
were entered into the computer.
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2.2.8 Breath-to-breath “noise” , editing, and analysis o f breath-by-breath data
Breathing has inherent irregularities that produce breath-to-breath fluctuations in gas 
exchange or “noise” . The confidence with which one can estim ate a param eter depends 
largely on how noisy the data set is; i.e. the more noisy are the data, the lower will be 
the confidence in the value estim ated for the param eter (Lam arra et al, 1987). Lam arra 
et al (1987) dem onstrated that this breath-to-breath “noise” follows an uncorrelated 
Gaussian stochastic process, the standard deviation of which is largely independent of 
metabolic rate.
These authors calculated that the expected confidence limits (Æ,J for the estimation of 
the time constant of VO^ was characterised by the equation:
Kn= An-AVOj„
y 7.
L is a constant, the magnitude o f which is dependent on the underlying time constant of 
the VO. response. It represents the amount of data relevant to the estimation i.e. the 
longer a time constant the more data points/tim e points there are available for analysis. 
So  is, the standard deviation o f the breath-to-breath fluctuation in VO 2  and n the num ber 
o f transitions that have been tim e-aligned and superimposed. Therefore, for any time 
constant calculated, the estim ated value will be at best within the value K,j-
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Based on the work of Lam arra et al (1987), removal of breaths outwith four standard 
deviations of the mean was carried out as standard on all raw breath-by-breath data. 
This procedure is statistically justified because small-sample physiological data appear 
to contain such values more frequently than expected from a Gaussian distribution, and 
retaining such values may degrade the results from responses containing limited 
amounts of data (Lamarra et al, 1987). Further editing o f breaths was strictly kept to 
rem oval of breaths that were physiologically atypical i.e. resulting from coughing, 
sneezing or swallowing.
W here applicable the breath-by-breath data was then interpolated to 1 s intervals 
allowing repeated tests to be averaged by superposition (W hipp et a l ,  1982); i.e. taking 
account of variations in breath duration (fig. 25). Following superposition, the resulting 
ensem ble-averaged response was then further averaged over 8-12 s to provide an 
average VO^ response suitable for kinetic analysis (i.e. with more favourable signal-to- 
noise characteristics).
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F igure 25  - T he effect o f the superposition  process on a da ta  set. T he open triang les represent the actual 
collected  data. T he open circles represent the data  after the superposition process. Superposition  allow s 
data from a num ber o f repeat collections to be ‘g rouped ’ for analysis. T his process reduces the breath-to- 
breath ‘no ise’ associated w ith breath-by-breath  data. Thereby im proving the accuracy with w hich a 
m odel can be fit to the data (L am arra  et al, 1987).
2.2.9 Ratings o f perceived exertion and dyspnoea
A 0 -  100 % visual scale was used to determ ine ratings of perceived exertion and 
ratings o f dyspnoea. The scale consisted of a row of 100 LED lights that could be lit in 
sequence using a dial m ounted on the handle bars of the ergometer. Subjects were asked 
to refer to the scale and illuminate the light strip to the appropriate score for ratings of 
perceived exertion and ratings of dyspnoea in turn. The score was noted and the scale 
reset to zero between each rating.
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2.2.10 General Constraints
The major constraint in these studies was the use of dichloroacetate. W hile there have 
been no significant side effects reported with acute doses of the drug, it is still 
recom mended that doses be kept to a m inim um  (personal correspondence, Dr P.W. 
Stacpoole and Dr Y. Pitsiladis). The maximal single dose in previous human studies has 
not exceeded 100 mg/kg body weight. The sum of the doses em ployed in studies with 
repeated dosing regimes has not exceeded this maximum when the population under 
study has been healthy (Roberts et al., 1997; Ludvik et a i ,  1991; Ludvik et al., 1993; 
Tim m ons et al., 1998; Carraro et al., 1989; Howlett et al., 1999; W ilson et al., 1988; 
Rossiter et al., 2003). A lactate-lowering effect has been shown with doses ranging 
from 20-100 mg/kg, the effect being more pronounced with higher doses. An oral dose 
o f 50 mg/kg was chosen for these studies. This dose had been used previously in 
human studies (Roberts et al., 1997; Ludvik et al., 1991; Ludvik et a l ,  1993; Timm ons 
et al., 1998; Rossiter et al., 2003) allowing a relevant comparison of results. A lower 
dose than the theoretical m axim um  of 100 mg/kg would also allow a repeated dose if a 
subject volunteered to take part in more than one experiment. Pilot work (refer to fig 
23), showed that the dosing strategy reduced resting blood lactate by >50 %,
It is preferable to repeat the experim ental protocol and add the data to the previous data 
set {Ecpt. 17) to further enhance the accuracy of a fitting strategy. As indicated above, 
this is often applied to breath-by-breath gas exchange data, especially when kinetics is 
the focus o f interest. In practical terms many repeats of the same exercise protocol are 
performed within the same day or over a num ber of days. However, the constraints of 
DCA usage lim ited us greatly in the num ber of repeats that could be performed and 
therefore resulted in a reduced confidence o f param eter estimation.
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2.2.10 Statistics
Statistical analysis was performed using M initab (version 13.1, M initab Inc., State 
College, Pennsylvania) and M icrosoft Excel (M icrosoft Corporation). The statistical 
approach was taken after consultation with an independent statistician.
Data sets were tested for normality using Anderson-D arling norm ality tests, and, where 
necessary, data were logarithm ically transform ed before statistical analysis. Statistical 
analysis was carried out using two-factor AN OV A with repeated measures, followed by 
S tudent’s paired f-test if a main treatm ent effect (i.e. placebo vs. supplem entation) was 
observed. Statistical significance was declared at P<0.05. Data are presented as mean 
values ± SEM  unless otherwise stated.
The VO2  m odelling functions were fit to a non-linear least-squares regression using 
com m ercially available software (M icrocal Origin). The ‘goodness’ of fit was 
determined by observing the flatness of the associated residuals and m inimising the sum 
squared errors.
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Chapter 3
The effect of dichloroacetate on oxygen uptake 
during incremental exercise
100
Chapter 3 
3.0 Introduction
The studies of Timm ons et al (1998), Howlett et al (1999) and Parolin et al (2000) 
reported a reduced PCr breakdown during exercise after DCA adm inistration. This led 
to the inference o f a reduction of the oxygen deficit due to an acceleration of oxidative 
phosphorylation from the start of exercise and/or a reduction in the fundamental gain. 
The associated reductions in blood lactate concentration further suggested that DCA 
augm ented the aerobic capability of the exercising muscle (M erill et a i ,  1980; Durkot et 
a i ,  1995; Schneider fl/., 1981 ; Carraro a/., 1989; HaitSietaL, 1991 ; Rossitcr a/., 
2003). It was the aim of this study to determ ine whether an increased aerobic capability 
was borne out at sub-m axim al work rates by an extended aerobic range as determined 
using the v-slope method, (Beaver et a i ,  1986) and at maximal levels by an increase in 
aerobic capacity ).
1 0 1
3.1 Methods
3.1.1 Subjects
8 men between the ages of 21 and 35 took part in the protocol. All subjects met the 
standard inclusion criteria (section 2.1 general methods). Table 2 shows the subject 
characteristics for each individual.
Table 2 - Subject characteristics
Subject Height
(cm)
Body Mass 
(kg)
Age
(yrs)
1 179 61 22
2 182 95 33
3 184 87 35
4 167 71 28
5 170 83 25
6 181 67 21
7 179 81 22
8 186 86 22
M ean 179 79 26
SD 7 11 5
3.1.2 Protocol
All subjects com pleted a standard incremental protocol until exhaustion on two 
occasions. The protocol is illustrated in fig. 26. Prior to this, subjects were familiarised 
with all equipm ent and procedures on m ultiple visits to the laboratory. At least one of 
these visits included an incremental test to exhaustion. DCA or a placebo was 
administered in a random ised fashion on one of the two visits. All exercise started 1 
hour after DCA or placebo adm inistration (see section 2.2.5). The test began with 3 
minutes of resting breathing and then 5 min o f low load pedalling at 20 W. The work
1 0 2
rate was increased by 15w • min ' (at a rate o f 3w • 12s ') until voluntary exhaustion or 
until a cadence of 50 rpm could no longer be maintained. W here possible a 10 min 
period of recovery data was collected post exhaustion with subjects sat stationary on the 
ergometer.
Exhaustion
I5W min ramp
W k ( W )
LL
2 0 W
O W
S t a g e  t i m e
( m i n )
Figure 26 - Schem atic representation  o f the increm ental exercise protocol. LL = Low load pedalling.
Blood samples were taken prior to DC A/placebo administration, 4 min into low load 
pedalling, every 3 min during the ramp, at exhaustion and 3 min, 6 min and 9 min post 
exhaustion. Ratings o f perceived exertion and dyspnoea were taken 45 s before each 
blood sample and as close to the point of exhaustion as possible.
The techniques for heart rate, gas exchange, and NIRS m easurement are described in 
the general methods (chapter 2).
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3.1.3 Analysis
Peak VOj was taken from  a moving average of the last 20 s o f the ramp data. Peak 
values were recorded for m aximum  work rate and m aximum  heart rate. The lactate 
threshold was determ ined by a standard visual identification technique based on the v- 
slope method (Beaver et aL, 1986). Independent checking o f the results was undertaken 
by 2 experienced personnel. W here the results were different an average o f the 
estim ates was taken. The threshold is defined as the slope change in a graph of 
pulmonary VCO 2  against VO2 . It is verified by a slope change in plots of EyOi and 
V EIVO 2  against VO 2  (Caiozzo et al., 1982; W hipp et a i ,  1986). The slope of 
APOj/AVWsT was determ ined by fitting a linear regression to the linear portion o f the 
relationship. Generally, this excluded the first 3 min of data and any evident plateaux in 
VO 2  in the last few m inutes o f the ramp.
3.1.4 Statistics
Statistical analysis followed that described in general methods chapter 2 (section 2.2.10)
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Results
3.2 Increm ental exercise
3.2.1 Blood borne m etabolic responses to increm ental exercise
The subject’s pre test activity and diet were controlled as described in the general 
methods. This ensured that they entered each trial in a sim ilar metabolic state. 
Therefore, as expected, no difference was found in pre dose values for blood [La], pH, 
standard bicarbonate (SBC) or glucose (Table 3).
Figure 27 illustrates that blood [Lactate] was significantly reduced during unloaded 
pedalling, and at 3 min, 6 min and 9 min in the DCA trial when compared to the placebo 
(Table 3). This data is shown more clearly in figure 27(b), which has been re-scaled to 
shows these time points only. The reduction in blood [lactate] is 39%, 33%, 21% and 
15% for each of these tim e points respectively. As can be seen in figure 27 a reduction 
in blood [Lactate] was not evident at exhaustion and at time points 3 min, 6 min and 9 
min post exercise (Table 3).
There are no significant differences in pH, SBC or glucose at any time (Table 3).
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R e s t  
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F igure 27  -  The effect o f D CA  on blood [Lactate] during increm ental exercise to exhaustion. Data are 
m ean values + SEM . C losed circles = placebo. O pen circles = DCA. Pre dose =  Sam ples taken prior to 
D CA  adm inistration . LL = low load pedalling  (20W ). m3 = m inute 3. mb = m inute b. m9 = m inute 9. 
ex = exhaustion . 3p = 3 m inutes post exhaustion , bp = b m inutes post exhaustion . 9p = 9m inutes post 
exhaustion . * S tatistically  significant betw een placebo and DCA trials. S tatistical analysis was carried 
out using tw o-factor A N O V A  for repeated  m easures, follow ed by a paired r-test if  a main treatm ent effect 
w as observed. S tatistical significance w as declared  at P<().05.
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Placebo
1B
17
a
1
03
DCA
Rest 
(pre  dose)
LL m3 m6 m9
F igure 27b -  The effect o f  D CA  on b lood (Lactate) during increm ental exercise to exhaustion. Figure 
27 re-scaled to show  m ore clearly  the data points where the d ifference betw een trials were 
significant. Data are m ean values + SEM . C losed circles = placebo. O pen circles = DCA. Pre dose 
= Sam ples taken prior to DCA adm inistration . LL = low load pedalling (20W ). m3 = m inute 3. ni6 
= m inute 6. ni9 = m inute 9. * S tatistically  significant for p lacebo vs D CA . Statistical analysis was 
carried  out using tw o-factor A N O V A  for repeated m easures, follow ed by a paired l-test if a main 
treatm ent effect was observed. S tatistical significance was declared at P<().()5.
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3.2.2 V O 2 response to increm ental exercise
Figure 28 shows the gas exchange plots used to estimate the gas exchange threshold 
(0 lt)  for one representative subject (subject 8). Corresponding points on the VCO 2  vs
VO2 , ETO2 vs VO 2  and VEIVO j  vs VO 2  plots consistently estimate the lactate 
threshold (0 lt)  at a VO2  of 2,25 1/min. 5 o f the 8 subjects exhibited an increase in 0 l t  
with DCA administration; however there was no significant difference between groups 
(M ean ±  SEM . 1.85 ±  0.14 1/min DCA. 1.78 + 0.15 1/min placebo. P = 0.54. Table 4).
No significant difference was observed in VO 2  during low load pedalling (M ean + 
SEM. 0.76 + 0.04 1/min DCA. 0.76 + 0.03 1/min placebo. P = 1.0. Table 4). 6 of the 8 
subjects had a higher ÊO jpeak post DCA administration; taken as a group mean this 
equated to a 0.09 L increase (Mean + SEM . 3.65 + 0.14 1/min DCA. 3.56 + 0.14 1/min 
placebo. Table 4) and this difference proved statistically significant (P= 0.018). There 
was no significant difference in peak work rate and time to exhaustion between DCA 
and placebo trials (P = 0.085 and P = 0.26 respectively. Table 4). The isVOj! àW R  
was 10.1 + 0.3 m l-m in ''-W ' for the DCA trail and 10.0 + 0.5 ml-min'^-W® for the 
placebo trial (P = 0.49. Table 4). These values compare favourably with the com m only 
reported value of 10 ml-min'^-W"^ for this measure (see W hipp et al, 1982).
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F igure 28 -  Gas exchange plots used (or the estim ation o f  the lactate threshold. A  single representative 
subject (Subject 8, D CA  trial). T op  panel; Solid  intersecting lines illustrate estim ation o f  lactate 
threshold using the V  -  slope m ethod (see section 3.1.3, for a descrip tion  o f  this m ethod). The dashed 
line on all panels represents 6, y at 2.25 (1/min).
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3.2.2 Cardiovascular responses to increm ental exercise.
After administration o f DCA the resting heart rate was elevated by as little as 1 
beat-min'* (subjects 3 & 5) and by as much as 15 beat min"' (subject 1), com pared to 
placebo administration. These differences proved statistically significant. (M ean + 
SEM . 69 + 5 beat-min"' DCA. 63 + 3 beat-min ' placebo. P = 0.033. Table 5). The 
heart rate continued to be significantly elevated during low load pedalling by an average 
of 4 beat-m in"'(M ean + SEM. 84 + 6 beat-min"' DCA. 80 + 5 beat-min"' placebo. P = 
0.0002. Table 5). No significant difference was found in peak heart rate (M ean + SEM. 
185 + 11 beat-m in"'DCA. 184 + 5 beat-m in"'placebo. P = 0.14. Table 5).
The results clearly show an increase in heart rate at rest and during unloaded pedalling 
during the DCA trial when com pared to the placebo. These changes are previously un­
described and indicate a possible chronotropic response associated with dichloroacetate 
administration. This has possible implications regarding the general assum ption that 
DCA has no effect on bulk oxygen delivery during exercise. See section 3.3 for further 
discussion.
No significant difference was found in O2 pulse during low load pedalling (M ean + 
SEM. 9.0 + 1.2 m l/beat DCA. 9.5 + 1.4 m l/beat placebo. Table 5) or between peak 
exercise values (Mean + SEM . 19.8 + 2.9 ml/beat DCA. 19.4 + 2.9 ml/beat placebo).
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As described, heart rate was elevated at rest and during unloaded pedalling for all 
subjects during the DCA trial. The sam e consistency of response is not replicated 
during the ramp exercise.
The group mean + SEM  heart rate responses are shown in figure 29. The clear 
elevation in baseline heart rate during the DCA trial is not evident early into the 
incremental protocol. There is a tendency for the heart rate to be higher on the DCA 
trial but not significantly. W hen the heart rate values are norm alised to baseline values 
(figure 30), the heart rate responses can be seen to overlay alm ost exactly.
The group mean + SEM  oxygen pulse responses are shown in figure 30. No significant 
differences are evident at any time during exercise.
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F igure 29 -  Heart rate response to increm ental exercise. D ata are group m ean + SEM . O pen circles = 
DCA. C losed circles = placebo. D ashed line indicates the start o f  the ram p increase in work rate from  a 
20W  baseline.
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F igure 30  -  Heart rate response to increm ental exercise norm alised to baseline values. D ata are group 
m ean + SEM . O pen circles =  DCA. C losed circles = placebo. Dashed line indicates the start o f the ram p 
increase in work rate from  a 20W  baseline.
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F igure 31 -  O xygen pulse response to increm ental exercise. Data are group m ean + SEM . O pen circles 
= DCA. C losed circles = placebo. D ashed line indicates the start o f  the ram p increase in work rate from 
a 20W  baseline.
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3.2.4 Muscle oxygen saturation responses to incremental exercise
Figure 32 shows the group mean + SEM  delta deoxyhaem oglobin plots. The data is 
corrected to % maximal M VC and norm alised to unloaded baseline. Values for the 
placebo trial are lower during the first minute o f exercise. Thereafter, values differ little 
between the two trials.
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F igure 32 - D elta deoxyhaem oglobin  responses to increm ental exercise. D ata are g roup mean + SEM . 
O pen circles = DCA. C losed c ircles = placebo. D ashed line indicates the start o f  the ram p increase in 
w ork rate from  a 20 W  baseline.
3.2.5 RPE and Dyspnoea ratings during increm ental exercise.
Figure 33 shows the group means + SEM  values for rating of perceived exertion. 
Values are given for rest, the incremental protocol and recovery. Graphically it appears 
on average the subjects rate exercise easier at 6 out of the 7 sub-maximal time points. 
However, these differences are not statistically significant. Ratings of dyspnoea (figure 
34) followed a sim ilar pattern, however again no significant differences were found.
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Figure - Ratings o f perceived exertion  during increm ental exercise. D ata are group mean + SEM . 
O pen circles = DCA. C losed circles = placebo. LL = low load pedalling (20W ). m3, mb. m9 =  m inutes 
3, 6, & 9 respectively. Ex = exhaustion . 3p, bp, 9p = m inutes 3, b, & 9 post, respectively.
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Figure 34 - R atings o f  dyspnoea during increm ental exercise. D ata are g roup mean + SEM . O pen circles 
= DCA. C losed circles = placebo. LL = low load pedalling (20W ). m3, mb, m9 = m inutes 3, b, & 9 
respectively . Ex = exhaustion . 3p, bp, 9p =  m inutes 3, b, & 9 post, respectively.
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Chapter 3
3.3 D iscussion
3.3.1 The effect o f DCA on V O 2 max
‘M axim al’ or ‘peak’ VO2 , its description, and the factors determ ining it have been a 
subject of debate for the best part of a century (Honig et aL, 1992; W agner, 1992; Green 
and Palta, 1992; Bassett and Howley, 2000; Noakes, 1997; Bergh et aL, 2000; W agner, 
1996; Di Prampero, 1985; Sutton et aL, 1988; Saltin et aL, 1976; Dem psey et aL, 1984). 
From this debate two principal paradigm s have developed: the first advocating oxygen 
delivery from atmospheric air to the m itochondria of the working muscle as the process 
setting the upper limit for oxygen uptake, the second suggesting that the demand set by 
the metabolic m achinery within the working muscle is responsible i.e. is
m etabolicaily limited. The principal m etabolic effect of DCA, up regulation of pyruvate 
dehydrogenase, does not easily fit into either o f these theories. Therefore the small but 
significant im provement in VOj max shown in this study is perhaps unexpected.
An initial hypothesis for this study was that the lactate lowering properties of DCA may 
delay the onset of fatigue and im prove exercise performance; and that this may result in 
an increase in max- There was little evidence to support this in this study. Tim e to 
exhaustion and maximum work rate were not significantly different between DCA and 
Placebo trials. Similarly the lactate concentration associated with exhaustion was not 
significantly different between the two trials. Therefore, the small but significant
1 2 2
increase in observed in this study is unlikely to reflect an increased tolerance to
m aximal exercise through DCA administration.
These findings are supported by the results reported by Putman et al (1993). These 
investigators suggested that a partial reduction in any ‘metabolic lim itation’ as a result 
o f DCA adm inistration would be unlikely during maximal exercise. They dem onstrated 
that activation of PDH above placebo levels was only evident for 3 min during heavy 
intensity exercise. Therefore a disparity between PDH activation during the final 
stages o f an incremental protocol to exhaustion is unlikely. The equivalence between 
peak blood lactate values in this study supports this.
Therefore, if the observed increase in not a result of a metabolic lim itation is it
a result of enhanced oxygen delivery? Factors governing the delivery of oxygen from 
environm ental air to the m itochondria o f the working muscle include 1) arterial O 2 
saturation (reflecting, ventilation, VA /Q inequality in the lung, pulmonary diffusion 
limitation, and Hb-Oz affinity); 2) arterial O2 concentration -  that is, O 2 saturation and 
[Hb]; 3) cardiac output or muscle blood flow; and 4) muscle O2 extraction (W agner, 
2000). O f these, the only ‘evidence’ we have of DCA affecting any o f these processes 
is a suggestion that maximal heart rate m ay be increased. W hile there was no 
significant difference between DCA and placebo trials when the groups were taken as a 
whole, 6 out of the 8 subjects showed an elevated peak heart rate on DCA with one 
unchanged and one 3 beats higher on the placebo trial (subject 6). W ith subject 6 
removed from the analysis the difference between DCA and Placebo trials becomes 
highly significant (P = 0.0107). W hile there is no reasonable justification for doing this, 
it is worth discussing the VO^ max changes with a view that an increase in maximum 
heart rate m ay have become significant with greater subject numbers. The obvious
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inference to make is that an increase in m axim um  heart rate will augment oxygen 
delivery by increasing cardiac output, assum ing that stroke volume is maintained. The 
dem onstration that elite level athletes may have maximal cardiac outputs o f up to twice 
that of ‘ordinary’ individuals has long identified it as a key factor influencing maximal 
oxygen uptake (B lom qvist et aL, 1983). Indeed Cerretelli and Di Prampero (1987) 
estim ated that 70 - 85 % of the lim itation in VOjm ax is linked to cardiac output. The 
influence of cardiac output on oxygen delivery can be illustrated by:
totalOjtransport = 139'x{Hb\x.Sa02>^QT
Eqn 18.
W here, Hb is haem oglobin concentration, SaOz is arterial oxygen saturation and Q T  is 
pulmonary blood flow /cardiac output (W agner, 1996).
Cardiac output is clearly a possible determ inant of ■ Il is changes in stroke
volume rather than changes in maximal heart rate that usually determ ine its influence.
For example observed increases in ^s a result of training have been attributed to
increasing stoke volume rather than changes in maximum heart rate (Saltin et a!., 1968; 
Ekblom  ef ri/., 1968).
There is no means in this study to support any increase in m axim um  cardiac output due
to an increase in stroke volume. The effects of DCA on haemodynamics are not well
docum ented (see section 6.8 for further discussion). In relation to this study however it
is worth noting that Stacpoole et al (1983) reported an increased cardiac output in
critically ill patients with hypotension and lactic acidosis. These findings are supported
by Ludvik et al (1991) who reported an increased cardiac output and enhanced oxygen
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delivery as result of DCA adm inistration in healthy volunteers. This increase in cardiac 
output was independent o f any change in heart rate and therefore related to an 
augm ented stroke volume. In this study we have demonstrated an increase in heart rate 
at rest, unloaded pedalling and suggested that with a greater num ber of subjects that this 
may have also been evident at maximal levels. The possible reasons for this increase in 
heart rate and its disparity with previous studies will be discussed further in the general 
discussion (Section 6.8). However, on the basis of the studies of Ludvik et al (1991) 
and Stacpoole et al (1983), a positive inotropic effect of DCA on stroke volum e at 
m aximal work rates in this study cannot be ruled out. Therefore a haem odynam ically 
m ediated im provem ent in a result of DCA adm inistration is not beyond
reason and warrants further investigation.
It is worth noting that increases in did not always go hand in hand with changes
in maximum  heart rate. For instance subject 6 whose heart rate was 3 beats lower on 
DCA showed a 0.13 1/min increase in FO^max subject 1 who showed a 4 beat 
increase in heart rate for the DCA trial showed essentially no difference in FD2max •
VO 2  max in athletic populations is thought to be more limited by pulm onary On-supply, 
while non-athletic populations are thought not to be pulmonary Oz-supply limited 
(Karas et aL, 1987). This was dem onstrated by Karas et al (1987) who showed an 
increase and decrease in VO2  max in athletic subjects with increasing and decreasing 
F 1O2. In untrained subjects they reported no increase in VO2  max with increasing F 1O2, 
nor a significant loss in VO 2  max as a result of moderate reductions in F 1O2. W hile the
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subjects in this study trained regularly and were well fam iliarised with cycling, the 
highest ÿO^max 55 ml-min-kg"^ (mean + SD 45+5 ml-min-kg"^) is below that expected 
for a well trained endurance athlete (>65 mfmin-kg'*). Therefore m echanism s other 
than an augm ented O2 delivery are perhaps more likely to show improvements in 
ÿ 0 2 mnx this subject group.
DCA activates pyruvate dehydrogenase in nearly all mammalian tissues, the testes and 
gut seem ingly the only exceptions (Stacpoole, 1989). Therefore an increase in pyruvate 
flux into the m itochondria and subsequent greater metabolism of lactate in tissues such 
as liver cells may increase oxygen consum ption above that required for force 
production. W hipp (1994) calculated the additional O2 cost of lactate oxidation in the 
liver during exercise to be approxim ately 17 ml/min. This was based on a blood lactate 
o f 7 mmol/1, a liver blood flow of 0.05 1/min and a 50% extraction. M aking an 
assum ption that the -40%  reduction in blood lactate seen during unloaded pedalling 
reflects a proportionate increase in liver lactate oxidation only, this would increase the 
17 ml/min estim ate of W hipp’s. Therefore, some of the increase in V(92max seen in this 
study may be apportioned to an up regulation of lactate oxidation in liver and/or other 
tissues not directly involved in force production. A further contribution from skeletal 
muscle to lactate m etabolism  may also be significant in the augmented W^max • W hipp
(1994) estim ated the value for lactate oxidation through this m echanism  could 
theoretically be as high as 660 ml/min. However, he argues that contracting muscle 
units are unlikely to be undergoing glycogenesis from lactate on therm odynam ic 
grounds, whereas the non lactate generating units are unlikely to be sufficiently 
glycogen depleted to constitute an available terminus for the resynthesis. However, it 
may be possible that DCA up regulates this process in non-contracting units 
subsequently increasing O2 consum ption. The results from this study show that lactate
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was significantly reduced throughout exercise. Therefore, a significant increase in VO 2  
due to increased lactate oxidation should also have been evident at rest and during the 
early stages of exercise. It is obvious from the VO 2  results that this is not the case.
VO 2  was statistically different between the 2 trials at the end of exercise when blood 
lactate concentrations are not significantly different. An increased peak VO^ due to 
increased lactate oxidation by non-contracting muscle units is plausible and this 
m echanism  may make a small contribution to the evident increase in . However,
the results from subm axim al exercise would suggest this is not the case.
Impaired pulmonary function may also prove a limitation to • High rates of
blood and gas flow could result in their non-uniform  distribution within the lungs. This 
would cause ventilation/perfusion (Va/Q) m ism atch and reduce arterial PO 2 as a result. 
Furtherm ore because VO 2  rises relatively m ore than cardiac output, mixed venous PO2 
falls. This could be to the extent that if there are any intra-pulm onary or post- 
pulmonary shunts, arterial PO 2 will be reduced more during exercise than at rest due to 
the lower PO 2 o f the blood (venous) that is carried. The net effect is an increase in the 
alveolar-arterial PO 2 difference to -3 0  mmHg at maximal exercise compared to 5-10 
mmHg at rest (W agner, 1996). A m ajor contribution to this increase is VA/Q inequality 
(Gledhili et a l ,  1982). Ludvik et al { \9 9 \ ), Stacpoole et al { \ 983) and W argovich et al 
(1988) reported decreases in peripheral vascular resistance resulting from 
dichloroacetate adm inistration. Therefore a sim ilar effect on the lung vasculature, 
perhaps coupled with an increased cardiac output/ pulmonary blood flow may result in a 
reduction of this VA/Q inequality. W hile this cannot be ruled out as a mechanism for 
increasing this subject group, a pulmonary limitation to is again
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thought to be reserved for more athletic subjects (in healthy subject groups). This 
relates again to studies showing the invariability of itt untrained subjects with
altering F1O2 and no evident desaturation of arterial PO 2 during m aximal exercise 
(Lawler et al, 1988; Roca et al, 1992).
W hile the increase in in this study was small (0.09 1/min) it remains statistically
significant. However, a small but improved oxygen uptake at maximal exercise 
intensities was not reflected in an increase in maximal work rate, time to exhaustion or a 
reduction in peak lactate. Therefore in terms of an improved ability to perform  exercise 
it is not proven to be important. M aking an assum ption that the delta VO2 I delta work 
rate relationship of 10.1 m fm in  W '\  calculated from the incremental responses in this 
study, holds for an increase in either variable at these work intensities. The 0.09 1/min 
increase in VO2  max would equate to an additional ~ 9 watts. W hile a significant increase 
in work rate is not dem onstrated in this study, an increase of this magnitude in an 
athletic population would be significant in events where max is considered to be 
limiting to performance.
Roberts et al (1997) is the only other study to look at the effects o f dichloroacetate on 
incremental exercise perform ance. Using the same dosing procedure as this study they 
showed no difference in TOjmax or time to exhaustion (n= 7). However lactate was 
lowered at rest, between 80-100%  of VO, max and throughout 8 min of recovery. W hile 
their findings contradict those found in this study it is difficult to make detailed 
com parisons because the Roberts et al (1997) study was only published in abstract 
form.
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On the basis of these findings further investigation of the effect of DCA  on maximal 
exercise performance is warranted, with an emphasis on a better description of the 
athletic ability of the population group and closer look at haemodynamic changes.
3.3.2 The effect o f DCA adm inistration on the lactate threshold.
The proposed reduction in oxygen deficit (Tim mons et al., 1996) and reduction in blood 
lactate concentration (M erill et a i ,  1980; Durkot et al., 1995; Schneider et al., 1981; 
Carraro et al., 1989; Hatta et al., 1991; Rossiter et al., 2003) upon DCA adm inistration 
suggest that the contracting m uscle units are functioning more aerobically during 
exercise. It was hypothesised for this study that this may be manifest in an increased 
VO 2  associated with an increased blood lactate concentration above an initial baseline 
i.e. a rightward shift in VO 2  0 as estim ated by the v-slope m ethod described by Beaver et 
al (1986). However, the results reported in this thesis show there was no significant 
difference in VO^O between the DCA and placebo groups. This is somewhat surprising 
as lactate concentration was significantly reduced throughout sub-m axim al exercise for 
the DCA condition com pared to the placebo. This was not accom panied by a 
significant change in either pH or standard bicarbonate measures. At first glance this 
seem s to be contrary to what may be expected and initially hypothesised at the 
beginning o f this study. H ow ever it is clear from Figure 27 that while blood lactate 
concentration remains lower during sub-m axim al exercise, it differs only in absolute 
term. The increase above an initial baseline occurs at the same time point for both trials 
i.e. the exercise blood lactate curve in the DCA condition has been displaced 
downwards rather than rightwards. Therefore while the m agnitude o f the blood [lactate] 
response is different betw een the two conditions 0 l t  is unlikely to be different. This
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would explain why no difference was seen in 0lt for the DCA trial com pared to the 
placebo trial, despite a significant reduction in blood lactate concentration being 
observed throughout the submaximal exercise range.
Several mechanism s have the potential to increase lactate production as VO^ increases 
during exercise. These include, an increase in glycolytic rate producing pyruvate in 
quantities greater than that that can be driven through PDH, a reduction in cytosolic 
redox state (NADH/NAD"^) due to the rate of oxidative phoshorylation being unable to 
sustain the re-oxidation of cytosolic NADH^, increased recruitm ent o f Type Ilb muscle 
fibres and a reduction in capillary PO2 to a level that impairs oxygen diffusion into the 
m itochondria. The effect o f DCA on lactate production and the m echanism /m echanism s 
behind this will be discussed in further detail in the general discussion (section 6.9).
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3.3.3 Summary of findings
DCA  did not improve perform ance o f the incremental exercise protocol for the subject 
group in this study. This was reflected by no difference in m aximum  work rate, time to 
exhaustion or lactate threshold between the DCA and placebo trials. There was 
however an unexpected, small, but significant increase in ^^r the DCA trial
com pared to the placebo trial. It is suggested here that this small increase in may
reflect haemodynamic changes associated with DCA. H ow ever no direct evidence is 
available from these studies to support this theory. These findings suggest that further 
investigation o f the effect of DCA on maximal exercise perform ance and associated 
haem odynam ic changes is warranted.
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Chapter 4
The effect of Dichloroacetate on oxygen uptake during 
‘moderate’ intensity exercise
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Chapter 4 
4.0 Introduction
Dichloroacetate has been shown to increase the activity o f the Pyruvate dehydrogenase 
complex (PDH) at rest and during exercise (Stacpoole, 1989; Tim m ons et al., 1998; 
Howlett et al., 1999a&b; G ibala and Sal tin, 1999; Parol in et al., 2000). A reduction in 
phosphocreatine degradation subsequent to this has led to the suggestion that a 
relatively slow activation of PDH could contribute to the lag in oxidative ATP 
regeneration at the start of exercise. Indeed Timm ons et al (1998) interpreted these 
results as evidence that PD H  activation played a major role in determ ining the 0% deficit 
at the onset of exercise. However, this relationship was inferred from PCr 
measurements. There was no direct m easurem ent of VO 2 , neither were there enough 
data points to allow kinetic discrim ination. The aim of this study was to examine the 
effect of DCA on the fundamental VO 2  kinetics during moderate intensity exercise. 
W orking within the m oderate exercise intensity domain elim inates the com plicating 
influence of the VOj slow component. This enables a more accurate m odelling o f the 
fundamental VO 2  response thereby ensuring a more accurate reflection of Qm us 0 2  
(Barstow et al., 1990; Grassi et al., 1996).
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4.1 Methods
4.1.1 Subjects
6 male subjects between the ages o f 21 and 35 took part in the protocol. All subjects 
met the standard inclusion criteria (section 2.1 general methods). Table 6 shows the 
subject characteristics for each individual.
Table 6 - Subject characteristics
Subject Height
(cm)
Body mass 
(kg)
Age
(yrs)
1 179 61 22
2 182 95 33
3 184 87 35
4 167 71 28
5 170 83 25
6 186 86 22
M ean 178 80 28
SD 8 12 6
4.1.2 Protocol
Prior to undertaking this study subjects were fam iliarised with all equipm ent and 
procedures on multiple visits to the laboratory. Prior to com pleting the DCA/Placebo 
trials subjects underwent an incremental exercise test to exhaustion for the 
determination of 9 lt , WR^ax and Iwo subsequent visits subjects com pleted
a double, sub-threshold, square wave protocol (fig. 36) consisting of: rest (4 min), low 
load pedalling (20 W , 5 min), exercise bout 1 (7 min), low load pedalling (20 W , 7 
min), exercise bout 2 (7 min), low load pedalling (20 W, 7 min).
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Figure 35  - Schem atic illustrating  the Sub threshold exercise protocol . L L l and LL2, represent the first 
and second periods o f low load pedalling  respectively  E x l and Ex2, represen t the first and second periods 
o f  loaded pedalling respectively. T he exercise  w orkload was set at 90%  o f  each individuals estim ated 
lactate threshold ( 0 l t ) -  The solid line illustrates the square wave nature o f  the w ork rate increase.
The work rate change for each individual was set at 90% of the workload corresponding 
to the estim ated lactate threshold ( 0 l T ) ,  determined from a standard ramp-incremental 
exercise protocol. The coefficient o f variance of the VOj response and the delta work 
rate (AWR) have been shown to be inversely related {Eqn, 19). Therefore, this workload 
provided the m aximum  change (delta) in work rate, allowing a margin for error, so as 
not to exceed 0 l t -
AWR = 1/C V
Eqn 19.
DCA administration and blood handling followed the proeedures described in section 
2.2.5. Blood samples were taken at rest prior to DCA adm inistration, I min before the 
start of each square wave exercise bout and at the end o f the 6*'^  min of each square 
wave. Ratings of perceived exertion and dyspnoea were taken 45 s before each blood 
sample. Heart rate, gas exchange, and NIRS measurements were made as described in 
chapter 2.
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4.1.3 Analysis
Each VO 2  data set was edited, as described in the general methods (Chapter 2). 
Gaussian distribution characteristics were assum ed as described by Lam arra et al 
(1987) and Rossiter et al (2000). The VO 2  response for each test was then interpolated 
on a seeond-by-second basis. This allowed subsequent superim position and averaging 
o f the responses from the 2 repeated transitions.
A comm ercial software package (M icrocal Origin) was used to m odel the phase II YOj 
response to each square-wave on-transient. A m ono-exponential function was fit to the 
data {Eqn. 20). The fit excluded the ‘cardiodynam ic’ or phase I region (i.e. 
approxim ately 20 s after exercise onset), and continued through at least one minute of 
steady state data (W hipp et al., 1982).
Eqn 20.
VO2 Q is the value of VOj at t = 0, A V 0 2 s^s) is the asymptotic value to which VG, is
assum ed to project, % is the time constant of the response and ô is a delay term  sim ilar to 
(but not equal to) the phase I-phase II transition time (W hipp et al., 1882; W hipp and 
Ozeyener, 1998). Best-fit values for x and 5 were found for each variable by an 
iterative least-squares process. The ‘goodness’ o f fit was determ ined by observing the 
flatness of the associated residuals and m inim ising the sum squared errors (i.e. %").
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The off-transient response was m odelled in the same fashion with the polarity of the 
equation switched from  positive to negative.
The fit for the calculation o f the oxygen deficit (O2 def) was constrained to start at the 
beginning of exercise (W hipp et al., 1982). The generated time constant (V) represents 
a mean response and allows the ealculation of the oxygen deficit using the following 
relationship (W hipp et al., 1982);
0 ,d e f  = \ V O ,„ T '
Eqn 21.
4.1.4 Statistics
Statistical analysis followed that described in general methods chapter 2 (section 2.2.10)
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Chapter 4
4.2 Results
4.2.1 Blood borne m etabolic responses to m oderate intensity exercise
Figure 36 shows the results of analysis of blood samples taken during these 
experiments. Blood [lactate] was not significantly different in the control period for 
both experim ents (M ean + SEM. 0.83 + 0.14 mmol/1 DCA. 0.74 + 0.16 mmol/1 
placebo. P = 0.67. Table 7). However, it was significantly reduced throughout the 
exercise protocol in the DCA trial. A reduction of 50% in the group mean lactate 
concentration was observed across all four tim e points. These data are shown in table 7. 
Importantly, no significant increase in blood lactate concentration was found during 
exercise. Indicating that exercise was undertaken at work rates below that associated 
with the lactate threshold. No significant change in pH was observed, there was a 
tendency for the standard bicarbonate concentration to increase and for the blood 
glucose concentration to decrease . However, these did not reach statistical significance.
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F igure 36 - The effect o f  D CA  on blood lactate during m oderate intensity exercise. D ata are group m eans 
+ SEM . C losed circles = placebo. O pen circles = DCA. D ata show s that the adm inistration  o f  DCA 
successfu lly  reduced blood [Lactate] during the sub-threshold  exercise protocol, com pared to the p lacebo 
trial. Furtherm ore, there was no significant rise in blood [Lactate] during either trial. Indicating that 
exercise w as indeed taking place in the ‘m oderate’ dom ain. Pre dose = Sam ples taken prior to DCA 
adm inistration . LL = low load pedalling (20W ). Ex = exercise sam ple. * S tatistically  significant betw een 
placebo and D CA  trials. S tatistical analysis w as carried  out using tw o-factor A N O V A  for repeated 
m easures, follow ed by a paired  r-test if  a main treatm ent effect was observed. Statistical significance was 
declared  at ?<0 .05 .
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4.2.2 VO^ responses to moderate intensity exercise
The group mean + SEM  on-transient VG^ responses are shown in figure 37. There are 
no differences between DCA and placebo trials. The time constant for the conditions 
(mean + SEM) was 18.3 + 1.22 and 16.1 ±  2.02 respectively (Table 8). The tim e 
constant for both conditions lie within the normal range previously reported for 
m oderate cycle ergom etry exercise (W hipp et a i ,  1982; Lam arra et al., 1987). The 2 s 
difference between the mean values is not statistically significant (P = 0.089). Figures 
39 a&b show m ono-exponential fits for the VO 2  responses for all subjects. The initial 
‘cardiodynam ic’ phase (-2 5  s) was excluded and the fit continued through at least 1 
m inute o f the steady state. The responses are generally well described by equation 20; 
that is the associated residuals fluctuate closely and random ly about zero. The residuals 
for subject 5 (fig. 38b) how ever show significant portions below zero for the placebo 
trial. This represented the best estim ate of the time course o f the response. Therefore, 
this data has been left in the analysis.
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Figure 3 7  — D ata are group mean + SEM . T he on-transient V O j  response to m oderate square wave
exercise. O pen circles = D CA . C losed circles = placebo. Dashed line indicates the start o f the step 
increase in work rate from a 20 W  baseline.
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The data in table 8 show that the values for the unloaded pedalling baseline, and 
exercise steady-state, VO 2  were very sim ilar for all subjects in the group. No significant 
difference was found between the two conditions. Thus there is no difference in the 
steady-state VO 2  gains (M ean + SEM. 10.3 + 1.08 m hm in '^-W ‘ DCA. 10.4 + 0.95 
mhmin'^-W'^ placebo, P = 0.71). The values for both conditions are comparable to the 
value o f 10 m l-m in"'-W ’ reported by W asserm an & W hipp (1975) and Hansen et al 
(1984) and the values reported for the incremental work protocol in chapter 3. As 
expected from the above results, the calculated O2 deficit (Mean + SEM ) of 0.59 + 0.11 
1/min DCA. and 0.55 + 0.09 1/min placebo was not significantly different between the 
two conditions.
The group mean ±  SEM  off-transient ÊO2 responses are shown in figure 39. The 
responses for both trials are well matched. This is evident in values for the off transient 
time constants which are not significantly different (Mean + SEM . 28.2 + 2.34 s DCA., 
28.7 + 2.14 s placebo. P = 0.089. Table 8). The time constant for the off transient 
responses of both groups were significantly longer than the corresponding on transient 
responses (Mean + SEM . 28.2 + 2,34 s DCA off-x. 18.3 + 1.22 s DCA on-x, 28.7 + 
2.14 s placebo off-x. 16 . 1+ 2.02 s on-x. P<0.05).
Figures 40 a&b show m ono-exponential fits for the off transient VOj responses for all 
subjects. Once again the initial ‘cardiodynam ic’ phase (-2 5  s) o f the response was 
excluded and the fit was continued through at least one minute of the steady-state
146
response. Generally, the off-transient steady-state response was inherently more ‘noisy’ 
than the on-transient response. This is likely due to the weight of the subject on the 
saddle o f the ergom eter becom ing more apparent to the subjects during the transition 
from  a high load to a lighter load. Furthermore, during unloaded pedalling their 
breathing tended to becom e less ‘rhythm ical’ as they attem pted to relax in anticipation 
o f the next step up in work rate. Therefore the fitting range was continued throughout 
the steady-state in order to m axim ise the num ber of data points used to determine the 
steady-state asymptote. The responses were generally well described by equation 20; 
that is the associated residuals fluctuated closely and random ly around zero.
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F igure 39  -  D ata are group mean + SEM . T he on-transient V O 2  response to m oderate square wave 
exercise. O pen circles = DCA. C losed circles = placebo. Dashed line indicates the start o f  the step 
increase in w ork rate from  a 20 W  baseline.
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4.2.3 Cardiovascular responses to moderate intensity exercise
Resting heart rate was significantly elevated on average by 10 beat-min"' in the DCA 
trial (M ean + SEM . 68 + 3.2 beat min'^ DCA. 58 + 2.3 beat-min'* placebo. P = 0.017. 
Table 9). This response was consistent for all subjects (Table 9). Heart rate continued 
to be significantly elevated during baseline low load pedalling (M ean + SEM. 87 + 3.4 
beat-m in'' DCA. 80 + 3.4 beat-min ' placebo. P = 0.002. Table 9) and steady-state 
exercise (M ean + SEM . I l l  + 3 . 2  beat-min’' DCA. 107 + 2.7 beat-min ' placebo. P = 
0.043. Table 9).
The m agnitude o f the difference betw een the two conditions proved to be smaller at the 
end o f the exercise when com pared to unloaded pedalling values; 4 beat-min ' versus 7 
beat min"' respectively. Likewise the difference was sm aller for unloaded pedalling 
com pared to rest; 7 beat min ' versus 10 beat-min'*. This indicates that the elevation in 
heart rate due to DCA adm inistration becam e progressively less as the work rate 
increased. This is illustrated in figure 41. The heart rate can be seen to be clearly 
elevated at more at baseline than at end exercise. Figure 42 shows the delta heart rate 
responses for all subjects. A lower delta heart rate requirem ent on com m encem ent of 
exercise is clearly evident.
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F igure 4 !  -  H eart rate response to m oderate ‘square w ave’ exercise. D ata are group mean + SEM . O pen 
c ircles =  DCA. C losed circles = placebo. D ashed line indicates the start o f  the step increase in work rate 
from  a 20 W  baseline.
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Figure 42 -  H eart rate response to m oderate ‘square w ave’ exercise, norm alised to baseline values. D ata 
are group mean + SEM . O pen circles = D CA . C losed circles = placebo. D ashed line indicates the start 
o f  the step increase in work rate from a 20 W  baseline.
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Oxygen pulse is significantly lower at rest in the DCA condition when com pared to the 
placebo condition (M ean + SEM. 6.77 + 0.36 ml/beat DCA. 8.00 ±  0.48 m l/beat 
placebo. P = 0.043. Table 9). The sum m ary data for each individual are shown in table 
9. Oxygen pulse continued to be significantly reduced during low load pedalling (M ean 
+ SEM. 8.73 ±  0.51 m l/beat DCA. 9.62 + 0.2 ml/beat placebo. P = 0.004. Table 9) and 
at end exercise (M ean + SEM . 14.06 ±  1.13 ml/beat DCA. 14.99 + 1.21 m l/beat 
placebo. P = 0.012. Table 9), in the DCA trial.
Group mean + SEM  oxygen pulse responses for both conditions are shown in figure 43. 
A reduction is evident throughout the DCA trial. This reflects the observed increase in 
heart rate with no change in VO 2 . Figure 44 shows the oxygen pulse responses 
norm alised to baseline values. The tim e course and magnitude of the change in oxygen 
pulse is shown to be sim ilar for both conditions.
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F igure 43 -  O xygen pulse response to m oderate ‘square w ave’ exercise. D ata are group mean + SEM . 
O pen circles = D CA . C losed circles = placebo. D ashed line indicates the start o f  the step increase in 
work rate from a 20 W baseline.
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F igure 44  -  O xygen pulse response to m oderate ‘square w ave’ exercise, norm alised to baseline values. 
D ata are group mean ±  SEM . O pen circles = D CA . C losed circles = placebo. Dashed line indicates the 
start oF the step increase in w ork rate from a 20 W  baseline.
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4.2.4 Muscle oxygen saturation responses to moderate intensity exercise
Group mean + SEM  deoxyhaem oglobin responses for both conditions are shown in 
figure 45. All data are corrected to a % of a maximal voluntary contraction and 
norm alised to the last m inute of the low load baseline. The m agnitude of the delta is 
reduced during the DCA trial. Figure 46 shows individual responses for all subjects. It 
is clear from  this figure that a low er delta is not consistent for all subjects. The 
m agnitude o f the drop in subjects 1 and 2 during the DCA trial clearly offsets the mean 
for this group.
Across all subjects there was a rapid drop in Hb during the first -2 5  s o f exercise. Taken 
as a group m ean this drop appears greater during the DCA trial. This may indicate a 
greater rate o f oxygen utilisation during this initial phase o f exercise. A response that 
would be m asked in the ‘cardiodynam ic’ phase of the VOj response. Alternatively, and 
perhaps more likely, this m ay indicate a greater increase in the size o f the blood volume 
under the field of study. This w ould cause a greater drop in the Hb signal during this 
time. This response is not consistent across all subjects (figure 46). The resolution of 
the responses in this phase is not high and therefore this finding m ay warrant further 
investigation.
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Figure 45  - D elta deoxyhaem oglobin  responses to m oderate ‘square w ave’ exereise. D ata are group 
mean + SEM . O pen circles = D CA . C losed circles = placebo. D ashed line indicates the start o f  the step 
increase in work rate from  a 20 W  baseline.
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4.2.5 Ratings of perceived exertion and dyspnoea during moderate intensity
exercise
Figures 47 and 48 illustrate the com parative group means + SEM  for ratings o f 
perceived exertion and ratings o f dyspnoea for the two conditions. No significant 
difference was found between visits for either measure. Interestingly, there was a 
tendency to rate both dyspnoea and RPE higher on the second exercise bout than the 
first. This m ay reflect general discom fort with the setup and prolonged use o f the 
mouthpiece. However, these differences did not reach statistical significance.
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Figure 4 7  - R atings o f  perceived exertion  during m oderate intensity exercise. D ata are group mean + 
SEM . O pen circles = D CA . C losed circles =  placebo. LL = low load pedalling (20 W ). Ex = exercise 
sam ple.
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Figure 48  - R atings o f  dyspnoea during  m oderate intensity exercise. D ata are group mean + SEM . 
circles = DCA. C losed circles = placebo. LL =  low load pedalling (20 W ). Ex = exercise sam ple.
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Chapter 4 
4.3 Discussion
4.3.1 The effect of DCA on oxygen uptake during moderate intensity exercise
The -50%  reduction in blood lactate concentration seen throughout exereise in this 
study is consistent with that reported in the literature (Roberts et al., 1997; Ludvik et al., 
1993; Timm ons et al., 1998; Ludvik et al., 1991; Carraro et al., 1989; Howlett et al., 
1999a&b; W ilson et al., 1988; Rossiter et al., 2003). This response provides evidence 
that the DCA prepai'ation was successful in activating PDH (Stacpoole, 1989; Tim m ons 
et a l ,  1998; Howlett et al., 1999a&b; Gibala and Sal tin, 1999; Parolin et a i ,  2000).
This apparent increase in PDH activity was not associated with any significant speeding 
o f the VO^ on kinetics. Indeed the steady state or kinetic responses show little 
variation between trials. As expected this is borne out in the calculated values for the 
O idef (0.59 + 0.26 DCA vs 0.55 + 0.21 placebo 1/min). Therefore, this study does not 
support the suggestion by Tim m ons et al (1998), and G reenhaff et al (2003), that an 
acetyl-group deficit lim its m itochondrial ATP production at the onset of exercise.
Tim m ons et al (1998), How lett et al (1999), Parolin et al (2000) and more recently 
Rossiter et al (2003) have all dem onstrated a significant reduction in PCr breakdown 
and blood lactate accum ulation in response to DCA adm inistration during constant load 
exercise (supra-threshold exercise intensity). In the study by Rossiter et al (2003) these 
responses were accom panied by a reduction in the fundam ental VO^ amplitude by -8 %
with no associated change in the fundam ental x. The suggestion from these
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investigators is that the reduction in PCr degradation on DCA adm inistration reflects an 
im proved energy state of the m uscle that is not associated with an altered tim e constant 
fo rÿO g . The evidence from  the above studies is derived from  supra-threshold exercise. 
However, the fundam ental response has been argued by M argaria et al (1965), Paterson 
& W hipp (1992) and Ozyener et al (2001) to be sim ilar in nature to that for sub­
threshold exercise. Therefore com parison of the fundam ental response from  this study 
and the results of Tim m ons et al (1998), Howlett et al (1999), Parolin et al (2000) and 
Rossiter et al (2003) is not unfounded.
The data from this study does not agree with that of Rossiter et al (2003) in that the 
steady state gain in VO^ was unaffected by DCA adm inistration (0.81 + 0.33 1/min 
DCA vs 0.83 + 0.33 Placebo 1/min). A reason for this difference could be that while the 
fundam ental response below and above the lactate ‘threshold’ are sim ilar in their 
description they are not wholly governed by the same m echanism /s of control. For 
instance, factors such as proportional recruitm ent of muscle fibre type and changes in 
pH could play more of a role in setting the fundam ental VO 2  gain above the threshold 
than below. Indeed, Burnley et al (2001) reported that prior heavy exercise increases the 
amplitude of the prim ary VO^ com ponent during supra-threshold exercise. However, 
the same group had previously shown no effect of prior heavy exercise on the 
fundam ental VO^ response to m oderate exercise (Burnley et al, 2000).
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4.3.2 Parameter discrimination
The small num ber of subjects in this study reduces the statistical pow er o f the results. 
Howlett & Hogan (2003) found a ~ 2 s increase in the rate o f fall in PO 2 using DCA in 
an isolated animal muscle preparation. Using the standard deviation in x from  this 
study; a retrospective pow er analysis indicates that the num ber o f subjects required to 
realise a significant change o f 2 s in x is 17. Therefore this study is underpowered. This 
result becom es less critical as the tendency was for x to be lengthened in the DCA trial. 
Therefore a significant speeding o f the kinetic response was unlikely to be seen even 
with greater numbers.
4.3.3 The effect o f DCA on m uscle oxygen saturation during m oderate intensity  
exercise
Delorey et al (2003) and Shibuya et a l (2003) have attempted to relate the change in 
NIRS-Hb and VO^ in response to m oderate intensity exercise. Both studies m odelled 
the deoxy-haem oglobin response to m oderate constant work exercise with a m ono­
exponential function. They found the on-kinetics for AHb to be faster than VO 2  
kinetics (6.5 + 2.2 s vs 23.8 + 4.4 s, D elorey et a l ,  2003; 10.0 ±  3 s vs 30 + 8 s Shibya 
et al., 2003). The AHb plots from  this study were not expressed well by a 
m onoexponential function, largely due to an inconsistent steady-state phase. However, 
visual inspection of the AHb tim e plots clearly show that the results from this study 
agree with those of Delorey et al (2003) and Shibya et al (2003) with the AHb response 
increasing more rapidly than the VO^ response. The AHb signal is an estim ate of
changes in muscle micro vascular deoxygenation within the field o f interrogation and
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reflects a balance betw een local musciilai' 0% delivery and muscle oxygen utilisation. 
The hypothesis from  this and the above studies was that the phase II VO2  response 
would reflect the NIRS-Hb response. That is, after an initial delay, the NIRS-Hb signal 
would increase following a m ono-exponential time course to a steady-state. As with the 
results of Delorey et al (2003), a clear delay o f -1 5  s between the start of transition and 
the increase in AHb is evident. How ever in contrast to the studies of Shibya et al 
(2003) and Delorey et al (2003), where AHb rem ained constant during this period, the 
results of this study show a clear decrease in the Hb signal during the initial phase of the 
response. It is likely that this initial drop in the AHb signal is evidence of either an 
increased perfusion of the m easurem ent field or an initial m ovem ent of Hb out o f this 
field. The latter suggestion could possibly be due to the actions of the muscle pum p at 
the onset of the exercise transition.
The rate of change of the AHb signal reflects the balance betw een muscle O? delivery 
and muscle O2 utilisation. This initial drop in the AHb signal could reflect a more rapid 
increase in muscle blood flow relative to m uscle O2 extraction. This would suggest that 
delivery of O2 is not lim iting during this initial phase of exercise. The time delay before 
muscle O2 extraction becom es evident agrees with the work of Grass! et al (1996) and 
Bangsbo et al (2000) in intact hum an m uscle and the work of Hogan (2001) in Xenopus 
single skeletal m uscle fibres. These authors report a -6 -20  s delay after the start o f 
muscle contraction before O 2 extraction was evident. This ‘apparent’ delay in 
mierovascular O 2 extraction may be due to a ‘metabolic inertia’ within the oxidative 
m achinery o f the m itochondria or it may reflect a m atching o f O2 extraction by local 
m uscular O2 stores and m uscle O2 delivery. However, the evidence from studies 
utilising magnetic resonance spectroscopy (W hipp et al., 1999; Rossiter et a l ,  1999)
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show PC r decreasing im m ediately at exercise onset. Furtherm ore, the work by Behnke 
et al (2002) shows that m easures of m ierovascular PO 2 also decrease without delay. 
These studies do not support the existence of an inherent ‘m etabolic inertia’ within the 
m achinery of oxidative phosphorylation. D elorey et al (2003) suggest that the constant 
AHb signal during the first -1 3  s of exercise in their study reflects a close m atching of 
perfusion and m etabolism  and that any delay in O 2 consum ption should be reflected by 
a decrease in AHb during this initial phase. Therefore, the results from this study 
appear to support the notion o f a delay in O2 consum ption at the start of exercise. 
W hether the early decrease in AHb evident in this study reflects a ‘m etabolic inertia’ or 
an increase in m uscle perfusion/oxygen extraction ratio cannot be determined.
DCA has been shown to decrease peripheral vascular resistance (W argovich et al., 
1988; Ludvik et al., 1991). This may augment muscle blood flow during the initial 
stages o f the exercise response. Therefore a reduction in the AHb signal at the start of 
exercise may be expected. There is a clearly exaggerated decrease in the AHb signal for 
3 o f the 6 subjects during the DCA trial in this study. However, no difference is seen 
for the rem aining 3 subjects. Therefore, DCA has had no consistent/if any effect on 
AHb during this phase of the response. A DCA induced increase in muscle perfusion 
m ay be expected to reduce the AHb response throughout the exercise bout. Again this 
is evident in only 3 of the 6 subjects. Generally there is no systematic difference 
betw een the AHb responses for the DCA and Placebo trials. The responses for all 
subjects reach a peak value within 1 min, evidently quicker than the VO2  response. By 
definition a steady state response is not met in the m ajority of subjects. This clearly 
does not reflect the VO^ response and differs from the results o f Delory et al (2003) and 
Shybia et al (2003), Both studies reported a m ono-exponential response to steady-state.
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Gloser inspections of the data from  the Delory et al (2003) study suggest their 
description of the response is not accurate. The individual plots clearly show a 
‘drifting’ in the ‘steady state’ portion o f the response. Shybia et al (2003) do not 
display the AHb response in their study. The drifting is d e a ry  evident in the results 
from  this study and likely reflects factors influencing the volum e of Hb in the region of 
interrogation.
The results from  this study suggest that DCA has no systematic effect on m ierovascular 
O 2 extraction during sub-threshold exercise. There may be a suggestion that DCA 
increases m uscle perfusion during the initial phase of the response, but there is clearly 
no effect on the point of increase in AHb and no evident speeding o f the response in 4 
out of the 6 subjects.
4.3.4 The effect o f DCA on heart rate during m oderate intensity exercise
As with the incremental exercise study described in chapter 3 of this thesis, the heart 
rate was elevated at rest and unloaded pedalling during the DCA trial. Unlike the 
incremental exercise, heart rate was elevated throughout the m oderate exercise 
transitions. The effect of DCA on heart rate will be discussed further in the general 
discussion (section 6.8). The delta heart rate plots from this study clearly show that the 
effect of DCA on heart rate during exercise is not simply additive. The difference in 
heart rate between the two trials is evidently reduced on exercise.
The result of an elevated heart rate is a reduction in the oxygen pulse. Oxygen pulse is 
a product of stroke volume and arterio-venous O 2 difference. Therefore a reduction in 
oxygen pulse can reflect either a reduced stroke volume, an increased oxygen delivery
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or a decreased oxygen extraction. The increased heart rate during the DCA trial reduces 
the O2 pulse, presum ably through changes in stroke volume. This contradicts previous 
discussion (see section 3.3) suggesting that DCA may play a role in increasing O2 
delivery by increasing cardiac output. H ow ever when the O2 pulse plots have been 
norm alised to a zero baseline it is evident that there is little change in the rate or 
m agnitude of the O2 pulse response. This suggests that there is little change in either 
stroke volume or arterio-venous O2 difference as a result of DCA adm inistration during 
exercise at m oderate work intensity.
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Chapter 5
The effect of Dichloroacetate on oxygen uptake during
‘heavy’ intensity exercise
170
Chapter 5
S.O Introduction
The hypotheses for this study were that DCA could alter the VO 2  response to ‘heavy’/ 
‘very heavy’ exercise in three ways: 1) by speeding the initial ‘fundam ental’ com ponent 
of the response 2) changing the gain o f the initial ‘fundam ental’ com ponent of the 
response 3) by reducing the am plitude of the slow com ponent response.
The reasoning for the first hypothesis is sim ilar to that described for sub-threshold 
exercise (section 3.0). T im m ons et al (1998) described a ‘functional stenosis’ at the 
level of pyruvate dehydrogenase that was considered to be ‘m ajor determ inant’ of the 
lag in oxygen uptake during the initial stages of exercise. This was supported by the 
results from subsequent studies by How lett et al (1999) and Parolin et al (2000). On the 
evidence from these studies, DCA adm inistration should result in a speeding of the 
initial ‘fundam ental’ VO 2  response.
In addition, studies have shown an apparent speeding of VO2  kinetics for exercise 
transitions com pleted from  a background of prior exercise (Gerbino et <3/., 1996; 
M acDonald et aL, 1997; Bohnert et al., 1998). It has been proposed that this speeding 
o f the VO2  response is due to a residual acidosis augm enting the oxygen delivery during 
the subsequent exercise bout (Gerbino et al., 1996). However, PDH is quickly activated 
during exercise (Putm an et a i ,  1998). Therefore it is conceivable that a prior bout of 
exercise effects a prim ing o f PDH, augm enting the VO 2  response to the subsequent bout 
o f exercise. This is an effect sim ilar to that described by Tim m ons et al (1998). Indeed 
C am pbell-O ’Sullivan et al (2002) reported a prior bout of low intensity exercise (55%
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max ) accelerated the on-kinetic response over the first m inute of a subsequent
higher intensity (75% ) exercise bout. This increase in speed of the on-
kinetic response was attributed to an increase in the acetyl group availability at the level 
of the TCA cycle, thereby aceelerating m itochondrial ATP production at the onset o f the 
second exercise bout. Therefore it is conceivable that DCA administration should 
exhibit similar effect on the YO^ on-kinetic response to supra threshold exercise in the 
‘heavy’ and ‘very heavy’ exercise intensity domains.
As described in the introduction (refer to section 1.11), the m echanism /s behind the 
m anifestation of the slow com ponent are not yet fully understood. How ever what is 
clear is that the slow com ponent is only evident at work rates that induce lactic 
acidaem ia and it is dependent on a relative work rate rather than an absolute work rate. 
W hile blood lactate is unlikely to be a prim ary cause of the YO^ excess, these two 
com ponents of the exercise response appear inextricably linked. This is particularly 
apparent as a result of prior exercise (Gerbino et al., 1996) and endurance training 
(Casaburi et a l ,  1987). It was o f interest therefore to investigate whether DCA, and 
subsequently PDH activation, exhibited sim ilar characteristics. That is, would a 
reduction of the anaerobic contribution to the fundam ental phase of the exercise 
response alter the relative intensity o f the exercise bout, and subsequently reduce the 
ŸO 2  excess? In addition, is a greater lactate clearanee, and a subsequent reduction in 
acid stress, responsible for a reduction in the slow component?
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Chapter 5
5.1 Methods
5.1.1 Subjects
7 men between the ages o f 21 and 35 took part in the protocol. All subjects met the 
standard inclusion criteria (section 2.1 general methods). Table 10 shows the subject 
characteristics for each individual.
Table 10 - Subject characteristics
Subject
M ean
SD
Height
(cm)
179
182
184
167
170
186
181
178
7
Body mass
(kg)
61
95
87
71
83
86
67
78
12
Age
(yrs)
22
33
35
28
25
22
21
27
6
5.1,2 Protocol
Prior to undertaking this study subjects were fam iliarised with all equipm ent and 
procedures during m ultiple visits to the laboratory. On two subsequent visits the 
subjects com pleted a single square wave exercise protocol until exhaustion or until they 
were no longer able to maintain a cadence o f 50 rpm. A fter 3 m in of resting breathing 
and 5 m in of low load pedalling at 20 W, the work rate was increased (fig. 49). Up to 10 
min of data was collected during the recovery period post exhaustion.
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W ork rates above the lactate threshold were calculated as a percentage of delta VO 2 .
D elta VO 2  is a term  used to define the VO 2  difference between VO 2  ^ ax VO 2  at the
lactate threshold i.e. (Rausch ef a/, 1991). The percentage of delta VOj
used was determ ined from  the fam iliarisation bouts. Typically 60% of delta VO 2  was 
used for exercise lasting approxim ately 20 min. DCA and placebo doses were 
adm inistered following a standard protocol (see section 2.2.5) to each visit in a double­
blind, random ised fashion.
Ex
% A
W k (W)
LL
20 W  
0 W
E xhaustion
- y /
Stage time 
(min)
F igure 49  - Schem atic illustrating  the Supra-thresho ld  exercise protocol . LL  =  Low  Load pedalling. 
Ex -  exercise. T he exercise w orkload w as set at approxim ately  60%  o f delta V 0 2 { à V 0 2 =  max "
y 0 2 i r  ) lo r each individual. T he solid line illustrates the square wave nature o f  the w ork rate increase.
Blood handling and analysis followed the standard procedures described in section 
2.2.4. Blood samples were taken prior to DCA administration, 4 min into low load 
pedalling, every 5 min during exercise, at exhaustion and 3 min, 6 min and 9 min post 
exhaustion. Ratings of perceived exertion and dyspnoea were taken 45 s before each 
blood sample and as close to exhaustion as possible. Heart rate, gas exchange, and 
NIRS m easurem ents were made as described in chapter 2.
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5.1.3 Analysis
Each VO 2  data set was edited as described by Rossiter et al (2000). Gaussian 
distribution characteristics were assum ed (Lam arra et a i ,  1987; Rossiter et al., 2000). 
The VO 2  response for each test was interpolated on a second-by-second basis. This 
allowed subsequent averaging (8-12 s) and com parison of the responses from  repeated 
tests. The first 3 m in of the VOj response was m odelled using the same m ono­
exponential function as that used for the sub threshold data {Eqn 20).
The initial ‘cardiodynam ic’ portion of the data was excluded from  the fit. The 3 min 
time point was chosen to standardise the fitting window for com parison betw een the 
two trials. 3 min was chosen to m axim ise the data set available for analysis while 
m inim ising the contribution of the slow com ponent response associated with exercise 
above the lactate threshold. The initial portion of the slow rise in VOj was described 
by subtracting an average of m inute 3 from  the average of m inute 6 to give the index 
VO 2  6-3- Peak VO 2  was taken as an average of the last 20 s of exercise.
This analysis was adopted as the standard approach. M ultiple exponential functions, as 
described in the general introduction, were unsuccessful in consistently describing the 
VO 2  response for each individual.
5.1.4 Statistics
Statistical analysis follow ed that described in general methods chapter 2 (section 2.2.11)
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5.2 Results
5.2.1 Blood borne metabolic responses to supra-threshold exercise
The group mean + SEM  blood lactate responses for both trials are shown in figure 50. 
It is clear that blood lactate was reduced throughout exercise on the DCA trial. This 
reduction was significant at baseline (Mean + SEM. 0.35 + 0.05 mmol/1 DCA. 0.71 ±  
0.0.08 mmol/1 placebo. P -  0.0005. Table 11), m inute 3 (Mean + SEM. 4.04 + 0.57 
mmol/1 DCA. 4.85 ±  0.59 mmol/1 placebo. P = 0.0009. Table II) ,  m inute 6 (M ean + 
SEM . 8.44 + 1.15 mmol/1 DCA. 7.55 + 1.22 mmol/1 placebo. P = 0.046. Table 11) and 
exhaustion (Mean + SEM. 11.82 + 1.29 mmol/1 DCA. 13.49 ±  1.55 mmol/1 placebo. P 
= 0.008. Table 11). Blood lactate values continued to be lower during recovery. A 
significant difference was observed at 3 min (M ean ±  SEM. 11.07 + 1.46 mmol/1 DCA. 
12.65 ±  1.46 mmol/1 placebo. P = 0.013. Table 11) and 6 min (M ean + SEM . 9.77 + 
1.87 mmol/1 DCA. 11.53 + 1.83 mmol/1 placebo. P = 0.036. Table 11) post exhaustion. 
DCA lowered blood lactate values across all time points by 51%, 11%, 9%, 12%, 12% 
and 15% respectively. Therefore the m agnitude o f the reduction becam e less the closer 
the suhject was to exhaustion.
There was a small but significant fall in pH from baseline to exhaustion (fig, 51) in both 
the placebo trial (M ean + SEM. 7.40 ±  0.003 baseline, 7.24 + 0.03 exhaustion. P = 
0.012. Table 11) and DCA trial (M ean ±  SEM. 7.41 ±  0.002 baseline, 7.25 + 0.03 
exhaustion. P = 0.011. Table 11). How ever there was no difference in the m agnitude of 
the drop between trials.
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Sim ilarly there was a fall in standard bicarbonate progressively throughout exercise 
until exhaustion (fig. 52). There appears to be a trend for the values to be higher on the 
DCA trial, the mean differences do not reach statistical significance (Sum m ary data are 
shown in Table 11).
Figure 53 shows that blood glucose increased at exhaustion and peaked post exercise for 
both trials. There appears to be a tendency for the mean values to be lower for the DCA 
trial how ever the differences do not reach statistical significance (Sum m ary data are 
shown in Table 11).
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Figure 50 - The effect o f D CA  on blood lactate during heavy intensity exercise. D ata are group m eans + 
SEM . C losed circles = p lacebo. O pen circles =  D CA . D ata show s that the adm inistration  o f  D CA  
successfully  reduced blood [Lactate] throughout the supra-threshold exercise protocol, com pared to the 
p lacebo trial. Pre dose = Sam ples taken prior to D CA  adm inistration . LL = low load pedalling (20W ). 
m3 = m inute 3. mb = m inute 6. ex = exhaustion. 3p = 3 m inutes post exhaustion, bp = 6 m inutes post 
exhaustion . 9p = 9 m inutes post exhaustion . * S tatistically  significant betw een D CA  and placebo trial. 
Statistical analysis was carried  out using tw o-factor A N O V A  for repeated m easures, follow ed by a paired 
r-test if a main treatm ent effect w as observed. Statistical significance w as declared  at P < 0.05.
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Figure 51 - The effect o f  D CA  on blood pH during  heavy intensity exercise. D ata are group m eans + 
SEM . C losed circles = placebo. O pen circles = DCA. Pre dose = Sam ples taken prior to D CA  
adm inistration . LL = low load pedalling  (20W ). m3 = m inute 3. mb = m inute 6. ex = exhaustion. 3p = 3 
m inutes post exhaustion. 6p = 6 m inutes post exhaustion . 9p = 9 m inutes post exhaustion. * S tatistically  
significant. S tatistical analysis was carried  out using tw o-factor A N O V A  for repeated m easures, follow ed 
by a paired r-test if  a main treatm ent effect was observed. Statistical significance was declared at P < 
0.05 .
179
27
25
23
21
19
17
15
13
Placebo
DCA
rest LL 
(pre dose) m3 m6 ex 
Sample
3p 6p 9p
Figure 52 - The effect o f  D CA  on blood b icarbonate during heavy intensity  exercise. D ata are group 
m eans + SEM . C losed circles = placebo. O pen circles = DCA. Pre dose = Sam ples taken prior to DCA 
adm inistration . LL = low load pedalling  (20W ). m3 = minute 3. mb = m inute 6. ex = exhaustion . 3p = 3 
m inutes post exhaustion . 6p = 6 m inutes post exhaustion . 9p = 9 m inutes post exhaustion . * S tatistically  
significant. S tatistical analysis w as carried  out using tw o-factor A N O V A  for repeated m easures, follow ed 
by a paired r-test if  a main treatm ent effect was observed. S tatistical sign ificance was declared at P < 
0.05.
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Figure 5 J  - T he effect o f  D CA  on blood glucose during heavy intensity exercise. D ata are group m eans + 
SEM . C losed circles =  placebo. O pen circles =  DCA. Pre dose =  Sam ples taken prior to DCA 
adm inistration . LL = low load pedalling  (20W ). m3 = m inute 3. mb = m inute 6. ex = exhaustion. 3p = 3 
m inutes post exhaustion . 6p = 6 m inutes post exhaustion . 9p = 9 m inutes post exhaustion . * S tatistically  
significant. S tatistical analysis was carried  out using tw o-factor A N O V A  for repeated  m easures, follow ed 
by a paired r-test if  a main treatm ent effect was observed. S tatistical sign ificance was declared  at P < 
0.05.
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5.2.2 The effect o f DCA on exercise perform ance
A reduction in blood lactate throughout exercise was not reflected in an increase in tim e 
to exhaustion (Tum) in the DCA  trial. Tum for DCA and placebo trials was 12.60 ± 1 . 13  
m in and 14.20 ±  1.53 m in respectively (M ean ±  SEM. P = 0.10).
5.2.3 V O 2 responses to ‘heavy’ intensity exercise
The group m ean ±  SEM  on-transient VO 2  responses are shown in figure 54. There is no 
difference between the DCA and placebo trials. This is reflected in the VO 2  values at 
baseline (M ean ±  SEM. 0.80 ±  0.039 1/min DCA. 0.79 ±  0.032 1/min placebo. P = 
0.65. Table 12), minute 3 (M ean ±  SEM. 3.08 ±  0.17 1/min DCA. 3.09 ±  0.16 1/min 
placebo. P = 0.82. Table 12), m inute 6 (M ean ±  SEM . 3.30 + 0.16 1/min DCA. 3.30 ±  
0.16 1/min placebo. P = 0.79. Table 12) and exhaustion (M ean + SEM. 3.35 ± 0 . 1 5  
1/min DCA. 3.34 ±  0.18 1/min placebo. P = 0.62. Table 12).
The fundam ental VOj tim e constant was not significant different between DCA and 
placebo trials (M ean ±  SEM . 31 ±  2.9 s DCA. 31 ±  2.6 s placebo. P = 0.91. Table 12). 
A  m ono-exponential function {Eqn 20) was fitted to the first 3 m inutes of the VO 2  
response excluding the initial ‘cardiodynam ic’ (-2 5  s) phase. Figures 55 a,b&c show 
the individual plots for each subject. The residuals associated with each of the plots 
fluctuate closely and random ly around zero. This indicates that this phase of the 
response was well described by the m ono-exponential function. The fit rem ained good 
for the first 3 m inutes with a small divergence in the residuals only evident in subjects 
3, 4 and 7.
183
An additional slow com ponent of the VO 2  response is clearly evident after 3 min in all 
subjects (fig. 55 a,b&c). The initial rise in this excess com ponent can be estim ated by 
expressing it as the m ean of the 6‘*’ min minus the mean of the 3"  ^ min. This difference 
was positive for all subjects. There was no difference betw een DCA and placebo trials 
(M ean + SEM. 0.22 + 0.047 1/min DCA. 0.22 + 0.034 1/min placebo. P = 0.96. Table 
12). The asymptotic steady-state VO 2 , predicted from the m ono-exponential fit through 
the first 3 min was not significantly different from  the average of minute 3 for both 
groups. This was true for all subjects indicating that the influence of a slow com ponent 
on the m odelled fundam ental VO 2  responses was at most minimal. Therefore, the 
choice o f 3 min was an appropriate tim e frame for m odelling using the m ono­
exponential fit.
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Start3.5
3.0
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DCA2.0
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Time (min)
F igure 54 -  D ata are group m ean + SEM . T he on-transient V O j  response to heavy intensity exercise.
O pen circles = DCA. C losed circles =  placebo. D ashed line indicates the start o f the step increase in 
w ork rate from a 20 W  baseline.
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5.2.4 Cardiovascular responses to ‘heavy’ intensity exercise
Heart rate was significantly elevated at rest by a mean of 9 beats-min^ during the DCA 
trial (Mean + SEM. 70 + 2.3 beats min"' DCA, 61 + 1.0 beats-min"' placebo. P  = 
0.013). This elevation in heart rate was maintained during low load baseline pedalling 
(Mean + SEM. 100 + 3.7 beats-min"' DCA, 90 ± 2.5 beats-min ' placebo. P  = 0.012. 
Table 13). By 3 min into exercise this effect is no longer seen. No differences in heart 
rate are discernable at 3min, 6nun or exhaustion (summary data are shown in table 13). 
This elevation in baseline heart rate can be clearly seen in figure 56 which shows the 
group mean + SEM responses for both trials. Figures 57 shows that when normalised to 
a zero baseline the delta heart rate requirement is significantly lower in the DCA trial.
From the VO 2  and heart rate responses it follows that the oxygen pulse was found to be 
significantly lower at rest during the DCA trial (Mean + SEM. 6.77 ±  0.44 ml/beat 
DCA. 8.00 ±  0.58 ml/beat placebo. P = 0.02. Table 13). This reduction was still 
evident during baseline low load pedalling (Mean + SEM. 8.09 + 0.54 ml/beat DCA. 
8.84 + 0.58 ml/beat placebo. P = 0.02. Table 13). No significant difference was found 
at any other time point (summary data are shown in table 13). The reduction in baseline 
oxygen pulse can be clearly seen in figure 58 which shows the group mean ±  SEM 
responses for both trials. Figure 59 shows the same data corrected for differences in 
baseline values. It is evident from this graph that the time course and magnitude of the 
responses are similar for both trials.
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Figure 56 -  T he heart rate response to heavy intensity  exercise. D ata are group mean + SEM . O pen 
circles = DCA. C losed circles = placebo. D ashed line indicates the start o f the step increase in w ork rate 
from a 20 W  baseline.
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F igure 5 7  -  The heart rate response to heavy intensity exercise, norm alised to baseline values. D ata are 
group m ean + SEM . O pen c ircles = D CA . C losed circles = placebo. D ashed line indicates the start o f 
the step increase in w ork rate from  a 20 W  baseline.
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F igure 58  -  The oxygen pulse response to heavy intensity  exercise. D ata are group mean + SEM . O pen 
circles = D CA . C losed circles = placebo. D ashed line indicates the start o f the step increase in w ork rate 
from a 20 W  baseline.
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F igure 59 -  The oxygen pulse response to heavy intensity exercise, norm alised to baseline values. D ata 
are group mean + SEM . O pen circles = DCA. C losed circles = placebo. D ashed line indicates the start 
o f  the step increase in work rate from  a 20 W  baseline.
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5.2.5 Muscle oxygen saturation during ‘heavy’ intensity exercise
Figure 60 shows the group mean ±  SEM deoxyhaemoglobin plots for both trials. The 
plots are well matched at baseline and throughout exercise. The initial drop in Hb seen 
at the beginning of the step change in work rate in chapter 4 is evident again in these 
results (refer to section 4.2.4). After an initial rapid response the plots show a slower 
rise in the Hb response developing approximately 1-2 min into exercise. This is much 
early than the slow component of the VOj response which only became evident at 
approximately 3 min into exercise.
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Figure 60  - D elta deoxyhaem oglobin  responses to heavy intensity exercise. D ata are group mean + SEM . O pen 
circles = DCA . C losed circles = placebo. D ashed line indicates the start o f  the step increase in work rate from  a 
20 W baseline.
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5.2.6 Ratings of perceived exertion and dyspnoea during ‘heavy ^ intensity exercise
No significant difference was found in rating of perceived exertion or rating of 
dyspnoea between the two trials at any time point. Figure 61 shows the group mean + 
SEM values for ratings of perceived exertion. Figure 62 shows the group mean + SEM 
values for ratings of dyspnoea.
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Figure 61- R atings o f  perceived exertion  during  heavy intensity exercise. D ata are group mean + SEM . 
O pen circles = DCA. C losed circles = placebo. LL = low load pedalling (20W ). m3, m6, m9 = m inutes 
3,6, & 9 respectively. Ex = exhaustion . 3p, 6p, 9p =  m inutes 3, 6, & 9 post respectively.
2OcCL(O
Q
1 0 0
80
60
40
20
Placebo
DCA
rest LL m3 m6 m9 ex 3p 6p 9p
Figure 62 - R atings o f dyspnoea  during heavy intensity  exercise. D ata are group mean + SEM . Open 
circles = DCA. C losed circles = placebo. LL = low load pedalling (20W ). m3, m6, m9 = m inutes 3,6, & 
9 respectively. Ex = exhaustion . 3p, 6p, 9p = m inutes 3, 6, & 9 post respectively.
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Chapter 5
5.3 Discussion
5.3.1 The effect of DCA on the fundamental VO2  time constant and gain
The initial phase of the VO2  response was well fitted by a mono-exponential response 
as previously described (Paterson and Whipp, 1992; Ozyener et aL, 2001) and the tan 
for this response (~30s) was similar to that expected for sub-threshold exercise (Whipp, 
1971; Whipp and Wasserman, 1972; Davies et ciL, 1972; Bakker et aL, 1980; Whipp 
and Ward, 1990; Whipp et aL, 1982; Hughson and Morrissey 1982). No difference was 
found however between the time constant of the response for DCA and placebo trials. 
Indeed with the exception of subject 1 the values for tau were within 4s of each other 
for all subjects. This finding is similar to that of Rossiter et al (2003) who reported no 
difference in VO2  on-kinetics during single leg knee extensor exercise before and after 
DCA administration. Similar results have been reported by Bangsbo et al (2002) and 
Savasi et al (2002) for higher intensity exercise in humans and Grassi et al (2002) for 
electrically induced exercise in dog gracilis muscle. However, where the results of 
these studies differ from that of Rossiter et al (2003) is in the amplitude of the 
fundamental VO2  and PCr responses, and level of reduction in blood [lactate]. Rossiter 
et al (2003) found that while the tau for the fundamental VO2  and PCr responses was 
unaltered the steady-state gain of the responses was reduced, coupled with this was a 
reduced blood [lactate] and an increase in pH throughout exercise. In contrast the 
studies by Bangsbo et al (2002), Savasi et al (2002) and Grassi et al (2002) reported no 
difference between the PCr, VO2  and lactate responses between the DCA and placebo 
trials.
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The data from Rossiter e t  a l  (2003) agrees with previous studies showing a reduced PCr 
breakdown after DCA administration (Timmons e t  a l . ,  1998; Howlett e t  a l . ,  1999; 
Parolin e t  a l . ,  2000). The reasons for the discrepancy between these studies and those 
of Bangsbo e t  a l  (2002), Savasi e t  a l  (2002) and Gras si e t  a l  (2002), may be related to 
the intensity of the exercise undertaken. The studies showing no difference in PCr 
breakdown were undertaken at a much higher intensity than those that do. Why this is 
the case is uncertain. The exercise intensity for this study was chosen to allow time for 
the slow component to develop, and to elicit fatigue in under -2 0  min. Therefore 
comparison with the studies of Rossiter e t  a l  (2003), Timmons e t  a l  (1998), Howlett e t  
a l  (1999) and Parolin e t  a l  (2000) are more apt for the initial phase of the response. 
However none of the aforementioned studies have continued the work rate protocol 
until exhaustion and only the study of Rossiter e t  a l  (2003) described the V O j  kinetic 
response.
The reduction in the fundamental V O j  gain demonstrated in the study by Rossiter e t  a l  
(2003) and inferred by Timmons e t  a l  (1998), Howlett e t  a l  (1999) and Parolin e t  a l
(2000) is not evident in the V O 2 responses from this study. The results of Rossiter e t  a l  
(2003) agree with those of Greenhaff e t  a l  (2002) who showed that the anaerobic 
component of ATP production was reduced after DCA administration. The mechanism 
behind this apparent reduction in ATP requirement are proposed by Rossiter e t  a l  
(2003) to include 1) a shift to a greater contribution from muscle fibres with a lower 
‘VG2 gain’; 2) a reduction in intramuscular pH (in either strongly acid-producing 
muscle fibres or in the muscle as a whole); 3) a greater reliance on oxidative 
carbohydrate metabolism; and 4) a greater mechanical efficiency of performing the task.
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The reason for the difference between the results from this study and those mentioned 
are not clear. However Rossiter et al (2003), when discussing greater mechanical 
efficiency, mentioned that all of their subjects spontaneously reported that exercise felt 
“easier” after DCA administration. In contrast no significant difference was found in 
this study between ratings of either RPE or dyspnoea. Indeed many of the subjects 
reported that the exercise felt “harder” after DCA administration, despite their 
remaining blinded to the experimental condition. This may suggest that the results 
could be specific to the mode of exercise. Differences between knee extensor exercise 
and upright cycling have been noted previously (Rossiter et a i ,  2001 vs. Burnley et al., 
2000), however no reason for these differences were given. In the Rossiter et al (2003) 
study, the exercise was carried out in a face down supine position. Koga et al (1999) 
demonstrated a reduced fundamental gain with no change in the VO^ time constant 
when heavy exercise was performed in the supine position. These results were thought 
to be as a consequence of a reduced perfusion pressure due to attenuated O2 delivery. 
While it is not expected that DCA causes a reduction in O2 delivery, the increase in 
heart rate upon DCA administration described in this study suggests that the 
haemodynamic properties of DCA are yet to be fully understood. The results of Koga 
et al (1999) demonstrate that the time constant and gain of the fundamental 
ÊO2 response can be dissociated. Furthermore they show that these parameters are 
sensitive to the mode of exercise employed.
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5.3.2 The effect of DCA on the slow component VO2  response
Similar to the initial phase of the exercise response, DCA had no effect on the 
subsequent slow component response. Indeed the VO2  response for all subjects was 
evidently similar in all subjects for both trials. The only comparable study for this work 
intensity is that of Rossiter et al (2003). Once more the results of the two studies differ. 
Rossiter et al (2003) observed, on average, a -28%  reduction in the VO2  slow 
component between the DCA and placebo trial and this was accompanied by a 32% 
reduction in end-exercise blood [Lactate]. A 12% reduction in blood lactate was 
observed in end-exercise blood [Lactate] in this study with no reduction in the slow 
component. Therefore an acid stress mediated reduction in the magnitude of the slow 
component is not supported by these results. The reason for this disparity between the 
studies is once again unclear. However Rossiter et al (2003) make the interesting 
observation that, when expressed as a percentage of the fundamental VO2  gain, there is 
no difference between magnitude of the slow component between DCA and placebo 
trials. Following this hypothesis, as there is no difference in the fundamental response 
between the two trial conditions in this study, a difference in the slow component 
response is not expected. Therefore the data set from this study would fit a theory that 
the fundamental response plays a role in determining the magnitude of the slow 
component response. However this experimental design presents a poor interrogation 
of this hypothesis and, as stated by Rossiter et al (2003), there is currently little 
evidence available to support this theory. Indeed, Jones et al (2002) demonstrated a 
reduction of the fundamental component of the VO2  response to heavy exercise with 
creatine supplementation and this reduction was not accompanied by a concomitant 
reduction of the slow component response.
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W hile the reasons for the disparity between the Rossiter et al (2003) study and this one 
are unclear it is worth noting that the metabolic demand associated with the two forms 
of exercise is markedly different. For example, the peak exercise blood [lactate] in the 
Rossiter et al (2003) study was 2.7 ±  1.8 (mmol/1) compared with 13.49 ±  3.80 (mmol/1) 
in this study. The A VO2 ,, was 0.84 ±  0.21 (1/min) in the Rossiter et al (2003) 
compared with 2.27 + 0.4 (1/min) in this study. Therefore while the acid stress was 
reduced in Rossiter et al (2003) study it was reduced from an already low background. 
The subsequent reduction in the slow component, assuming cause and effect, was of the 
magnitude 0.07 (1/min). Therefore, it may be that the greater metabolic demand of the 
exercise in this study precludes/masks any appreciable effect of DCA on the O2 kinetic 
response. This could possibly be due to differences in proportional activation of PDH. 
PDH has been shown to be activated fully shortly into higher intensity exercise 
(Putman, 1995). Or perhaps the greater variance in the oxygen uptake measures with 
this protocol did not allow for discrimination of small changes in VO2 . Interestingly, if 
the magnitude of the reduction in the slow component from the Rossiter et al (2003) 
study is factored by the observed difference in the A VO2  ss values between that study 
and this (i.e. ~x3), the resulting change of 0.21 (1/min) lies within ISD of the mean VO2  
values reported for both conditions in this study. This further suggests that any 
appreciable change in VO2  may be to small to detect with this experimental design. 
Howlett and Hogan (2003), upon demonstrating a speeding of the fall in P02 with DCA 
at the onset of contraction in isolated Xenopus single muscle fibres, questioned whether 
the differences in oxidative metabolism shown in their preparation were large enough to 
be discernable in whole muscle preparations.
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The results from this study therefore do not support a role for PDH in either a 
significant speeding of the fundamental component of the VO2  response or an 
attenuation of the slow component response to dynamic exercise in the ‘heavy’ exercise 
domain.
5.3.3 The effect o f DCA on m uscle oxygen saturation
The deoxyhaemoglobin responses show some marked yet inconsistent differences 
between DCA and placebo trials. As discussed previously (see section 5.2.5) the acid 
shift evoked by the H+ ion associated with lactate facilitate the unloading of O2, 
illustrated by a right shift of the oxyhaemoglobin dissociation curve. Therefore a 
marked reduction in blood [lactate] through PDH activation in the working muscle may 
attenuate the rise in muscle deoxygenation. This effect is not apparent in this study.
The profile of the deoxyhaemoglobin plot is very similar to that of VO2  in that after an 
initial rapid response a second slower response is evident 1-2 min into exercise. Poole 
et al (1991) and Rossiter et al (2002) have shown that -70%  of the VO2  slow 
component originates from within the exercising muscle mass and this is reflected by 
the increase in the deoxyhaemogloin plots here. Interestingly, figures 55a&b show the 
first 3 min of the VO2  response are fit well by an exponential response, with divergence 
in the residuals only evident in subject 1 (after -2  min); however it is clear from the 
deoxyhaemoglobin plots that the ‘slow component’ of the response is manifest within 3 
min of exercise onset. A previous study by Belardinelli et al (1995) showed an increase 
in both VO2  and muscle deoxygenation after 3 min of constant work exercise, however 
the data from their study did not allow discrimination of an exact point of change of the 
two responses. While an attempt has not been made in this study to discern an exact
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point of increase in the ‘slow component’ of the deoxyhaemoglobin plot, a clear 
divergence can be seen visually to occur within the first 2 min of exercise. The greater 
data density in this study compared to the Belardinelli et al (1995) study allowed for 
better discrimination of the initial signs of divergence in the deoxyhaemoglobin plot. 
Therefore it appears that the slow component of the response may be evident in the 
muscle significantly earlier than it is evident in pulmonary VO2 . A possible reason for 
this is that the relatively small region under interrogation may not reflect the energetics 
of the combined exercising musculature. Therefore the slow component may develop 
more quickly in one region of the muscle in relation to the other and this may be borne 
out in pulmonary VO2  as a mean response. This heterogenic QmusO^ response within 
a muscle group has been reported by Quaresima et al (2001). Indeed Van Beekvelt et al
(2001) reported that the Pick method of determining whole muscle O2 uptake did not 
correlate with the regional assessment from NIRS. This disparity between local 
muscular oxygen uptake and whole muscle/whole body oxygen uptake could be a 
consequence of local perfusion-metabolism mismatching (Grassi, 2001) or, as discussed 
by Whipp et al (2002), individual oxygen uptake responses for each muscle fibre. 
Either of these two would lead to a mean response that differed from a local muscular 
response. The extent and significance of this difference requires further investigation. 
However these results present interesting questions on modelling the phase Il-phase III 
ŸO 2 transition and its relevance to the onset of the slow component response.
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5.3.4 The effect o f DC A on heart rate
In agreement with the first two studies, heart rate was significantly increased at rest and 
during unloaded pedalling during the DCA trial. However this marked increase was not 
continued throughout exercise. Group averages across minute 3, minute 6 and at 
exhaustion showed no variance between trials. Delta heart rate responses were once 
again consistently lower on the DCA trial, illustrating a lower heart rate recruitment. 
This suggests the effects of DCA on heart rate are not additive throughout the period of 
exercise and/or the mechanism/s by which heart rate is increased by DCA are 
functionally no different to those increasing heart rate during the placebo trial. As with 
previous chapters this subject will be covered in more detail during the general 
discussion. Oxygen pulse is reduced as a result of the elevated heart rate response at 
rest and during low load pedalling.
5.3.5 Exercise perform ance and fatigue
Of the main factors thought to contribute to muscle fatigue during exercise such as [Pi], 
pH, alterations in Ca^^ release and sensitivity and muscle glycogen content; DCA has 
been shown to improve the [Pi] and pH responses and elicit a muscle glycogen sparring 
effect (Timmons et al., 1996; Grassi et a i ,  2002; Schneider et a i ,  1981; Durkot et al., 
1995; Rossiter et al., 2003). Therefore there appears to be a role for DCA in improving 
muscle function and reducing fatigue.
Timmons et al (1996) demonstrated that DCA reduced muscle fatigue by -35%  during 
20 min of ischaemic contraction in a canine model. Similarly Grassi et al (2002) found 
that the fatigue index in electrically stimulated dog gracilis muscle was improved by
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- 8% after DCA infusion during a 4 min electrically stimulated isometric tetanic 
contraction, corresponding to -60-70%  of peak VO2 . Schneider et al (1981) found rats 
dosed with DCA to swim an additional 99 s before exhaustion. Durkot et al (1995) 
found improved run times in DCA treated rats when compared to controls (169 min vs. 
101 min). In both the Durkot et al (1995) and Schneider c/ «/ (1981) studies there was a 
glycogen sparing effect in the DCA trial.
Of the studies that include humans exercising until exhaustion (Ludvik et aL, 1993; 
Carraro et aL, 1989; Roberts et aL, 1997), only Ludvik et al (1993) report an improved 
performance. Each of these studies employed an incremental exercise protocol to 
exhaustion. No previous studies have looked at an exercise trial in humans to determine 
whether DCA has a ergogenic effect on performance.
No significant difference was seen between trials in this study. This suggests that any 
improvement in muscle function at the onset of exercise was not sufficient to delay the 
onset of fatigue in this study. Therefore DCA does not appear to improve muscular 
function during prolonged ‘heavy’ intensity exercise. This will be discussed further in 
the general discussion.
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Chapter 6 
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Chapter 6
6.0 General Discussion
The results from these studies do not support those from previous studies (Howlett et 
aL, 1999; Timmons et aL, 1996, Timmons et aL, 1998) whose findings have advocated 
a role for the Pyruvate Dehydrogense complex in the determination of the rate of 
oxygen uptake at the onset of dynamic exercise. However, they are in agreement with 
the more recent investigations (Bangsbo et aL, 2002; Grassi et aL, 2002; Rossiter et aL, 
2003; Jones et aL, 2003; Koppo et aL, 2004) which have demonstrated that activation of 
the pyruvate dehydrogenase complex through dichloroacetate administration has no 
effect on oxygen uptake kinetics.
These latter findings, coupled with the results from chapters 2 and 3 would suggest that 
there is no apparent ‘functional stenosis’ at the level of the PDH complex controlling 
the VOj response to exercise. However, evidence has been presented by Howlett and 
Hogan (2003) that suggests that a degree of rate limitation may lie, at least in part, at the 
level of the PDH complex. Howlett and Hogan (2003) demonstrated an accelerated 
decrease in PO2 in isolated single frog muscle fibres with DCA administration. This 
finding agrees with the studies which have advocated the PDH complex as a ‘major 
determinant’ of the oxygen deficit through evidence of a reduced level of substrate 
phosphorylation upon DCA administration (Howlett et aL, 1999; Timmons et aL, 1996; 
Timmons et aL, 1998). Why therefore has no discernable effect on the O2 deficit been 
evident in those studies which have directly measured pulmonary gas exchange? As 
discussed previously (section 4.2.2), it is likely that the magnitude of the response in the 
Howlett & Hogan study (~2 s) is too small to be appreciable in vivo. This observation 
was made by the authors themselves. Likewise, Rossiter et al (2003) made the
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suggestion that, because aerobic ATP production is more efficient than anaerobic ATP 
production, only a small increase in VO 2  would be required to compensate for a 
relatively large reduction in energy provision through nonoxidative pathways, and that 
this increase in VO2  might therefore be too small to detect. Furthermore, Jones et al 
(2003) suggest that the principal effects of DCA on muscle metabolism occur early 
following the onset of contraction (i.e. in the first 10-20 s) when muscle VO 2  is low 
(Behnke et aL, 2002; Hogan, 2001) and therefore little influence on VOj kinetics would 
be expected i.e. much of the information would be incorporated in the 
‘cardiodynamically’ mediated phase I of the pulmonary VO 2  response. This is in 
agreement with the findings of Roberts et al (2002) who reported that the ‘acetyl group 
deficit’, described by Green haff et al (2002), exists only during the first 10-20 s of 
exercise and that after this period acetyl groups accumulate in the muscle (Howlett et 
aL, 1999; Savasi et aL, 2002). This suggests that after this initial phase, PDH 
activation, and the availability of acetyl groups is unlikely to be limiting oxidative 
phosphorlyation. Therefore, activation of PDH by DCA administration may increase 
the rate of oxygen consumption at the onset of exercise, however it is likely that this 
effect is appreciably small that it cannot be determined through the measurement of 
whole body VO2  • The functional significance of this increase is therefore minimal.
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6.1 The accuracy o f the pulm onary V O 2 responses in reflecting a DCA induced  
m uscle m etabolic response
As described in section 2.2.8, the breath-by-breath noise associated with gas exchange 
analysis determines the sensitivity of the kinetic modelling (Lamarra et aL, 1987; 
Rossiter et aL, 2002). Every attempt was made in this study to minimise the signal-to- 
noise ratio by, averaging repeat transitions (where possible), maximising the sub­
threshold delta VO2 , recruiting large muscle groups, excluding breaths out with 4 
standard deviations of the mean response (Lamarra et aL, 1987), and familiarising the 
subjects thoroughly with all protocols and procedures. As a result the 95% confidence 
intervals for the fundamental kinetic response in these studies averaged 0.15 s and 0.13 
s for the sub and supra threshold kinetic analysis respectively. This is consistent with 
the values reported by Rossiter et al (2003), Jones et al (2003) and Koppo et al (2004). 
Therefore an appreciable change in the phase II VOj kinetics i.e. greater than 2 s, would 
be realised by the analysis in this study. Rossiter et al (2003) calculated a predicted 
change in t  of -3  s for the -2  mmol/1 difference in [PCr] measured in their study (on the 
basis of no change in the fundamental VO2  gain as originally hypothesised). This lay 
outside the average 95% confidence intervals of < + 2 s in their study and similarly lies 
outside the limits reported for the studies in chapters 3 and 4. Therefore it can be said 
that the study designs afforded adequate discriminability for a significant difference in 
VO 2  kinetics to be realised.
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6.2 Exercise intensity dependent responses to Dichloroacetate administration.
Much of the discrepancy between the results of DCA studies is likely due to the 
intensity of the exercise employed. PDH activation has been shown to be highly 
dependent on work rate (Constantin Teodosiu et aL, 1991; Howlett et aL, 1998). This is 
likely to be a primary contributing factor to the differences in muscle metabolic 
responses observed between studies (Howlett et aL, 1999; Timmons et aL, 1996; 
Timmons et aL, 1998; Savai et al., 2002; Bangsbo et aL, 2002; Howlett et aL, 1999). 
Studies undertaken in ‘very hard’ or ‘severe’ exercise domains (Savai et aL, 2002; 
Bangsbo et aL, 2002; Howlett et aL, 1999) have not reported the effects of DCA on 
muscle metabolism described for exercise at a lower intensity (Timmons et aL, 1998). 
The ‘acetyl group deficit’ as described by (Greenhaff et aL, 2002) is suggested by 
Timmons et al (1998) to be the major determinant of oxidative phosphorylation during 
the transition from a lower to higher level of muscular work. However, Roberts et al
(2002) have suggested that acetyl group availability is likely to limit oxidative 
metabolism at low to moderate exercise intensities (<65% VGjtuax) and that PDC 
activation is likely to be sufficiently rapid at high exercise intensities (>90% TOjmax). 
Therefore, the intensity of exercise under study is likely to be a major determinant of 
any expected change in metabolic response post DCA administration.
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6.3 The effect of DCA on muscle fatigue and exercise performance
Alterations in the ‘fatigue status’ or ‘fatigue index’ may be an important mechanism by 
which DCA would improve the overall energy status of the exercising muscle (Rossiter 
et aL, 2003). Factors that are thought to contribute to muscle fatigue include alterations 
in [Ca^^] release and sensitivity, [Pi] and intracellular pH (Allen, 2001; Westerblad, 
2002). Rossiter et al (2003) have shown improvements in both the [Pi] and intracellular 
pH responses in response to DCA administration i.e. a decrease in pH elevation on 
exercise and a decrease in the magnitude of the [Pi] response. Furthermore, an 
improved muscle performance has been reported in the studies of Grassi et al (2002), 
Roberts et al (2002) and Timmons et al (1996). Grassi et al (2002), using an isolated 
dog muscle preparation, found that in response to electrical stimulation the fatigue index 
was improved by - 8% in the DCA condition. This was manifest as a better maintenance 
of force production at the same QO2 rather than a reduced QO2. Jones et al (2003) 
suggested that any positive effect of DCA on muscle energy state in the immediate 
transition to exercise would be hypothesised to reduce muscle fatigue and enhance 
performance later in exercise. The supra-threshold exercise in this study is the first 
reporting the effects of DCA on performance of dynamic exercise to exhaustion at a 
work intensity that required the subjects to tolerate elevated levels of blood lactate for a 
sustained period. That no significant difference was seen between trials suggests that 
any improvement in muscle energy state during the early response of this exercise 
protocol did not influence performance during the latter stages. Therefore these results 
do not agree with the argument of Jones et al (2003). Furthermore they indicate that 
none of the reported benefits to muscle function described by previous studies were 
significant enough to be realised by an improvement in exercise performance for the
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type of exercise employed here. The discrepancy between this study and those studies 
that have shown improvements is muscle performance may relate to the exercise 
conditions. Many of the studies demonstrating an improved muscle performance 
employed exercise under ischaemic (Roberts et aL, 2002; Timmons et aL, 1996; 
Timmons et aL, 1998), or hypoxic (Parolin et aL, 2000) conditions. Whereas those 
studies that maintained an intact circulation (Howlett et aL, 1999; Bangsbo et aL, 2002; 
Grassi et aL, 2002; Savasi et aL, 2002; Jones et aL, 2003) report no effect on muscle 
metabolism and/or VO2  kinetics. That DCA had no appreciable effect on exercise 
performance for the subject group in this study does not mean that further investigation 
in this area is not warranted. In diseases such as heart failure, exercise capacity is 
reduced. Reduced cardiac function and in some cases a thickening of the alveolar- 
capillary membrane, cause under-perfusion and poor oxygen delivery to the working 
muscle. The subsequent increase in glycolysis causes production of lactate and 
associated muscle fatigue (Spurway, 1992). Therefore the haemodynamic effects and 
the lactate lowering properties of DCA may make a difference to exercise performance 
in patient groups where it may have a significant impact on patient quality of life.
6.4 The effect o f DCA on the O xygen Deficit
Greenhaff et al (2002), Timmons et al (1998) and Howlett et al (1999) have all shown 
that the anaerobic component of ATP production is reduced during the first few minutes 
of exercise after DCA administration, indicated by a reduced PCr breakdown and a 
decrease blood [Lactate]. However, in these studies neither muscle nor pulmonary VO 2  
was measured and therefore assumptions were made that the reduction in substrate 
phosphorylation reflected an increased mitochondrial ATP production. The results from 
chapter 4 are in agreement with that from other authors (Koppo et aL, 2004; Jones et aL,
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2004, Rossiter et aL, 2003), clearly dem onstrating that this is not the case when 
pulm onary VOj is m easured directly. Jones et al (2003) suggest that near maximal 
acétylation of the carnitine pool prom otes a shift towards a relatively greater oxidation 
of carbohydrate over fat. Increasing the am ount of ATP resynthesised for a given VO^ ■ 
The enhancem ent of metabolic efficiency though this mechanism might partly explain 
the reduction in substrate level phosphorylation observed following DCA infusion 
(Roberts et aL, 2002). However, it should be considered that the effects of PDC 
activation on muscle VO 2  might be so small, or might occur so early in the transition to 
exercise, that they cannot be accurately m easured (Howlett and Hogan, 2002; Jones et 
aL, 2004). For example, Rossiter et al (2003) make the observation that because 
aerobic ATP production is more efficient than anaerobic ATP production, only a small 
increase in VO^ would be required to com pensate for a relatively large reduction in 
energy provision through nonoxidative pathways. Furthermore, it has been proposed 
that the efficiency of exercise might be improved with DCA because the greater flux of 
acetyl groups promotes increased carbohydrate oxidation over fat oxidation with a 
corresponding reduction in the O2 cost o f exercise (i.e. increased P-to-O ratio); that 
m ight partially m ask any increase in TO, resulting from DCA infusion (Grassi et aL, 
2002; Roberts et aL, 2002). However, the ^^P magnetic resonance spectroscopy study 
of Rossiter et al (2003) indicates that DCA might improve muscle efficiency by 
reducing the rate o f ATP turnover (as estim ated by d[PCr]/dt) for the same work rate. 
The reduction in substrate -leve l phosphorylation with DCA reported previously 
(Howlett et aL, 1999; Timm ons et aL, 1998, Timmons et aL, 1996) might therefore 
reflect the requirem ent for a lower A TP turnover and need not be explained by any 
effect on the VO^ kinetic response. Therefore, the reduction in the O idef originally 
described by Tim m ons et al (1998) could be considered to reflect a reduced amplitude
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of the fundamental response and not a decrease in the TO^ lim e constant. Suggesting 
that the availability o f TCA  intermediates plays no appreciable role in the determ ining 
TO^kinetics (and by inference QmusOj)^
The m echanism  behind the reduction in the ATP requirem ent for the same level of 
m uscular work described by Rossiter et al (2003) is unclear. The authors suggest that a 
reduction in acid stress in the DCA trial due to a reduction in build up of fatigue 
m etabolites Pi, or H2PO4 may affect a shift towards more efficient muscle fibres. 
This in turn would necessitate a lessened requirem ent for continued (and additional) 
fibre recruitm ent throughout the exercise period, leading to an improved ATO^ / AWK 
with DCA infusion. No effect o f DCA was observed on the fundamental delta VO 2 or 
time constant for sub-threshold or supra-threshold exercise in chapters 3 and 4. 
Therefore, no effect o f DCA on the oxygen deficit is supported by these results. As 
discussed previously, the discrepancy between these results may relate to the mode of 
exercise i.e. supine knee extensor versus upright cycling (refer to section 5.3).
6.5 The effect o f DCA on the V O 2 slow com ponent
Casaburi et al (1987) and Poole et al (1990) showed that the reduction in the VO 2 slow 
com ponent with training was associated with the reduction in blood [lactate]. 
Therefore, it was hypothesised that the demonstration of a reduction in acid stress in the 
exercising muscle with DCA adm inistration (Howlett et aL, 1999; Timm ons et aL, 
1996; Tim m ons et aL, 1998; Rossiter et aL, 2003) may lead to a decrease in the VO 2  
slow component. This was evident in the study of Rossiter et al (2003) who reported a 
-28%  reduction in the TO, slow component, accom panied by a 32% decrease in end
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exercise blood [La]. The proposed m echanism  behind this reduction was thought to 
relate to a reduced requirem ent for recruitm ent of low oxidatively efficient muscle 
fibers (presumably type II), due to decrease in concentration o f metabolites predisposing 
the exercising muscle to fatigue (Rossiter et aL, 2003). D irect measures of QO 2 (Poole 
et aL, 1991) & P-NM RS (Rossiter et aL, 2001 ; Rossiter et aL, 2002) have dem onstrated 
that -85-90%  of the VOj slow com ponent originates in the exercising muscle. The 
recruitment of fast tw itch type II muscle fibers during high-intensity exercise has long 
been proposed to be a potential major factor in the em ergence of the VO 2  slow 
com ponent (W hipp, 1994). However, when Rossiter et al (2003) expressed the TO, 
slow component as a % of the fundam ental amplitude the magnitude between CO N and 
DCA not significantly differ. This is in agreem ent with the results from chapter 4 
which clearly showed no difference in the TO^ responses during - 2 0 min of supra- 
threshold exercise. These results and those from Rossiter et al (2003) and Jones et al 
(2000, 2004) may support a theory that the fundam ental gain may play a role in 
m odulating the m agnitude of the TO^ slow component response. However, more 
research is needed in this area before any link can be realistically hypothesised.
6.6 Putative controllers o f the oxygen uptake kinetic response
The question of what m echanism  or, more likely, what mechanisms control the rate of 
oxidative phosphorylation remains. Kindig et al (2002) and Jones et al (2003) have 
dem onstrated that a degree o f control can be exerted through inhibition o f nitric oxide 
synthase through L-NAM E adm inistration. Studies m anipulating O2 delivery to 
working muscles, com m only through the increase or decrease of FIO 2, have also shown 
this to be lim iting when PO 2 falls below normoxic levels (Linnarson, 1974; Lawler,
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1988; Roca, 1992). Sim ilarly, the reported speeding of the supra-threshold VO^ kinetic 
response (although debated see Burnley et aL, 2000) after both hard (Gerbino et al, 
1996) and moderate (Koppo and Bouckaert, 2000) prior exercise may also suggest that 
O2 availability plays a role in determ ining the rate of the VO^ response at higher work 
rates (Grassi et aL, 2000). Furtherm ore, the findings of Howlett and Hogan (2003) 
dem onstrating an increased rate o f fall in PO2 following DCA adm inistration in isolated 
Xenopus frog muscle, do not discount a partial lim itation to O2 uptake due to a lag in 
PDH activation during the early stages of exercise.
The results of Kindig et al (2002) and Jones et al (2003) have dem onstrated that 
controllers of the VOj kinetic response can be borne out through the m odelling of 
breath-by breath data. However, even the most significant o f these effects - -1 9 %  
(Jones et aL, 2003)- does not identify this m echanism  as a principal loci for control. 
Therefore, it is still likely that a greater degree of control may lie in feedback from 
products associated with the turnover of the high energy phosphate pool (Chance and 
W illiam s, 1955; M ahler M, 1985; W hipp and M ahler, 1990; Chance, 1979; Veach, 
1979; Rossiter et aL, 2002; Rossiter et aL, 2003), and/or in the activation of enzym es in 
the TCA cycle or electron transport chain (Blomstrand et aL, 1997; Kindig et aL, 2002; 
Jones et aL, 2003; Brown, 1999).
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6.7 The effect of Dichloroacetate on heart rate during exercise
Throughout this series o f studies D ichloroacetate had a clear and consistent effect on 
heart rate. This effect was m arked at rest and during sub m axim al exercise. However at 
higher exercise intensities the effect was lost until perhaps at m axim um  exertion where 
all but one subject dem onstrated a 1-3 beat increase in heart rate max.
An increase in heart rate in response to DCA  administration was unexpected with many 
studies reporting no change in this measure (Stacpoole et al., 1983; W ilson et al., 1988; 
W argovich éf/u/., 1988; Ludvik e ra /., 1991; Ludvik er a/., 1993; Tim m ons e ra /., 1998). 
Parolin et al (2000) however noted a 17 beat increase in heart rate at rest with DCA 
adm inistration. Furthermore, Koppo et al (2004) reported a 7 bpm elevation in HR in 
the DCA condition com pared with the control condition im m ediately prior to exercise. 
The magnitude of the heart rate increases in both studies is com parable with the results 
reported for the studies in this thesis.
Previous studies have indicated that DCA has a haemodynamic effect in humans at rest 
(Stacpoole et al., 1983; W argovich et al., 1988; Ludvik et al., 1991). Stacpoole et al 
(1983) reported an increase in systolic pressure and cardiac output in patients with 
hypotension and lactic acidosis. W argovich et al (1988) dem onstrated an increased left 
ventricular stroke volume, an improved myocardial efficiency and a decrease in 
system ic vascular resistance in patients with coronary artery disease. Ludvik et al 
(1991), in healthy individuals, found that cardiac index was increased by alm ost 20% at 
rest and that this was accom panied by a similar reduction in peripheral vascular 
resistance. Stacpoole (1989) has also reported evidence indicating DCA as a potent 
vasodilator.
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Two m echanism s may be responsible for an increase in heart rate with DCA 
administration 1) a direct stim ulatory effect o f DCA upon the heart 2) peripheral 
vascular changes.
A direct stim ulatory effect on the heart seems unlikely as an increase in heart rate would 
be expected to have been reported m ore frequently in previous studies and Stacpoole 
(1989) has reported evidence from isolated animal heart preparations that showed 
increases in cardiac function with no change in heart rate.
A reduction in stroke volume as a result o f a drop in peripheral vascular resistance 
would also necessitate a rise in heart rate to maintain cardiac output. As the early 
cardiovascular response to exercise is m ainly due to an increase in stroke volume, a 
response that is lost after about 40%  of TO^ peak, this com pensatory increase in heart 
rate would be expected to be more evident at lower exercise intensities. As described, 
the heart rate responses in these studies would fit this hypothesis.
The reported increases in stroke volum e upon DCA administration are contradictory to 
this theory. How ever a possibility for the disparity between the results of this series of 
studies and those showing no augm ented heart rate response is the body position 
associated with the m easurem ents in these studies. Stacpoole (1983) and W argovich et 
al (1988) used patient populations. W hile the position of these patients during 
m easurem ent was not reported, considering their health it is likely that they were bed 
bound and therefore supine. Similarly, Tim m ons et al (1998) and Rossiter et al (2003) 
utilised a protocol requiring the subjects to assume a prone position. Ludvik et al 
(1991) did not report the subject position for measurement, however it was reported that
221
blood pressure m easurem ents were perform ed in the supine position. W ith the body in 
this orientation stroke volume is already high at rest and this may be enough to negate 
the effect DCA may have on heart rate in the upright posture (these studies and Parolin 
et aL, 2000). In addition, the increases in stroke volume dem onstrated in the study by 
W argovich et al (1988) and inferred in the study of Ludvick et al (1991) may not be 
enough to com pensate for the need to increase heart rate during rest and early stages of 
exercise in an upright orientation.
The reason for the heart rate increase in these studies remains unclear however it may 
have a functional significance by im proving bulk oxygen delivery. W hile this is not 
thought to influence the oxygen uptake response in healthy populations under ‘norm al’ 
conditions (Grassi, 2000), it may have im plications in patient populations or hypoxia 
conditions where an O2 lim itation may be significant. Tim m ons et al (1996, 1997) 
present evidence which suggests that an improved oxygen delivery upon DCA 
adm inistration is unlikely. Using a canine gracilis model they found no difference in 
blood flow and perfusion pressure after DCA administration. Similarly, Grassi et al 
(2 0 0 2 ) using isolated canine gastrocnem ius found no difference in the variables 
pertinent to O2 transport between DCA and placebo trials. Furthermore, Bangsbo et al 
(2 0 0 2 ) found no difference in thigh blood flow for the two conditions during knee 
extensor exercise. On the basis of the responses described in these studies, inferences 
made from isolated muscle preparations may not be applicable to the in vivo 
haemodynamic response. Furtherm ore the knee extensor exercise in the study of 
Bangsbo et al (2002) was performed on subjects in the supine position.
2 2 2
W hile as yet unsubstantiated, it has been suggested here that the haem odynam ic effects 
of DCA may be highly dependant on posture. Therefore while the evidence from 
Tim m ons et al (1996, 1997), Grassi et al (2002) and Bangsbo et al (2002) support the 
notion that DCA has no effect on O2 delivery further studies may be necessary before 
this can be substantiated. Therefore, at present, DCA should perhaps not be assum ed to 
target an improvement in VO^ kinetics simply through an increase in substrate 
availability.
6.8 The Effect o f D ichloroacetate on blood [lactate] during exercise
Dichloroacetate has previously been shown to be effective in reducing blood lactate at 
rest and during exercise (M errill et al., 1980; Parolin et al., 2000; Stacpoole et a i ,  1983; 
Durkot et al., 1995; Schneider et a l ,  1981; Carraro et a l ,  1989; Hatta et a l ,  1991; 
Roberts et a l ,  1997; Rossiter et a l ,  2003).
The results from these studies support the findings of Carraro et al (1989) and Hatta et 
al (1991) who dem onstrated a reduced blood [lactate] during submaximal but not 
maximal exercise. This suggests that DCA is less effective at reducing blood lactate 
closer to peak exercise levels. The reduction in blood [lactate] through increased PDH 
activation is the result o f 2 m echanism s 1) an increased rate of pyruvate catabolism  
increasing pyruvate flux into the m itochondria and subsequently reduction o f blood 
[lactate] 2) a decrease in the rate o f glycolysis. W hile a greater proportion of this lactate 
oxidation takes place in the skeletal muscle (Atomi et a l ,  1987; Ivy et a l ,  1980). DCA 
is effective in activating PDH in most mammalian tissues (Stacpoole, 1989). Therefore 
lactate oxidation in tissues such as heart and liver may also be increased.
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Bangsbo et al (2002) reported PDH activation remained ~ 130% and 100% higher after 
5 s and 15 s of severe (-110%  VO^ peak) exercise but showed no difference 3 min into 
the exercise bout. Sim ilarly, Savasi et al (2002) found PD H activation to be increased 
by DCA 30s into very heavy exercise (90% TOg max) but found no difference 90s into 
exercise. Indeed, How lett et al (1998) demonstrated that PDH transform ation into its 
active form is directly related to increasing power output and Constatin-Teodosiu et al 
(1991) observed com plete PDH activation occurs at a workload of -75%  TO^ max-
The results of these 3 studies support the original concept of Brooks (1985) who 
advocated that blood [lactate] reflected the balance between lactate production and 
removal. The reduction o f blood [lactate] at rest, and during sub-m axim al exercise, 
with DCA administration dem onstrate a capacity for increased lactate removal through 
activation of PDH. How much the decreased blood [lactate] reflects an increased 
oxidative capacity o f exercising or non exercising contractile muscle units, or represents 
a greater contribution from non m uscular lactate oxidation cannot be determined. 
Tim m ons et al (1998) noted that during submaximal knee extensor exercise blood 
lactate was reduced after DCA administration, however, muscle [lactate] in this study 
remained unchanged. Sim ilarly Bangsbo et al (2002) reported decreases in venous 
[lactate] with no change in muscle lactate production. Therefore it is likely that PDH 
activation in inactive and partly active m uscle fibres, in conjunction with other body 
tissues, leads to a greater conversion of lactate to pyruvate and not to a decreased lactate 
production.
The results from the incremental study agree with this, with the point of lactate increase 
(and subsequently 0 l T )  being sim ilar between DCA and placebo conditions, despite a 
-50%  reduction in resting blood [lactate] in the DCA study. This was coupled with no
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observable difference between the rise in muscle deoxyhaem oglobin between the two 
trials. This is further supported by the submaximal blood [lactate] values being lower in 
both the constant work rate studies and during the submaximal portion of the ramp, with 
no observable difference at maximal work intensities. This is consistent with the data 
o f Carraro et al (1989) who found no difference in m aximal blood [lactate] and the data 
from  Rossiter et al (2003) and Hatta et al (1991) who showed blood [lactate] to be 
reduced throughout subm axim al exercise.
Therefore there is evidence for a lactate clearance reserve that can be reduced through 
activation of PDH during subm axim al exercise intensities. This decrease persists until 
perhaps such levels that clearance has reached a maximal level and PDH activation no 
longer effects lactate removal. These results partly support the ‘lactate shuttle’ 
hypothesis of Brooks (1986) advocating that lactate removal plays an important role in 
blood [lactate] both at rest and during exercise. However the results also support the 
theories that suggest while lactate production / removal does play a role in determining 
the absolute blood [lactate] it is not a primary cause of increased lactate production 
(W asserm an and M cllroy, 1964; Katz and Sahlin, 1988; Bonen et al, 1997; Gladden, 
2004).
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6.9 Conclusions
This series of studies have dem onstrated dichioroacetate to have no significant effect on 
subm axim al oxygen uptake kinetics during dynamic exercise in humans. This was 
evidenced as no change in the am plitude or time course of the fundam ental phase II 
response during exercise above or below the lactate threshold ( 0 l T ) ,  and no change in 
the slow com ponent response above the lactate threshold. DCA administration did 
promote a small but significant increase inÿo^nmx » possibly due to an augmented 
cardiac output. Control of oxygen uptake kinetics at the level of pyruvate
dehydrogenase is therefore not supported by these studies. However, a degree of 
influence from PDH activation during the initial phase (10-20s) could not be ruled out 
(Howlett and Hogan, 2003). The differences between these studies and those that have 
report an im provement in muscle efficiency during whole body exercise (Grassi., 2002; 
Ross iter et al.,2003\ Jones et a l,  2003) m ay be explained by the mode and intensity of 
the exercise employed. This has im plication for further studies looking at kinetic 
control and the conclusions that can be made from this area o f study.
Blood [Lactate] was reduced at submaximal exercise intensities. However, no 
significant difference was evident during maximal exercise. This suggests a greater 
clearance of blood lactate due to up regulation of PDH by dichioroacetate and not a 
reduction in lactate production. This would appear to highlight a possible ‘lactate 
clearance reserve’ during exercise.
Exercise time to exhaustion was not significantly different between the two trials during 
supra threshold exercise, indicating that DCA is not associated with a performance 
effect for this subject group and the exercise mode employed. H ow ever the small
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im provem ent in suggests that further investigation into the ergogenic effects of
DCA may be warranted. The reported im provem ents in m uscular perform ance reported 
during conditions of hypoxia or ischaemia, and the possibility o f im provements in bulk 
O2 delivery indicated by this study, suggest that the while DCA appears to have little 
effect under ‘norm al’ energetic conditions, a significant im provem ent in muscular 
perform ance may be realised when ‘norm al’ function is constrained. This may improve 
exercise perform ance in patient groups with limited aerobic capability or athletic/patient 
populations working under hypoxic or anaerobic conditions.
DCA was shown to have haemodynamic properties evident by an observed increase in 
heart rate at rest and during the early stages o f exercise above and below the lactate 
threshold. This may indicate changes in cardiac output during this period. These 
effects of DCA have not previously been described and these results suggest that further 
investigation in this area is needed.
The notion that a lim itation to the rate o f oxidative phosphorylation at the onset of 
exercise exists at the level of pyruvate dehydrogenase is not supported by the results 
from these studies. Therefore the principle rate limiting step for this m echanism  must 
lie at a level beyond this point.
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Effects o f  dichloroacetate on m etabolic param eters during increm ental and constant-load  
exercise in  healthy hum an subjects.
L Describe Üie basic purposes of tlie research proposed.
Background of investigation
Dichloroacetate (DCA) is a potent stimulator of pyruvate dehydrogenase, a mitochondrial enzyme which 
catalyses metabolism of pyruvate and lactate and inhibits glycolysis (for review, see ref 1). Adminstration 
of DCA has been shown to significantly reduce blood lactate levels in healtliy volunteers (2) and in 
patients witli lactic acidosis (3, 4). Additionally, DCA stimulates myocardial contractility and decreases 
peripheral vascular resistance (4) tliereby increasing muscular- oxygen delivery. Systemic limitations to 
intense exercise may result from eitlier insufficient oxygen availability or from the metabolic 
consequences of tliose reactions which provide the alternative energy for tire oxygen which is required but 
not utilised. Given tlrese metabolic and liaemodynamic effects, DCA would be expected to influence 
exercise tolerance by increasing muscle oxygen availability and reducing muscle lactate, and tlierefore, 
hydrogen ion production. This hypothesis will be tested in normal healthy subjects by examining tire 
effects of DCA on tire lactate tlrreshold, maximal oxygen uptake and the metabolic aird acid-base 
response profiles to constant-load exercise below and above tire "lactate tlrreshold" (LT - tire highest work 
rate at which tlrere is no sustained increase in blood lactate) (6).
2. Outline tlie design and metliodology of tire project. Please include in tliis section details of tlie 
proposed sample size.
Methods/Design of investigation
We propose to study eight normal heal dry male subjects aged between 18 aird 35 years (this sample size is 
in line widr dre statistical procedures to be used). All subjects will be in good healdr at dre time of testing 
and take part in at least two aerobic exercise sessions per week. Subject elligibility will be assessed by 
subjects completing a medical and a physical activity questionnaire. Subjects will also be required to read 
aird sign die enclosed information sheet.
Testing will take place in die Exercise Physiology laboratory in die West Medical Building. All subjects 
will perform drree incremental and drree constant-load cycle ergometer tests, which will be carried out in 
dre late afternoon on six separate occasions. The first maximal incremental and constant-load cycle 
ergometer tests are aimed at familiarising subjects widr the exercise protocol and experimental 
procedures. One hour prior to dre second and drird maximal incremental and constant-load exercise tests 
(see protocols below), subjects will consume eidrer a 50mg kg ' body weight acute dose of DCA or an 
equivalent amount of placebo. Test solutions will be administered to die subjects in die laboratory in a 
double blind fashion. The DCA oral foimulation to be used will be prepaied by phaimacy at dre Western 
Infinnaiy. Subjects will consume dreir normal diet drroughout the study period and will be required to 
refrain from all strenuous exercise in dre 24 Ir period prior to each test.
Protocols
M a x i m a l  i n c r e m e n t a  e x e r c i s e  t e s t :  On drree occasions, subjects will perfoim a maximal incremental
exercise test, as follows. A direct measurement of maximal oxygen uptake (Vq2 tttax) and die lactate
drreshold will be determined on a computer controlled cycle ergometer (Lode). This test will involve a
step-wise increase in workiate (e.g. 15-20 watts min ') until volitional exhaustion. The results from this 
test will allow die lactate threshold to be esthnated using gas exchange criteria. Subjects will be given a 
familiarisation trial and a warm-up before die test and a wann-down after die test.
S u b m a x i m a l  t e s t s  -  c o n s t a n t  l o a d :  On drree separate occasion, subjects will perform two consecutive 
bouts of constant-load exercise at a moderate exercise intensity (below the lactate threshold) for 10 
minutes, followed by one bout of constant-load exercise at a high exercise intensity (above die lactate 
threshold) designed to induce fatigue widiin about 10 minutes. Ten minute periods of unloading cycling 
will be carried out between dre drree exercise bouts. The results from dris test will allow die gas exchange 
kinetics, metabolic and perceptual responses of dre two exercise domains to be determined (see 
measurements below). Subjects will be given a familiarisation trial and a warm-up before dre test and a 
warm-down after die test.
Measurements
C a r d i o v a s c u l a r  M e a s u r e m e n t s :  Hear t rate will be monitored by electrocardiography.
R e s p i r e d  A i r  M e a s u r e m n t s :  Respired air will be measured continuously for volume (turbine) and oxygen 
(Oj) and carbon dioxide (CO,) and nitrogen (N,) concentration using a mass spectrometer for on-line
breadi-by breath determination of O, uptake (V^  ^) CO, output (V  CO,) and ventialtion (V  J  and
alveolar PO, and CO, partial pressure (PO,, CO,) (QP9000, Morgan Medical).
B r e a t h l e s s n e s s  a n d  R a t i n g  o f  P e r c e i v e d  E x e r t i o n :  Breadilessness and Rating of Perceived Exertion will 
be monitored at regular' intervals diroughout the tests, using eidier a standard Borg or visual analogue 
scale.
A r t e r i a l  o x y g e n a t i o n  m e a s u r e m e n t s :  Arterial blood oxygen saturation will be rnonitiored continuously, 
noriinvasively from a finger or an ear lobe by pulse oximetry.
M u s c l e  O x y g e n a t i o n :  Intravascular oxygen saturation will be monitored continuously and noninvasively 
from the surface of the right or left quadriceps muscle using near- infra-red spectroscopy (Hamamatsu).
B l o o d  A n a l y s i s :  Arterialised-venous blood samples will be drawn at rest and at 5 min intervals during 
exercise from a 20 G indwelling catheter placed by percutaneous puncture into a vein on tlie dorsum of 
tlie heated hand (this yields blood witli a composition indistinguishable from arterial, but witliout tlie 
associated degree of invasion and tlierefore subject discomfort) (7, 8). Blood samples (5 ml or 1 teaspoon 
each) will be analysed for blood gas and acid-base variables, blood lactate and pyruvate (9),
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3. Describe Üie research procedures as Uiey affect tlie research subject and any other par ties involved.
All tests will take place in tlie Exercise Physiology Laboratory, West Medical Building. Dr Yannis 
Pitsilaids and/or Professor Sue Ward will be present at all tests. Botli are certified phlebotomists and 
tiained in CPR. Before all exercise tests, a medically qualified person will be informed of tlie time of tlie 
test and asked if he/she is available. Exercise tests specific to tliis study will only be conducted if a 
medically qualified person can be contacted and is able to be present witliiii a short time period. A 
defibrillator and emergency drugs are on site in tlie laboratory.
Some subjects may experience mild discomfort during the placement of and/or sampling of blood from a 
catlieter placed in a vein on the dorsum of tlie heated hand. In our experience, tliis is minimal because: 
the catlieter size is small (20 G); it is only placed when the hand has been heated to 44° C for at least 10 
min, allowing a substantial local vasodilatation of the superficial blood vessels, which facilitates their 
cannulation; tlie catheter is indwelling, allowing for multiple sampling; while it is safely secured in place 
with adhesive tape, tliere is sufficient ‘play’ to allow sampling witliout ‘pulling’ on tlie vessel (i.e. the 
catlieter can slide easily within tlie vessel); upon withdrawal of the catlieter at the end of tlie experiment, 
firm pressure is maintained over tlie site for at least 15 min to prevent any leakage from the vessel into 
tlie suiTounding interstitium which could lead to local oedema and bruising. Importantly, if a vessel 
cannot be readily caiinulated or if tlie subject is nonetlieless not comfortable witli proceeding, the 
experiment is halted. No more tlian 100 ml or 20 teaspoons of blood will be sampled for each test.
Some subjects may experience a mild tianquilizing or sedative effect following tlie administration of 
DCA. In most cases, tlie effect is short lived and is too slight to be measured by objective tests that are 
sufficiently sensitive to detect early stages in cognitive dysfunction induced by sedative hypnotics or 
tricyclic antidepressants (1). In occasional subjects who metabolise tlie drug slowly, drowsiness may 
persist for several hours (1). Subjects will not be peimitted to leave the laboratory until fully recovered.
Potential paiticipants will be identified eitlier by personal contact or by advertisement. They will be asked 
to meet witli tlie investigators to discuss the project and whetiier tliey would be suitable as a subject. All 
subjects will be healtliy individuals witliout a history of any significant medical problem(s). All subjects 
will be moderately-trained and tlierefore accustomed to strenuous exercise. The good healtli of each 
subject will be established prior to tlie study by taking the subject's medical history, which is supported 
by a written assurance from the subject. Subjects witli a history of cardiorespiratory or neurological 
disease will be excluded from paiticipation, as will tliose having an acute upper respiratory uact 
infection. Subjects who take drugs (recreational or perfonnance enhancing drugs) or who have consmned 
alcohol witliin 48 h of an experiment will be excluded.
Close supervision of tlie subject is ensured at all times by tlie supervising investigator. The well-being of 
tlie subject is established at frequent intervals throughout all tests by asking tlie subject "Is everything 
alright?". Subjects are instructed, prior to the test, to respond to tliis question witli a thumbs-up sign if 
everytliing is fine, and a tliumbs-down sign if tliere is problem. If a problem is indicated, tlie investigator 
will ask furtlier questions to establish whether tliere is a technical problem tliat could lead to potential 
hazard or whether the subject is feeling unwell. In eitlier case, the test is immediately halted.
All subjects are routinely instiucted to cease exercising if tliey experience any discomfort or have any 
concern for their well-being.
The risks associated with performing maximal exercise are minimal as long as the subject is appropriately 
instructed and familiarised witli tlie device prior to participation and also is appropriately supervised 
during tlie experiment. All exercise bouts aie botli preceded by a 5 min "warm-up" and by a 5 min 
"warm-down". The latter is of particular importance during high-intensity exercise, when the local 
accumulation of exercise metabolites can cause an "expansion" (or vasodilatation) of the blood vessels in 
tlie lower limbs, which can impair the adequate return of blood to the hear t - predisposing to fainting on 
dismounting from the ergometer. This risk is minimised by having tlie subject exercise at a mild level 
during recovery to "wash away" these metabolites and tlierefore to restore tlie capacity of the involved 
blood vessels to their resting levels.
Some subjects experience difficulty swallowing while breatliiiig tlirough a moutlipiece and wearing a 
noseclip, due to some transient build-up of pressure in tlie ears.
Some subjects experience increased salivation when breatliing tlirough a mouthpiece.
Some subjects experience mild discomfort from prolonged sitting on the seat of tlie cycle ergometer.
4. What in your opinion are tiie etliical considerations involved in tliis proposal? (You may wish for 
example to coimnent on issues to do witli consent, confidentiality, risk to subjects, etc.)
Administration of DCA in human subjects has been limited to short term studies in healtliy volunteers, 
adults witli type II diabetes, and children and adults witli various forms of lactic acidosis (for review, see 
ref 1). Aside from typically mild drowsiness in about one half the adult recipients, no otlier drug related 
adverse effects are reported. There have been claims tliat unpurified preparations of DCA may be 
mutagenic (11-14). However, studies using DCA of established purity failed to show any mutagenicity 
(15). There was one case of peripheral neuropatliy in a young adult man witli homozygous familial
hypercholesterolemia who received single daily doses of 50 mg kg ' body weight DCA for up to four 
montJis (16). Toxicity was manifested by loss of deep tendon reflexes, mild weakness of facial and 
interosseous muscles, and diminished tibia! nerve conduction velocity. This neuropatliy was resolved 
several weeks after cessation of tlierapy, suggesting tliat functional rather tliaii morphologic changes were 
responsible for the toxicity. Furtlieremore, two infants witli severe neuropatliy and congenital forms of 
lactic acidosis were treated for approximately 1 year with similai' doses of DCA witli no adverse effects
(17, 18). In summary, acute doses of 50 mg kg ' body weight DCA administered orally or intravenously is 
safe and represents a valuable tool for exploring tlie metabolic patliways botli in health and disease.
Exercise has negligible risk in healtliy adults, altliough maximal exercise has a small risk of inducing 
myocardial ischaemia.
The insertion of a catlieter into a vein may rarely cause irritation at tlie site of insertion, venospasm (or 
constriction of the cannulated vein which may lead to interference with blood flow tlirough it) and 
phlebitis. These risks are minimized in tliis investigation by the short duration of the test and by tlie 
procedures described above.
Blood will be handled, stored and disposed of according to standard health and safety procedures.
5. Outline tlie reasons which lead you to be satisfied tliat die possible benefits to be gained from die project justify 
any risks or discomforts involved.
The research undertaken will allow gas exchange kinetics, metabolic and perceptual responses to maximal 
incremental and constant-load exercise following DCA administration to be determined and compard to normal 
responses. It is envisaged diat diis research will benefit the identification of die physiological mechanisms which 
limit exercise tolerance (i.e. die ability of individuals to perfonn exercise) in healdi and disease. The minimal risk 
and discomfort associated widi die above procedures are considered to be wordiwhile to gain die information 
required.
6. Who are die investigators (including assistants) who will conduct die research and what are dieir qualifications 
and experience?
Professor Susan Ward BSc BA D Phil, Dr Yannis Pitsiladis PhD MMedSci BA, Mi- John Wilson and Mrs Heatlier 
Collin (Senior Technicians). The principal investigators have wide ranging experience of exercise testing over 
periods of up to 25 years without incident.
7. Are anangements for the provision of clinical facilities to handle emergencies necessary? If so, briefly 
describe the arrangements made.
A clinician will be alerted before all experiments and can be in attendance widiin a short space of time. The 
Exercise Physiology laboratory has a set of instructions fixed to die wall next to the telephone, so that die caller 
can identify him/herself and die location of the laboratory.
In die event of an untoward incident diat is not an emergency, die supervising Principal Invesdgator will 
administer appropriate first aid, if necessary. The subject will not be permitted to leave die laboratory until he has 
fully recovered. The subject will be encouraged to contact his local GP. The subject will be told diat one of die 
Principal Investigators will conduct a follow-up by telephone at die end of the same day. The subject will also be 
provided widi 24-hour contact numbers for bodi Principal Investigators.
In cases where subjects are identified from infonnation held by another party (for example, a doctor or 
hospital) describe die arrangements whereby you gain access to diis information.
N/A
9. Specify whedier subjects will include students or odiers in a dependent relationship.
Some students may be recruited but will be under no pressure from staff to participate in die study.
10. specify whetiier tlie research will include children or tliose witli mental illness, disability or handicap. If so, 
please explain tlie necessity of using tliese subjects.
N/A
11. Will payment be made to any reseaich subject? If so, please state tlie level of payment to be made, and tlie 
source of tlie funds to be used to make tlie payment.
NO
12. Describe the procedures to be used in obtaining a valid consent from the subject. Please supply a copy of the 
information sheet provided to tlie individual subject.
Each subject will recieve an information sheet outlining tlie tests to be performed (see enclosed copy), A verbal 
explanation will also be given and any queries answered.
13. Comment on any cultural, social or gender-based characteristics of the subject which have affected the design 
of tlie project or which may affect its conduct.
None
14. Give details of tlie measures which will be adopted to maintain tlie confidentiality of tlie reseaich subject.
The information obtained will be aiionymised and individual information will not be passed on to anyone outside 
the study group. The results of the tests will not be used for selection purposes.
18. Please state location(s) where tlie project will be cairied out. 
Exercise Physiology laboratory, West Medical Building
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INFORMATION SHEET
TITLE OF INVESTIGATION: Effects o f dichloroacetate on metabolic parameters during 
incremental and constant-load exercise in healthy human subjects.
W e invite you to participate in an investigation which we beheve to be o f potential importance. In 
order to help you to understand what the investigation is about, we are providing you with the 
following information. Be sure you understand it before you formally agree to participate. A sk 
any questions you have about the information which follows. We will do our best to explain and 
to provide any further information you require. You have been selected as a possible participant 
in this investigation because you are in good health.
The mechanisms that determine the abUity to sustain moderate to severe exercise are poorly 
understood. Such information, however, is crucial if we are to improve exercise tolerance (i.e. the 
ability o f individuals to perform exercise) in both health (e.g. the performance o f the elite athlete) 
and disease (e.g. patients with compromised energy metabolism). This study aims to com pare a 
range o f responses to different intensities and duration of exercise following the administration o f 
a drug know n to influence the chemical reactions involved in energy production.
Testing w ill take place in the Exercise Physiology laboratory. W est M edical Building at 
G lasgow University. You will be asked to visit the laboratory on six occasions and to take part 
in the following tests:
Progressive Exercise Test: You will be asked to perform a maximal progressive exercise test on 
a stationary com puter controlled cycle so that we can assess your level of fitness (i.e. m aximal 
oxygen uptake and the lactate threshold). During this test, the pedaling load increases over the 
course o f 15-25 m inutes until you have to stop cycling either because of fatigue or 
breathlessness. You will repeat this test on two further occasions. One hour prior to 
com m encem ent o f these two subsequent tests you will be required to consum e 100 ml o f a drink 
containing either 50m g/kg o f your body weight of a drug called D ichloroacetate (DCA) or an 
equivalent am ount o f an inert placebo.
Submaxiinal test - constant load test: On three separate days, you will cycle at moderate and 
high exercise intensities (below and above the lactate threshold) for periods ranging between 5 - 
10 m inutes, w ith 10 m inutes of unloaded cycling between the execise bouts. The total test 
duration w ill be no m ore than one hour. The first constant-load test aims to fam iliarise you with 
the exercise protocol and experim ental procedures. One hour prior to the next two constant-load 
exercise tests you will again be required to consume 100 ml of the drink containing the drug or 
an equivalent am ount o f the placebo.
D CA  is a drug which effects the energy production pathways and reduces the amount o f lactic 
acid produced (lactic acid is a breakdown product o f anaerobic metabolism). This drug is used in 
the treatm ent o f lactic acidosis. DCA may cause you to become a little drowsy, however these 
effects are normally mild and do not persist for very long.
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During each exercise test and at regular intervals, we would like to take a small amount o f b lood 
from  an intravenous line in the back o f your hand. Intravenous lines may cause some bruising and 
subsequent soreness over the site of puncture and, rarely, a smaU wound which takes a few days 
to heal.
Arterial blood oxygen saturation wiU be monitored continuously noninvasively from a linger o r an 
ear lobe by pulse oximetry. Intravascular oxygen saturation wÜl be m onitored continuously and 
noninvasively from the surface o f the right or left quadriceps muscle using near infra-red 
spectroscopy (Hamamatsu).
Breathlessness and Rating o f Perceived Exertion will be monitored at intervals throughout tests, 
using either a standard Borg (i.e. numbers with word anchors to help you rate a variable) o r  a 
visual analogue scale (VAS) (the VAS scale consists of a horizontal hue. The word "none" is 
placed at one end o f the scale and the word "very severe" at the other). You wiU be asked provide 
a response which relates to your level of Breathlessness and Rating o f Perceived Exertion usmg 
these scales.
During the exercise tests, you may breathe through a rubber mouthpiece which is similar to that 
used for snorkeling, and wear a noseclip. You may experience difficulty swallowing while 
breathing through a mouthpiece and wearing a noseclip, due to some pressure in the ears. Som e 
subjects experience increased salivation when breathing through a mouthpiece. Some subjects 
experience müd discomfort from prolonged sitting on the seat o f the cycle ergom eter.
Exercise has a negligible risk in healthy adults, although maximal exercise has a small risk o f 
inducing myocardial ischaemia. The primary symptom of myocardial ischaemia is chest pain on 
exertion. If you experience any unusual sensations in your chest during the experiment, you 
should cease exercising immediately. Y our heart rate wdl be m onitored via adhesive surface 
electrodes for the monitormg of the heart's electrical activity (the "electrocardiogram").
Before you become a subject, you wiU complete a medical questionnaiie. People who have 
asthma, heart related and/or circulatory problems, hypertension or any other contraindicated 
condition wUl not be aUowed to take part in the study.
AU information obtained both from the preliminary medical questionnaire and from the study itself 
wUl be treated confidentiaUy. It is our intention to pubUsh the results o f this study, but not in a 
way which wUl not enable individuals or theii’ performance to be identified.
Y ou are free to leave the study at any time. The outcome of the study may not benefit you 
dii’ectly. Som e parts o f the study constitute a possible transient risk to your health. There is a 
smaU cardiac risk to your health. You may feel uncomfortable during certain stages o f the tests.
If you are worried about any unwanted side effects from any of the above procedures, you should 
contact;
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Dr Yannis Pitsiladis
Lecturer, Institute of Biomedical and Life 
Sciences
W est M edical Building
U niversity of Glasgow
Glasgow, G12 8QQ
Phone: 0141 330 3858
Fax: 0141 330 6542
e-mail: Y .Pitsiladis@ bio.gla.ac.uk
Professor Susan A W ard, Director 
Director, Institute of Biomedical and L ife  
Sciences
W est Medical Building 
University of Glasgow,
Glasgow G 12 8QQ 
Phone: 0141 330 6287 
Fax: 0141 330 6345
e-mail: S.A .W ard@ bio.gia.ac.uk
Consent Form
give my consent to the research procedures which are outlined above, the aim, procedures 
and possible consequences o f which have been outlined to me
Signature
Date
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Appendix 2
CENTRE FOR EXERCISE SCIENCE AND MEDICINE
MEDICAL HISTORY
(CONFIDENTIAL)
Please read.
It is im portant to take a record of your medical history. You may 
have, or may have once had a condition that would m ake this type of 
testing unsuitable for you. For this reason we ask you to be as 
truthful and detailed as possible. At no point will this inform ation be 
made available to any one other than the principal investigators for 
this study. If  you have any doubts or questions, please ask.
SUBJECT DETAILS:
NAME;
AGE: D.O.B:
SEX (M/F):
GP NAM E & ADDRESS:
SM OIONG:
Never Sm oked ........
Not for >6 m onths ........
Smoke <10 per d a y ........
Smoke >10 per d a y ........
ILLNESSES:
ALLERGIES:
HOSPITALISATIONS:
M USCULO-SKELETAL DISORDER:
(Artlnitis, Joint Pain, Fractures, Sports injury, Others)
CARDIOVASCULAR DISORDER: (Fever, Heart M urmurs, Chest Pain, Palpitations, High Blood 
Pressure, Others)
RESPIRATORY DISORDER: (Asthma, Shortness o f  Breath (SOB), Cough, Upper Respiratory Tract 
Infection (URTI), Others)
GASTROINTESTINAL DISORJDER: (Jaundice, Bleeding, Others)
DIABETES:
CNS DISORDER: (Fits, B lackouts, Tremor, Paralysis, Epilepsy, Other)
PSYCHIATRIC TREATM ENT:
FAM ILY HISTORY: (Sudden death in a first degree relative under the age o f  35 years)
II
ARE YOU CURRENTLY TAKING ANY M EDICATION? No / Yes' 
("''Please specify)_______________________________________________________
ARE YOU CURRENTLY TAKING ANY SUBSTANCES TO HELP IM PROVE YOUR TRAINING  
OR CONTROL YOUR W EIGHT i.e. CREATINE. PROTEIN SUPPLEM ENT? No / Yes*
(*Please specify)
ARE YOU CURRENTLY TAKING ANY OTHER SUPPLEM ENTS i.e. FOOD SUPPLEM ENTS, 
VITAMINS? No / Yes*
(*Please specify )_______________________________________________________________________________ _
CAN YOU THINK OF ANY OTHER REASON W HY YOU SHOULD N O T TAKE PART IN A N Y  OF 
OUR TESTS?
SYMPTOMS:
Do you experience any of the following, particularly on exercise?
Breathlessness No / Yes
Chest Pain N o / Y e s
Dizzy Fits/Fainting No / Yes
Palpitations N o / Y e s
Please note that if  you feel unwell on the day of the proposed test, or have been feeling poorly over 
the preceding day or two, please inform  the investigators and DO  NO T TAKE PART in the 
exercise test.
DECLARATION:
I have completed this questionnaire fully and truthfully. I have not kept any information from the 
investigators that may put m yself at risk during high-intensity exercise, or affect the results that they 
obtain. I understand that I m ay w ithdraw  from  any one test or the study as a whole if  I feel unwell, or feel 
uncomfortable with any part o f the testing procedure.
(Signature)......................................
(D a te ) ..................
i i i
PHYSICAL EXAM:
WEIGHT;
PULSE (Resting):
HEIGHT:
BP (Resting):
Screened by; 
(Signature) . (Date)
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